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 L-type calcium channels (LTCCs) are critical conduits for Ca2+ entry into many excitable 
cells. In ventricular myocytes, they are responsible for shaping the action potential and triggering 
Ca2+ release from the sarcoplasmic reticulum leading to myocyte contraction. In the brain, these 
channels are vital for excitation-transcription coupling, synaptic plasticity, and neuronal firing. 
To perform their functions properly LTCCs employed two principal forms of feedback 
regulation which include voltage-dependent inactivation (VDI) and Ca2+-dependent inactivation 
(CDI). Disruptions in either of these two processes were linked to multiple disorders. For 
example, mutations in a Ca2+ sensor calmodulin (CaM), a known mediator of CDI, have been 
associated with long-QT syndrome (LQTS). Patients afflicted with these mutations 
(calmodulinopathies) suffer from life-threatening arrhythmias, refractory to conventional 
treatments. First, we dissected the mechanistic underpinnings of the LQTS form of 
calmodulinopathies. We found that disruption of CDI of CaV1.2 was a major culprit behind this 
disease. Leveraging off this knowledge, we created a customizable therapy for patients suffering 
from this group of diseases. Moreover, we investigated mechanisms underlying an autism-
associated mutation A760G in CaV1.3 channels. Interestingly, this mutation disrupts both VDI 
and CDI of CaV1.3 which enables us to explore the intimate interplay between VDI and CDI. 
The knowledge gained from studying these two diseases extend beyond facilitation of therapy 
development and prove to be valuable in further our understanding in LTCC regulation under a 
physiologic state. 
 Next, we utilized an in silico approach to complement our in vitro disease-based models 
of LTCC regulations. Although it is well known that each lobe of CaM is capable of responding 
spatially distinct Ca2+ sources, most CDI models fail to capture this unique property of CaM. 
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Therefore, we developed the first kinetic model of CDI which truly captured the bi-lobal nature 
of CaM. From this model, we were able to gain deeper insight into the extent of interaction 
between the two lobes of CaM and explained the pathophysiology behind the LTQS form of 
calmodulinopathies. Once incorporated into a whole-cell or tissue level model, this novel CDI 
model could be an invaluable asset in understanding of both physiological and pathological 
states of the overall cardiac and neuronal electrical activities. 
 Lastly, we developed an animal model as a new tool to investigate regulations of cardiac 
LTCCs in situ. Understanding of these channels’ modulation with high fidelity relies on 
examining LTCCs in their native environment with intact interacting proteins. Thus, such studies 
would benefit from genetic manipulation of endogenous LTCCs and their binding partners which 
often proves cumbersome in mammalian models. We have identified Drosophila as an 
alternative model to study LTCC regulation. Not only is Drosophila genetically pliable, but it 
also possesses conserved Ca2+ channels in its cardiomyocytes. Thus, this model may serve as a 
robust and effective platform for studying in situ LTCC regulation. 
 In all, we utilized multiple approaches to dissect the mechanistic underpinnings of VDI 
and CDI modulation of LTCCs. We wish that this knowledge could help propel further scientific 
understanding of these channels’ regulations and brought hope to those suffering from 
dysregulations of these processes.  
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Introduction and background 
L-type voltage-gated Ca2+ channels (LTCCs) are critical conduits for Ca2+ entry into 
many excitable cells, including skeletal muscle, cardiomyocytes, neurons, and endocrine cells. 
There are four major types of LTCCs which include CaV1.1 (skeletal muscle), CaV1.2 
(ventricular cardiomyocytes, neurons, pancreatic β-cells, and adrenal chromaffin cells), CaV1.3 
(atrial cardiomyocytes, neurons, auditory and vestibular hair Cells, and adrenal chromaffin cells), 
and CaV1.4 (retinal cells) (Zamponi et al., 2015), each with unique biophysical properties 
precisely tuned to their functions. Here, we focus on detailed mechanisms underlying regulations 
of CaV1.2 and CaV1.3, the major types of LTCCs in cardiomyocytes and neurons, in both 
physiologic and pathologic states. 
CaV1.2 and Cav1.3 channels employ two major forms of feedback regulation, voltage-
dependent inactivation (VDI) and Ca2+-dependent inactivation (CDI). The mediator of CDI in 
these channels is the ubiquitously expressed Ca2+ sensor calmodulin (CaM), a 17 kDa protein 
comprised of N- and C-terminal lobes linked by a flexible helix. Each lobe of CaM contains two 
EF hands, canonical Ca2+ binding motifs, with the N-lobe having slightly lower Ca2+ binding 
affinity. Ca2+ binding to these EF hands induces a conformational change that alters function of 
target molecules to which CaM is bound, thus transducing changes of intracellular Ca2+ 
concentration (Mori et al., 2004) into modulation of molecular function. At a resting level of 
Ca2+, Ca2+-free CaM (apoCaM) preassociates with the carboxy-tail of the channel (Erickson et 
al., 2001; Pitt et al., 2001; Mori et al., 2004). This apoCaM bound channel possesses a high 
open-probability (PO), known as mode 1 gating (Imredy and Yue, 1994). Upon Ca2+ binding, 
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Ca2+/CaM departs from its preassociation site, resulting in a reduction of the channel PO (mode 
Ca gating). Ca2+/CaM then tether to the channel via the Ca2+/CaM effector sites within the amino 
and carboxy termini of the channel (Ben Johny et al., 2013). Moreover, CaM has the remarkable 
ability to respond differentially to Ca2+ originating from distinct spatial sources. This feature is 
enabled by the bi-lobal design of CaM, where each lobe is capable of binding Ca2+ with different 
affinities (Dick et al., 2008; Tadross et al., 2008). Specifically, the C-lobe of CaM senses the 
fluctuation of local Ca2+ concentration at the mouth of the channel, while the N-lobe detects the 
global cytosolic Ca2+ level, arising from the cumulative effect of multiple Ca2+ sources (Dick et 
al., 2008; Tadross et al., 2008). 
Besides orchestrating CDI, CaM also controls signaling cascades via Ca2+-dependent 
adjustment of numerous proteins. So important are the functions of CaM that it has long been 
thought that naturally occurring mutations within this molecule would prove lethal, and that such 
mutations would thereby play little role in disease processes afflicting living individuals. Yet, a 
role for CaM in a number of diseases has begun to emerge. Alterations in the overall level of 
CaM have been implicated in heart failure (Ikeda et al., 2009), schizophrenia (Chambers et al., 
2005), and Parkinson disease (Lee et al., 2002; Chan et al., 2007; Bazzazi et al., 2013). Very 
recently, human genetic studies uncovered de novo and heritable CaM mutations 
(calmoduilnopathies) that are associated with life-threatening cardiac arrhythmias. This new 
group of diseases includes catecholaminergic polymorphic ventricular tachycardia (CPVT) 
(Nyegaard et al., 2012; Makita et al., 2014), severe long-QT syndrome (LQTS) (Crotti et al., 2013; 
Makita et al., 2014; Reed et al., 2014; Boczek et al., 2016), and idiopathic ventricular fibrillation 
(IVF) (Marsman et al., 2013). The symptoms of these patients are often resistant to conventional 
therapy, suggesting alternate underlying disease mechanisms which require novel therapeutic 
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strategies. In Chapter 2, we dissected the mechanistic underpinnings of the LQTS form of 
calmodulinopathies. We found that a major underlying mechanism concerned the attenuation of 
CaV1.2 CDI and that apoCaM preassociation with the channel amplifies the phenotypes of a 
limited fraction of CaM mutants in the cells. Equipped with this knowledge, we devised 
customizable therapies for this group of patients (Chapter 3). 
In Chapter 4, we utilized an in silico approach to gain further understanding of CaV1.2 
CDI. To date, several methods have been deployed to model the CDI of cardiac CaV1.2 channels. 
However, they do not take into account the true allosteric and bi-lobal nature of CaM, thus 
limiting their utility in describing CaV1.2 gating in response to variable spatial Ca2+ signals. One 
critical barrier to achieving a detailed kinetic model of CDI has been the difficulty in uncoupling 
channel gating from the Ca2+ initiating CDI. To overcome this obstacle, we use Ca2+-
photouncaging to deliver a measurable Ca2+ input to CaM/CaV1.2. These high-resolution 
measurements enable us to build the first full-scale bi-lobal kinetic model of CDI which can 
accurately recapitulate the kinetics and steady-state properties of CDI in both physiologic and 
pathologic states. Thus, this model offers powerful new insight into the mechanistic alterations 
underlying system-level (patho)physiology. 
We also examined dysregulation of CaV1.3, another major type of LTCCs, in Chapter 5. 
Although CaV1.2 and CaV1.3 possess unique biophysical properties finely tuned to each of their 
biological functions, they shared multiple mechanisms of channel regulation, including VDI and 
CDI. Here, we focus on the de novo missense mutation A760G which has been linked to autism 
spectrum disorder (ASD) (O'Roak et al., 2012). To explore the role of this mutation in ASD 
pathogenesis, we examined the effects of A760G on CaV1.3 channel gating and regulation. Using 
an allosteric model of channel gating, we found that the underlying mechanism of CDI reduction 
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is likely due to enhanced channel opening within the Ca2+-inactivated mode. Remarkably, the 
A760G mutation also caused an opposite increase in VDI, resulting in a multifaceted mechanism 
underlying ASD. When combined, these regulatory deficits appear to increase the intracellular 
Ca2+ concentration, thus potentially disrupting neuronal development and synapse formation, 
ultimately leading to ASD. 
Besides investigating LTCC regulation in mammalian systems, we also developed an 
animal model that allows investigating LTCCs in their native environment with intact interacting 
proteins (Chapter 6). Drosophila offers a potentially efficient alternative to mammalian models 
as it possesses a relatively simple heart, is genetically pliable, and expresses well-conserved 
genes. Through genetic and functional characterizations, we found that Drosophila heart 
possessed a conserved compendium of Ca2+ channels (LTCCs and T-type Ca2+ channels). 
Moreover Drosophila LTCCs maintained major regulations observed in mammalian cardiac 
LTCCs, such as VDI, CDI, and current augmentation via adrenergic stimulation. Thus, the 
Drosophila heart may serve as a robust and effective platform for studying LTCC modulations in 
situ. 
In all, this work utilized multiple approaches to dissect the mechanistic underpinnings of 
LTCC regulation, including in vitro investigation of LTCC current in both physiologic and 
pathologic states, construction of an in silico model of CaV1.2 CDI, and development of a 
genetically pliable animal model to study modulation of CaV1.2 in situ. The knowledge gained 
from this study could offer invaluable insight into mechanisms underlying LTCC regulation in 




Mechanistic dissection of calmodolinopathies 
2.1 Introduction 
CaM is a ubiquitous Ca2+-sensor molecule that modulates a vast array of proteins, thereby 
controlling signaling cascades via Ca2+-dependent adjustment of relevant proteins. As such, CaM 
critically orchestrates numerous functions, including cellular excitability, muscle contraction, 
memory, and immunological responses (Hoeflich and Ikura, 2002; Pitt, 2007). So important are 
the functions of CaM that it has long been thought that naturally occurring mutations within this 
molecule would prove lethal, and that such mutations would thereby play little role in disease 
processes afflicting living individuals. Yet, a role for CaM in numerous diseases has begun to 
emerge. Perturbations in the overall level of CaM have been implicated in heart failure (Ikeda et 
al., 2009), schizophrenia (Chambers et al., 2005), and Parkinson’s disease (Lee et al., 2002; Chan 
et al., 2007; Bazzazi et al., 2013). Outright CaM mutations in Drosophila have been associated 
with muscle malfunction (Wang et al., 2003). Very recently, human genetic studies uncovered de 
novo and heritable CaM mutations associated with CPVT (N54I and N98S) (Nyegaard et al., 
2012) and LQTS (D96V, D130G, and F142L) (Crotti et al., 2013). Each of the LQTS mutations 
resides at or near Ca2+ coordinating residues within the EF hands of the C-lobe of CaM, and have 
been shown to decrease affinity for Ca2+ binding (Crotti et al., 2013). By contrast, the reported 
CPVT mutations in CaM imparted little-to-mild reduction of Ca2+ binding affinity (Nyegaard et 
al., 2012). It is perhaps interesting to speculate that the contrasting effects on Ca2+ binding may 
underlie the elaboration of distinguishable LQTS and CPVT phenotypes by these two classes of 
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mutations. At present, however, the mechanisms linking these mutations in CaM to their 
corresponding disease phenotypes are essentially unknown. 
 That being said, progress towards elucidating these mechanisms will ultimately prove 
invaluable in devising personalized therapeutics for afflicted individuals and in gleaning general 
lessons about LQTS pathogenesis from these single-point-mutation case examples. Among the 
most prominent mechanistic unknowns are the following. First, do the LQTS CaM mutations 
actually cause the emergence of LQTS substrates in heart? Currently, no experimental evidence 
directly establishes such causality. Second, what are the predominant molecular targets through 
which CaM mutations exert their actions in heart? Likely cardiomyocyte targets abound, 
including ryanodine receptors (RyR2), voltage-gated Na channels (NaV1.5), slowly activating 
delayed-rectifier K channels (IKs), and LTCCs (Mori et al., 2004; Saucerman and Bers, 2012; 
Crotti et al., 2013) (CaV1.2). All of these contribute to shaping action-potential morphology and 
thereby represent plausible candidates. Third, the severity of the LQTS fits in a seemingly 
incongruous fashion with the redundancy of human CaM genes (CALM1, CALM2, and CALM3), 
each of which encodes for an identical CaM molecule at the protein level. Given the 
heterozygosity of these LQTS patients (Crotti et al., 2013), this redundancy implies that only one 
of six alleles of CaM would possess a mutation, yielding only a portion of mutant versus wild-
type CaM.  
 Here, therefore, we acutely introduce LQTS CaM mutants into adult guinea-pig 
ventricular myocytes (aGPVMs) and demonstrate marked prolongation of action potentials, 
along with intense disturbance of Ca2+ cycling. As these effects are reminiscent of those we 
observed previously by man-made CaM mutants acting strongly through diminished CaM-
mediated regulation of LTCCs (Alseikhan et al., 2002), we tested directly for the effects of 
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naturally occurring LQTS CaM mutants on these very channels. Indeed, we establish that Ca2+ 
regulation of LTCCs can be strongly suppressed by overexpression of LQTS CaM mutants, 
posturing altered regulation of these channels as an important contributor to the LQTS 
phenotype. By contrast, overexpressing CPVT CaM mutants caused weaker or undetectable 
perturbation of LTCC function and action potentials. Finally, we note the requirement that a 
single Ca2+-free CaM (apoCaM) must first preassociate with LTCCs for subsequent Ca2+ 
regulation to occur (Erickson et al., 2001; Pitt et al., 2001; Mori et al., 2004; Liu et al., 2010; 
Bazzazi et al., 2013; Ben Johny et al., 2013), and substantiate how this feature rationalizes how a 
limited fraction of LQTS CaM mutants can nonetheless elaborate significant perturbation of 
channel regulation, sufficient to appreciably prolong action potentials. 
2.2 Materials and methods 
2.2.1 Adult guinea-pig ventricular myocyte isolation and adenoviral transduction 
Adult guinea-pig ventricular myocytes (aGPVMs) were isolated from whole hearts of 
adult guinea pigs (Hartley strain, 3–4 wk old, weight 250–350 g). Hearts were excised after 
guinea pigs were anesthetized with pentobarbital (35 mg/ kg, intraperitoneal injection). Single 
ventricular myocytes were isolated from both ventricles according to a published protocol (Joshi-
Mukherjee et al., 2013) and plated on glass coverslips coated with laminin (20 μg/ml overnight at 
4 °C). Cells were transduced with adenovirus carrying wild-type or mutant CaM upon plating in 
the presence of M199 medium supplemented with 20% fetal bovine serum. Expression of wild-
type CaM had little effect on action-potential morphology or duration, as compared to uninfected 
myocytes (Supplementary Figure 2.1). After 4 hours, the medium was replaced by M199 
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medium with 0% fetal bovine serum to maintain the phenotype of acutely dissociated myocytes. 
Cells were maintained at 37 ºC and recording was done at room temperature 20-36 hours later.  
2.2.2 Molecular biology 
LQTS CaM mutations were generated using QuikChange™ site-directed mutagenesis 
(Agilent) on rat brain CaM (M17069) in the pcDNA3 vector (Alseikhan et al., 2002) 
(Invitrogen). CPVT CaM mutations were generated on human CALM1 gene in the pcDNA3 
vector (a kind gift from Michael T. Overgaard (Nyegaard et al., 2012)). For electrophysiological 
recordings in HEK293 cells, both wild-type and LQTS mutant CaMs were cloned into the 
pIRES2-EGFP vector (Clontech Laboratories, Inc.) using NheI and BglII. For adenoviral 
expression in aGPVMs, wild-type and mutant CaMs were cloned into the pAdCiG viral shuttle 
vector using XhoI and SpeI. Adenovirus was amplified via a standard cre-recombinase method as 
previously described (Alseikhan et al., 2002). 
 The human cardiac α1C cDNA was constructed by cloning in an ~1.6 kb upstream 
fragment of the cardiac (containing exon 8a) channel variant (kind gift from Tuck Wah Soong 
(Tang et al., 2004)) into a human α1C-1 backbone (NM_000719 kindly gifted from Charlie Cohen 
of Merck Pharmaceuticals) contained within pcDNA3.1, via HindIII and ClaI sites. 
 For FRET two-hybrid constructs, CaM and CI region of CaV1.2 channels (as defined in 
Figure 5A and described previously (Ben Johny et al., 2013)) were tagged on their amino termini 
with fluorophores (cerulean and venus, respectively) with a linker of 3 alanines, and cloned into 




2.2.3 Transfection of HEK293 cells 
For whole-cell patch clamp experiments, HEK293 cells were cultured on glass coverslips 
in 10-cm dishes and Ca2+ channels were transiently transfected using a standard calcium 
phosphate method (Peterson et al., 1999). 8 µg of human cardiac α1C cDNA (as described above) 
was co-expressed heterologously with 8 µg of rat brain β2a (M80545), 8 µg of rat brain α2δ 
(NM012919.2) subunits, and 8 µg of wild-type or mutant CaMs, except for mixing experiments 
(Figure 2.6) where various molar ratios of wild-type to mutant CaM were transfected. The 
auxiliary β2a subunit was chosen so as to minimize the confounding effects of voltage-dependent 
inactivation on CDI (Dafi et al., 2004). To increase expression levels, 2 µg of simian virus 40 T 
antigen cDNA was co-transfected. Expression of all constructs was driven by a cytomegalovirus 
promoter.  
 For FRET two-hybrid experiments, HEK293 cells were cultured on glass-bottom dishes 
and transfected with polyethylenimine (Lambert et al., 1996) (PEI) before epifluorescence 
imaging. Whole-cell patch clamp and FRET two-hybrid experiments were performed 1-2 days 
after transfection. 
2.2.4 Electrophysiology 
Whole-cell voltage-clamp recordings of HEK293 cells were done 1-2 days after 
transfection at room temperature. Recordings were obtained using an Axopatch 200B amplifier 
(Axon Instruments). Whole-cell voltage-clamp records were lowpass filtered at 2 kHz, and then 
digitally sampled at 10 kHz. P/8 leak subtraction was used, with series resistances of 1-2 MΩ. 
For voltage-clamp experiments, internal solutions contained (in mM): CsMeSO3, 114; CsCl, 5; 
MgCl2, 1; MgATP, 4; HEPES (pH 7.3), 10; and either BAPTA, 10 or EGTA, 1; at 295 mOsm 
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adjusted with CsMeSO3. The free Ca2+ concentrations in these BAPTA- and EGTA-containing 
solutions were respectively estimated to be ~2.4 and 0.45 pM (Moretti et al., 2010), assuming a 
contaminant Ca2+ concentration of 25 µM (standard conversion at 
http://maxchelator.stanford.edu/). External solutions contained (in mM): TEA-MeSO3, 140; 
HEPES (pH 7.4), 10; and CaCl2 or BaCl2, 40; at 300 mOsm, adjusted with TEA-MeSO3. These 
solutions produced the following uncorrected junction potentials: 10 BAPTA/40 Ca2+: 10.5 mV; 
10 BAPTA/40 Ba2+: 10.2 mV; 1 EGTA/40 Ca2+: 11.4 mV; 1 EGTA/40 Ba2+: 11.1 mV (Barry, 
1994). Fraction of peak current remaining after 300-ms depolarization (r300) at various voltages 
were measured. The extent of Ca2+/CaM-dependent inactivation (CDI) was calculated as 
300 300/ Ba 300/ Ca 300/ Ba( ) /f r r r= − . 
 Whole-cell recordings of aGPVMs were performed 20-36 hours post isolation on the 
same recording setup. Internal solutions for voltage clamp experiments contained, (in mM): 
CsMeSO3, 114; CsCl, 5; MgCl2, 1; MgATP, 4; HEPES (pH 7.3), 10; BAPTA, 10; and 
ryanodine, 0.005; at 295 mOsm adjusted with CsMeSO3. External solutions contained (in mM): 
TEA-MeSO3, 140; HEPES (pH 7.4), 10; and CaCl2 or BaCl2, 5; at 300 mOsm, adjusted with 
TEA-MeSO3. These solutions produced an 8.4 mV uncorrected junction potential (Barry, 1994). 
For current clamp, experiments, internal solutions contained (in mM): K glutamate, 130; KCI, 9; 
NaCl,10; MgCl2, 0.5; EGTA, 0.5; MgATP, 4; HEPES, 10 (pH 7.3 with KOH). External solution 
(Tyrode's solution) contained (in mM): NaCl, 135; KCl, 5.4; CaCl2, 1.8; MgCl2, 0.33; NaH2PO4, 
0.33; HEPES, 5; glucose, 5 (pH 7.4). Junction potentials for current-clamp solutions were 
calculated to be only 0.5 mV (Barry, 1994).  The time from upstroke to 80% repolarization 
(APD80) was used as the metric for action potential duration throughout. SDcell, the mean 
standard deviation of APD80 within individual cells, was used to assess the dispersion of APD80 
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at the same expression level of CaM. Throughout, whole-cell voltage-clamp records were 
lowpass filtered at 2 kHz, and then digitally sampled at 10 kHz. Current-clamp recordings were 
filtered at 5 kHz, and sampled at 25 kHz. 
2.2.5 Ratiometric Ca2+ imaging 
Single aGPVMs were plated on glass-bottom dishes coated with laminin. Cells were 
loaded with Indo-1 AM (1 µM) at room temperature for 5 minutes, rinsed, and further incubated 
for 10 minutes in Tyrode's solution at room temperature to allow for de-esterification of Indo-1 
AM. Cells were stimulated by application of an electric field across individual cells using a 
Grass stimulator (SDD9) and bipolar point platinum electrodes. Recordings were made at room 
temperature in Tyrode's solution supplemented with 10 µM ascorbic acid (Sathaye et al., 2006) 
to buffer free radicals generated from electrical pacing and exposure to UV light. Fluorescence 
was measured using 340-nm excitation and 405- to 485-nm emission wavelengths. The 
intracellular Ca2+ concentration ([Ca2+]) was calculated as 
2
/ min max[ ] ( ) /( )d IndoCa K R R R Rβ
+ = ⋅ ⋅ − − . R  is the ratio of fluorescence signal at 405 and 485 
nm. /d IndoK was determined as 800 nM (Bassani et al., 1995). minR was determined to be 0.53 in a 
0 mM Ca2+ Tyrode’s with 5 mM EGTA  and 1 µM ionomycin. maxR was determined to be 2.60 in 
a Na+-free Tyrode’s (Na+ was replaced with choline ion to minimize the action of Na-Ca 
exchanger) with 10 mM Ca2+, 1 µM ionomycin and 10 mM 2,3-butanedione monoxime. β , as 
defined by the ratio of fluorescence signal at 485 nM under Ca2+-free and Ca2+-bound conditions, 
was determined to be 2.33. Cells were stimulated with a single electrical pulse after steady-state 
pacing at 0.1 Hz. The total amount of Ca2+ entry was determined by integration of the area under 
Ca2+-versus-time waveforms. Sarcoplasmic reticulum Ca2+ content (SR content) was determined 
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by application of 5 mM caffeine to aGPVMs superfused with a Na+-free Tyrode’s (Na+ was 
replaced with choline), containing 1.8 mM Ca2+ and 10 mM 2,3-butanedione monoxime. The 
concentration of caffeine was chosen to minimize Indo-1 quenching (McKemy et al., 2000) but 
was still sufficient to empty the sarcoplasmic reticulum. 
2.2.6 FRET two-hybrid measurement 
Three-cube FRET measurements were performed on HEK293 cells cultured on glass-
bottom dishes using an inverted fluorescence microscope in modified Tyrode's solution (in mM, 
NaCl, 138; KCl, 4; CaCl2, 2; MgCl2, 1; HEPES, 10; glucose, 10). FRET efficiency (EA) of 
individual cells was computed based on a published protocol (Erickson et al., 2001). Differential 
expression of test constructs across individual cells allowed decoration of a binding curve. 
Effective dissociation constants (Kd,EFF) were calculated by fitting the binding curve with the 
equation A free d,EFF free A,max[ ] / ( [ ] )E D K D E= + ⋅ , where [D]free is the free concentration of donor 
molecules.  
2.2.7 Data analysis and statistics 
All data were analyzed in MATLAB (The MathWorks) using custom-written scripts. For 
APD80 and Ca2+ transient measurements the Wilcox rank sum test was used to assess statistical 
significance of differences between cells expressing wild-type and mutant CaMs. In addition, 
variability not due to expression differences was assessed by calculating the standard deviation 
within each cell (SDcell) for both APD80 and Ca2+ transient measurements. Statistical significance 
for variability was determined by a student's t-test with the Bonferroni correction for multiple 
samples as appropriate. Average Ca2+ transients are displayed ± SD. Statistical significance for 
SR content was assessed using a Student’s t-test with a Bonferroni correction for multiple 
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samples. The values are displayed as mean ± SEM. For electrophysiology and FRET two-hybrid 
measurements, f300 and EA values were expressed as mean ± SEM, and a student's t-test was used 
to assess statistical significance. 
2.3 Results 
2.3.1 CaM mutants promote proarrhythmic electrical and Ca2+ activity in ventricular myocytes 
CaM mutations have been associated with severe LQTS and recurrent cardiac arrest 
(Crotti et al., 2013), but to date, no direct evidence exists that these mutations can actually 
promote proarrhythmic properties in an experimental cardiac model. Accordingly, before 
investigating specific Ca2+ regulatory disturbances relating to the interaction of LQTS CaM 
mutants and individual molecular targets, we tested whether the expression of these mutants at 
all perturbed the overall electrical and Ca2+ cycling properties of aGPVMs. This particular model 
was chosen because it features action potentials with a prominent plateau phase reminiscent of 
that in humans, making this system particularly suitable for understanding long-QT phenomena. 
 Figure 2.1A displays the prototypic action potentials of a single such myocyte expressing 
only wild-type CaM (CaMWT), obtained at 0.5-Hz stimulation under whole-cell current clamp. 
The timing of current injection stimuli is shown underneath for orientation. The waveforms are 
nearly identical from one stimulus to the next, with a mean action potential duration (APD80) of 
~300 ms (Alseikhan et al., 2002). Population behavior for APD80 is summarized in Figure 2.1B, 
which plots the cumulative distribution of durations drawn from 285 responses in 10 cells, where 
PAPD is the probability that APD80 is less than the value on the abscissa. The sharp rise of the 
distribution confirms a mean duration of 349.6 ms, with a modest standard deviation of 79.6 ms. 
Additionally, the mean standard deviation of APDs within individual myocytes (SDcell, intra-cell 
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standard deviation) was only 21 ms, further indicating relatively homogeneous behavior. By 
contrast, adenoviral-mediated expression of CaMD96V induced a strikingly different profile 
(Figure 2.1C). Here, action potentials could be enormously elongated (red), exceeding even the 
inter-stimulus interval of 2 seconds. For reference, the control waveform with only CaMWT 
present is reproduced in gray. Population data, displayed in cumulative histogram format (Figure 
2.1D), reveal marked lengthening and dispersion of APD80 values (red), with mean and standard-
deviation values of 897.3 and 222.9 ms (p < 0.001). Here, SDcell increased to 156.3 ms, 
indicating significant variability within each cell as compared to CaMWT (p < 0.01).  Both of 
these features furnish the cellular substrates for electrically driven arrhythmias at the tissue and 
organ level  (Arevalo et al., 2007). Similar results were obtained for expression of CaMD130G 
(Figures 2.1E-F, APD80 = 915.3 ± 231.7 ms, p < 0.001; SDcell = 78.5 ms, p ≤ 0.01) and CaMF142L 
(Figures 2.1G-H, APD80 = 864.9 ± 320.1 ms, p < 0.001; SDcell = 179.1 ms, p < 0.01). The 
exemplar for CaMD130G illustrates the occurrence of alternans (Figure 2.1E), and that for 
CaMF142L exemplifies simple APD prolongation. All these behaviors (Figures 2.1C, E, and G) 
could be observed in the presence of any of the CaM mutants and persist at faster pacing rates 
(Supplementary Figure 2.2). Detailed parameters for action potential recordings are in Table 2.1 
and Supplementary Table 2.1. 
 Beyond electrical disturbances, Ca2+ cycling dysfunction may also drive 
arrhythmogenesis (Xie and Weiss, 2009).  Accordingly, we examined the effect of LQTS CaM 
mutant expression on intracellular Ca2+ transients. Figure 2.1I displays the typical Ca2+ 
waveform in a myocyte expressing only CaMWT. Ratiometric Indo-1 imaging was used to gauge 
Ca2+ activity, and data are shown as the mean ± SD drawn from multiple cells. The black trace 
plots the mean, and standard deviation bounds are shown by gray shadows. Upon expression of 
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CaMD96V, Ca2+ transients are markedly amplified and prolonged (Figure 2.1J, red). Reproduction 
of the control CaMWT waveform (gray) serves to emphasize the strong changes in Ca2+ activity. 
Likewise, expression of CaMD130G and CaMF142L produced similarly striking increases of Ca2+ 
transients (Figures 2.1K-L). Representing these data in cumulative histogram format serves to 
emphasize the increased dispersion of peak Ca2+ transient amplitude produced by CaM mutants 
(Figures 2.1M-N). Shown here are the cumulative probabilities of the area under Ca2+ transients 
(PQ) for CaMWT and CaM mutants as labeled. The precipitous rise of the wild-type distribution 
confirms the similarity of Ca2+ amplitudes among cells (Figure 2.1M, black relation). By 
contrast, the sluggish rise of distributions for CaM mutants (Figures 2.1M and N, red relations) 
reveals marked heterogeneity of Ca2+ transients among cells, as confirmed by significantly larger 
intra-cell standard deviations (gray bars, p < 0.05). Additionally, both diastolic Ca2+ 
concentrations and SR Ca2+ content were significantly elevated by overexpressing LQTS CaM 
mutants (Supplementary Figure 2.3). In all, CaM mutants furnish the cellular substrates for Ca2+-
driven arrhythmias (Xie and Weiss, 2009), by increasing amplitude and dispersion of Ca2+ 
transients, heightening diastolic Ca2+ concentration, and augmenting SR Ca2+ content. 
2.3.2 LQTS calmodulin mutants suppress CDI of CaV1.2 Ca2+ channels 
The ability of naturally occurring LQTS CaM mutants to prolong and disperse action 
potentials was reminiscent of effects we and others observed previously under expression of 
man-made CaM mutants in the same and similar model systems (Alseikhan et al., 2002; Mahajan 
et al., 2008a). There, many of the action potential effects could be attributed to the suppression of 
CDI of CaV1.2 Ca2+ channels. We therefore tested for the effects of the naturally occurring 
LQTS-related CaM mutants on CaV1.2 CDI, heterologously expressed in HEK293 cells for 
maximal biophysical resolution. In this regard, CaV1.2 expression here included the use of an 
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auxiliary β2a subunit to better visualize CDI effects by minimizing voltage-dependent 
inactivation (Dafi et al., 2004). 
 Figure 2.2A displays exemplar currents of CaV1.2 channels coexpressed with CaMWT. 
The sharp decay of Ca2+ current (red) evoked by a 30- mV depolarizing step is the well-known 
result of the CDI process. As confirmation, Ba2+ current (black) evoked in the same cell hardly 
decays, as Ba2+ binds poorly to CaM. Population data shown below (Figures 2.2B-C) rounds out 
characterization of the baseline behavior of channels in the presence of CaMWT. Figure 2.2B 
displays the average of the peak normalized Ba2+ current as a function of step potentials, and 
Figure 2.2C plots the fraction of peak current remaining after 300-ms depolarization to various 
voltages (r300). The U-shaped Ca2+ r300 relation (red) recapitulates the classic hallmark of CDI 
(Brehm and Eckert, 1978; Brehm et al., 1980), while the flat Ba2+r300 relation (black) confirms 
the lack of appreciable inactivation without activation of CaM. Hence, the difference between 
Ba2+ and Ca2+ r300 relations at 30 mV, as normalized by the corresponding Ba2+ r300 value, 
formally gauges the extent of CDI (f300 = 0.690 ± 0.028).  
 Upon coexpressing CaV1.2 channels with mutant CaMD96V, a starkly different functional 
profile is observed (Figures 2.2D-F). Here, CDI is strongly suppressed (f300 = -0.009 ± 0.008, p < 
0.001), without shift in the voltage activation profile (Figure 2.2E). Similarly, coexpression of 
channels with CaMD130G or CaMF142L also sharply diminished CDI (Figures 2.2G-I and Figures 
2.2J-L, f300 = -0.002 ± 0.011, p < 0.001 and 0.065 ± 0.005, p < 0.001, respectively). The above 
results were obtained with strong intracellular Ca2+ buffering by 10 mM BAPTA, to restrict Ca2+ 
elevations to those in the nanodomains of individual channels, and thereby minimize cell-to-cell 
variations owing to differences in current amplitudes. Importantly, however, under more 
physiological Ca2+ buffering (1 mM EGTA) that allows global elevation of Ca2+, strong but 
17 
 
incomplete blunting of CDI was produced by the CaM mutants (Supplementary Figure 2.4). This 
residual CDI can be attributed to signaling through the N-terminal lobe of CaM (largely 
unaffected in LQTS CaM mutants), which is sensitive to sustained global elevation of calcium 
(Dick et al., 2008; Tadross et al., 2008). Overall, the naturally occurring CaM mutants 
suppressed CaV1.2 channel CDI, in a manner indistinguishable from that of a man-made mutant 
CaM34 molecules that selectively eliminate Ca2+ binding to the C- but not N-terminal lobe of this 
molecule (Peterson et al., 1999; Dick et al., 2008; Tadross et al., 2008). 
 By contrast, overexpressing CPVT CaM mutants had weaker effects on CaV1.2 channel 
CDI. CaMN54I yielded no appreciable change in CDI compared to CaMWT (Figures 2.3A-C, f300 = 
0.583 ± 0.043, p > 0.01). On the other hand, CaMN98S managed only to partially diminish CDI 
(Figures 2.3F-H, f300 = 0.367 ± 0.023, p < 0.001). Both results in Figure 2.3 were obtained under 
high Ca2+ buffering conditions (10 mM BAPTA). Under more physiological Ca2+ buffering (1 
mM EGTA), we observed a similar trend wherein CaMN54I and CaMN98S exerted at most modest 
diminution of CDI (Supplementary Figure 2.5). To assess further the more integrative 
consequences of these CDI profiles (Figures 2.3A-C, F-H), we investigated the effects of these 
CPVT CaM mutants within aGPVMs. As might be expected, action potentials in the presence of 
CaMN54I were nearly identical to those with CaMWT (Figures 2.3D-E). On the other hand, 
CaMN98S significantly prolonged action potentials (Figures 2.3I-J, red p < 0.01) as compared to 
CaMWT (gray). Additionally, intra-cell standard deviation (Figure 2.3J, gray bar) was also larger 
than CaMWT (p < 0.05), positioning CaMN98S for moderate LQTS and affiliated arrhythmias. For 
CaMN54I, the nearly complete lack of effect on CDI helps explain why this mutation was not 
associated with LQTS. Interestingly, the intermediate effects of CaMN98S on CDI and action 
potentials match well with reports of LQTS in an unrelated patient (Makita et al., 2013). 
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Thus far, we have demonstrated the ability of the naturally occurring LQTS CaM mutants 
to markedly attenuate CDI of CaV1.2 channels heterologously expressed in HEK293 cells, to 
facilitate biophysical resolution. Nonetheless, we next wondered whether similar effects would 
be observed in native L-type Ca2+ currents, as present in the same aGPVMs as used in Figure 
2.1. Figure 2.4A displays exemplar L-type currents evoked under whole-cell voltage clamp, 
using 10 mM BAPTA as the intracellular Ca2+ buffer, so as to mimic the condition of Figure 2.2. 
Ryanodine (5 µM) was included in the intracellular dialyzate to eliminate phasic Ca2+ release 
from the sarcoplasmic reticulum, and limit CDI to that driven by Ca2+ entry through individual 
L-type Ca2+ channels (Grandi et al., 2010). We again observed strong CDI when Ca2+ was used 
as the charge carrier (red) as compared to a limited amount of voltage-dependent inactivation 
(VDI) seen in the Ba2+ current (black). This additional VDI component is expected in this native 
setting due to a mix of endogenous beta subunits (Hullin et al., 1992; Olcese et al., 1994), 
compared to the pure population of β2a subunits utilized in HEK293 cell experiments. That said, 
the baseline f300 value estimating isolated CDI in control myocytes (Figures 2.4A-C)  was 
nonetheless 0.67 ± 0.04 (obtained at 20-mV step), which is quite similar to that obtained in 
recombinant channel expression experiments (Figure 2.2C). Likewise, population data shows a 
similar current-voltage relationship and U-shaped Ca2+ r300 curve (Figures 2.4B-C). Importantly, 
expression of mutant CaMD96V essentially abolished CDI in this native setting (f300= -0.18 ± 0.03, 
p < 0.001, Figures 2.4D-F) and so did CaMD130G and CaMF142L (f300= 0.02 ± 0.09, p < 0.001, 
Figures 2.4G-I and -0.09 ± 0.03 , P < 0.001, Figures 2.4J-L , respectively), supporting a strong 
mechanistic link between CaV1.2 channel deficits and the LQTS effects seen in patients carrying 




2.3.3 Limited expression of LQTS CaM molecules still affects CaV1.2 channel CDI 
We have so far demonstrated that strong overexpression of LQTS-associated CaM 
molecules in myocytes can produce both strongly dysfunctional electrical and Ca2+ cycling, and 
potently diminished CDI. However, in the actual related patient population, only one of six 
alleles encodes a mutant CaM, while the other alleles would elaborate wild-type CaM. 
Accordingly, we would anticipate that only a limited fraction of CaM molecules would bear the 
pathogenic mutation (Crotti et al., 2013). How then could the significant cardiac deficits 
encountered by patients be rationalized? Previous mechanistic studies of L-type channel CDI 
offer a potential explanation. In particular, it has been shown that for CDI to occur, channels 
must initially preassociate with a Ca2+-free CaM (apoCaM), to which subsequent Ca2+ binding 
triggers CDI (Zuhlke et al., 1999; Erickson et al., 2001). That is, bulk CaM in the cytoplasm does 
not appreciably trigger CDI. Thus, if LQTS-associated mutant CaM molecules can still 
preassociate on par with wild-type CaM, then a sizeable fraction of channels would be bound to 
mutant CaM, and thus unable to undergo strong CDI (Figures 2.2 and 2.3). Thus, the overall 
decrease in CDI should be appreciable, reflecting the aggregate fractional presence of mutant 
CaM in cells.  
 Accordingly, we utilized a well-established live-cell FRET two-hybrid binding assay to 
determine whether mutant CaMs can still interact with CaV1.2, in a manner similar to wild-type 
CaM. Figure 2.5A (top) cartoons the relevant sites of apoCaM interaction with CaV1.2 channels, 
in particular the CI region of the channel carboxy tail. Our FRET assay therefore paired the 
CaV1.2 CI region with CaM (Figure 2.5A, bottom). As baseline reference, Figure 2.5B shows the 
canonical binding curve between the CI region and CaMWT, where this plot displays the 
acceptor-centric FRET efficiency of interaction (EA) as a function of the relative free 
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concentration of donor-tagged molecules Dfree (cerulean-CaMWT). The curve resembles a typical 
binding reaction, and the Dfree that produces half-maximal EA yields an effective dissociation 
constant (Kd,EFF) of 12,000 Dfree units (Bazzazi et al., 2013). Reassuringly all three mutant CaM 
molecules bind at least as well as wild-type CaM (Figures 2.5B-5E), demonstrating that mixed 
expression of mutant and wild-type CaM will result in some fraction of channels bound to 
mutant CaM. 
 To test this notion quantitatively, we first devised simple means to control the expression 
ratio of wild-type to mutant CaM molecules ( γ̂ ) (Supplementary Note 2.6.6). Then, we 
performed whole-cell electrophysiology experiments to test explicitly whether the strength of 
CDI in CaV1.2 channels would be graded by different γ̂  values, just as anticipated by the relative 
binding affinities of channels for mutant versus wild-type apoCaM (Figures 2.5B-E). Here, our 
approach was to strongly overexpress variable ratios of such molecules so that the contribution 
of endogenous CaM would be negligible. If such a scenario were to hold true, we could 
quantitatively predict that the aggregate CDI strength (CDI) as a function of the protein 
expression ratio of wild-type to mutant CaM, as the Langmuir equation in Figure 2.6A 
(Supplementary Note 2.6.7). CDIWT is the full-strength CDI measured with only wild-type CaM 
strongly overexpressed, and Kd/WT and Kd/MUT are the dissociation constants for channel 
preassociation with wild-type and mutant apoCaM, as specified in Figures 2.5B-E. Figure 2.6B 
plots this relation explicitly as the smooth black curve. Colored data symbols, with 
corresponding exemplar traces in Figure 2.6C, nicely decorate this Langmuir function, as do data 
from numerous other cells (open symbols in Figure 2.6B). Similar results were obtained for the 
other two LQTS-associated CaM mutants (Supplementary Figure 2.9). Thus, mixtures of wild-
type and mutant CaM would weaken L-type channel CDI as predicted by the relative channel 
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affinities for these two molecules in their Ca2+-free form. Based on the relative expression profile 
of each CALM during infancy (Crotti et al., 2013), heterozygous D96V mutation on CALM2 
gene yields γ̂  ~7, predicting the substantial decrement of CDI indicated by the light rose shading 
in Figure 2.6B, likely sufficient to appreciably prolong APDs (Mahajan et al., 2008a; Morotti et 
al., 2012). Interestingly, the corresponding prediction for a hypothetical homozygous scenario (
γ̂  ~3, dark rose shading) suggests a severe reduction in CDI, potentially incompatible with life. 
This would perhaps predict the absence of living homozygous individuals. 
 In all, we would argue that the electrical and calcium dysfunction affiliated with LQTS-
associated CaM mutations arises as summarized in Figure 2.7. Mutant CaM elaborated by a 
single allele among three CALM genes would yield a mixture of wild-type and mutant CaM 
molecules, as specified by the expression ratio γ̂ . Because channels must first preassociate with 
apoCaM to undergo subsequent CDI, this fractional expression of mutant CaM would produce 
graded reduction of overall CDI in myocytes, as demonstrated in Figure 2.6. This decrement of 
Ca2+ feedback inhibition would elaborate abnormally long action potentials and QT intervals 
(Alseikhan et al., 2002), likely in a cell-specific manner dependent on both the precise value of 
γ̂ , and complex interactions with the configuration of other ion-channel and Ca2+-cycling 
molecules present. The latter interaction factors likely contribute to the impressive dispersion of 
properties documented in Figure 2.1. Given the variable propensity for action potential 
prolongation and calcium augmentation within different cells, arrhythmogenic behavior at the 
tissue and organ level could thus result. Although other effects of mutant CaM molecules are 
likely to contribute to overall pathogenesis (Figure 2.7, gray pathway with arrow), this study 
furnishes strong evidence that a major underlying mechanism concerns the attenuation of L-type 
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calcium channel CDI by the presence of LQTS-associated mutant CaM molecules. This outcome 
furnishes at least one major molecular target that merits scrutiny for potential therapeutics. 
2.4 Discussion 
Our experiments demonstrate that CaM bearing LQTS mutations induce the cellular 
substrates that would favor a LQTS phenotype. Acute introduction of LQTS mutant CaMs into 
aGPVMs lead to: (1) electrical disturbances including prolonged APD and electrical alternans, as 
well as (2) Ca2+ cycling disturbances, such as increased Ca2+ transients and SR Ca2+ load. 
Importantly, such alterations manifested in a highly dispersed fashion across and within cells, 
thus furnishing a critical ingredient for arrhythmogenesis at the tissue and organ levels (Arevalo 
et al., 2007). The present study also clearly indicates that a key contributor to these effects 
involves the disruption of L-type channel CDI by LQTS CaM mutants. Such CDI attenuation 
would elaborate increased Ca2+ current during phases 2 and 3 of the action potentials, thus 
prolonging APD and increasing SR Ca2+ load. Finally, we have established one scenario by 
which a small fraction of CaM mutants would suffice to create an appreciable prolongation of 
action potentials. Preassociation of apoCaM to the CaV1.2 channels plays a critical role, enabling 
a fraction of channels to be occupied by the CaM mutants with resulting failure to undergo CDI. 
Interestingly, CaM mutants commonly affiliated with CPVT exhibited negligible or 
weaker effects on action potential duration and L-type channel CDI. The complete lack of effect 
of CaMN54I on CDI and action potential duration is well explained by its near wild-type Ca2+ 
binding affinity (Hwang et al., 2014), and these molecular and cellular outcomes fit nicely with 
the lack of appreciable QT prolongation in corresponding probands (Nyegaard et al., 2012). This 
CPVT-associated mutant could nonetheless interact with other targets like RyR2 calcium release 
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channels to potentially contribute to pathogenesis (Hwang et al., 2014). On the other hand, the 
CPVT CaM mutant N98S is capable of producing either CPVT (Nyegaard et al., 2012; Hwang et 
al., 2014) or LQTS in patients (Makita et al., 2013). This dual effect may well arise from the 
overlapping effects of these mutations on multiple CaM targets in the heart. Indeed, CaMN98S 
turned out to both reduce L-type channel CDI and moderately prolong cardiac action potentials 
(Figure 2.3). The intermediate effects of this CaM mutant thus rationalize how LQTS or CPVT 
may become the more prominent clinical phenotype, perhaps as a function of differing 
expression levels among patients.  
 In addition to L-type (CaV1.2) channels, other molecular targets of CaM remain as 
potential contributors to LQTS pathogenesis. Focusing in particular on targets that preassociate 
with Ca2+-free CaM, voltage-gated Na channels (Van Petegem et al., 2012) (NaV1.5) and  slow 
delayed rectifier K channels (Shamgar et al., 2006) (IKs) loom among likely targets. In NaV1.5 
channels, Ca2+/CaM is proposed to both facilitate initial opening and stabilize the inactivated 
state (Van Petegem et al., 2012). However, a recent study reports that LQTS CaM mutants 
lacked significant effects on most splice variants of NaV1.5 channels, though the CaMD130G 
mutant appeared to moderately enhance persistent current in one fetal splice variant (Murphy et 
al., 2013). For IKs, Ca2+-free CaM may help traffic channels to plasmalemma (Roden, 2006), and 
Ca2+/CaM is believed to facilitate opening. In fact, mutations in IKs that disrupt CaM binding 
result in decreased K current, thus causing LQTS (Ghosh et al., 2006; Shamgar et al., 2006). 
More broadly, because CaM regulates many other Ca2+ channel subtypes, including those 
predominate in neurons and immune cells, disruption of CDI could lead to a multi-system 
disorder similar to Timothy syndrome (Splawski et al., 2004; Splawski et al., 2005; Raybaud et 
al., 2006).  It may well be that extra-cardiac effects are also present in patients possessing LQTS 
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CaM mutants, but that these effects were not recognized in the face of immediately life-
threatening cardiac-related sequelae. For other CaM-modulated signaling molecules that do not 
preassociate with Ca2+-free CaM, the present study would suggest that a limited fraction of 
LQTS CaM mutants would matter little. Only when the fraction of CaM mutants approaches 
unity would this class of targets be predicted to exhibit altered function. Key members of this 
class of CaM targets in cardiac myocytes would include Ca2+/CaM-dependent kinase II 
(CaMKII) and calcineurin (CN). CaMKII has been argued to influence the electrical properties 
of cardiomyocytes by phosphorylation of ryanodine receptors, phospholamban, SERCA, and L-
type Ca2+ channels, all of which could alter electrical and Ca2+ function (Rokita and Anderson, 
2012). By contrast, the Ca2+/CaM-activated phosphatase CN dephosphorylates numerous targets 
including the transcription factor NFAT, implicated in regulating expression levels of numerous 
ion channels in heart (Eder and Molkentin, 2011). Nonetheless, if our insights are correct 
regarding the necessary role of target preassociation with apoCaM to amplify the effects of a 
limited fraction of CaM mutants, molecules like CaMKII and CN may play little role in the 
LQTS phenotype at hand. 
 Even before testing for a role of the additional target molecules alluded to above, 
potential targeted therapeutic strategies in patients expressing LQTS CaM mutants are suggested 
by our finding that LTCC dysfunction likely contributes in this particular setting. In addition to 
beta-adrenergic blockade, as per the general standard of care for LQTS patients, immediate 
benefits may arise by seeking  appropriate modulators of LTCCs such as roscovitine, which has 
demonstrated beneficial effects within certain in vitro models of LTCC-related LQTS (Yazawa 
et al., 2011). Additionally, a recent study implicates a non-linear threshold effect between the 
extent of CDI diminution in LTCCs and onset of outright arrhythmias (Dick et al., 2012), rather 
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than a continuously graded interrelation. Accordingly, only a few-fold decrease in the fraction of 
CaM mutants ( γ̂ ) may yield marked improvement of electrical stability and decrease in the 
incidence of cardiac arrest. The limited alteration of γ̂  potentially required to bring about these 
benefits may considerably improve the feasibility of devising novel therapies towards this end.  
 Although the prevalence of diseases caused by de novo CaM mutations is limited, 
investigating their pathogenesis may offer revealing opportunities to expand our basic 
knowledge of LQTS-related arrhythmogenesis. Moreover, additional discoveries of CaM 
mutations will help expand our database of related genotype-phenotype correlations, lending 
further resources for understanding. Indeed, following the first discoveries of CaM mutations, 
three more recent preliminary studies (Boczek et al., 2013; Makita et al., 2013; Marsman et al., 
2013) have uncovered further CaM-affiliated arrhythmias. These include the following, listed 
according to gene and syndrome: D134H (CALM2; LQTS), N98S (CALM2; LQTS), D132F 
(CALM2; LQTS and CPVT), N54I (CALM1; LQTS and/or sudden unexplained death in the 
young (SUDY)), A103V (CALM3; CPVT and/or SUDY), F90L (CALM1; ventricular 
fibrillation). These exciting discoveries suggest that a small yet substantial population of patients 
with CaM mutations is emerging, thus necessitating the inclusion of CALM genes in genetic test 
panels for LQTS and CPVT, and providing added motivation for the discovery of new therapies. 



















Figure 2.1 CaM mutants induce arrhythmia. (A) Exemplar action potentials recorded via 
current clamp from one-day-old aGPVMs transduced with CaMWT. The stimulus waveform is 
depicted below. The dashed horizontal gray line indicates 0 mV, here and throughout. (B)  
Population data corresponding to A plotted as the cumulative distribution of APD80 (285 
responses from 10 cells). All APD80 population data in panels B, D, F, and H from myocytes 
stimulated at 0.5 Hz. Gray bar in B displays SDcell. Inset shows confocal image of typical 
myocyte expressing GFP as a marker of transduction by adenoviral CaMWT. (C) Transduction of 
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the mutant CaMD96V induced marked prolongation of action potentials in this exemplar recording 
(red) as compared to CaMWT transduction (gray, reproduced from A). (D) The cumulative 
distribution for APD80 from CaMD96V transduced aGPVMs (red) demonstrates a dramatic 
increase in APD80 and much greater APD80 variability (gray bar, p < 0.01),  both as compared to 
myocytes transduced with CaMWT. (E-H) Similar AP disturbances were induced via transduction 
of CaMD130G (E, F) and CaMF142L (G, H). Example of electrical alternans in aGPVM expressing 
CaMD130G (E). Data displayed in E and G were obtained during pacing at 1 Hz. (I) Average Ca2+ 
transient (black) recorded from aGPVMs transduced with CaMWT after steady-state pacing at 0.1 
Hz, n =5 cells. Standard deviation range shown as gray shading. Indo-1 AM was used as the 
inorganic Ca2+-sensitive fluorescent dye. (J-L) Transduction of mutant CaMs resulted in 
dramatic increases in the amplitude and variability of the Ca2+ transients. Solid gray trace 
reproduces the CaMWT data for reference, while red and rose depict average and standard 
deviation of Ca2+ transients from aGPVMs expressing the three mutants as labeled. Data 
averaged from n = 11, 9, and 15 myocytes for respective panels J-L. (M)  Population data for 
CaMWT (black) and CaMD96V (red), plotted as cumulative histograms for the area integrated 
under the Ca2+ transient waveform recorded from each myocyte. Horizontal error bars depict 
average standard deviation of Ca2+ entry for transients within the same cells, and is significantly 
larger for each LQTS CaM mutant (p < 0.05). The significant right shift due to transduction of 
CaMD96V demonstrates a remarkable increase in Ca2+ entry during single APs, while the slower 
rise indicates greater heterogeneity across myocytes transduced with CaM mutants. (N) 
Cumulative histograms of Ca2+ entry for CaMD130G (red, left) and CaMF142L (red, right), with the 












Figure 2.2 LQTS CaM mutants diminish CDI in HEK293 cells. (A) Exemplar currents 
evoked by 30-mV voltage step (top) in cells co-transfected with CaV1.2 and CaMWT. CDI 
manifests as the stronger decay in Ca2+ (red) current as compared to Ba2+ (black). Ba2+ trace is 
scaled downward to match the peak of the Ca2+ trace, thus facilitating comparison of decay 
kinetics, and the scale bar for current references the Ca2+ trace, here and throughout. (B)  
Average normalized peak current versus voltage relation obtained with Ba2+ for the same cells as 
in A.  Data are plotted as mean ± SEM here and throughout. (C) Population data for CDI across 
voltages. r300 measures the current remaining after 300 ms, after normalization to peak current.  
f300  is the difference between Ca2+ and Ba2+ at 30 mV, after normalization by the Ba2+ r300 value. 
(D) Expression of CaMD96V severely blunts CDI of CaV1.2. (E) The current-voltage relation for 
the CaMD96V scenario remains unaltered. (F) Population data bears out the CaMD96V reduction of 
CDI across voltages. For reference, the Ca2+ r300 curve for CaMWT is reproduced in gray. (G-L) 


















Figure 2.3 CPVT CaM mutants exert weaker effects on CDI. (A) Exemplar currents evoked 
by 30-mV voltage step (top) in HEK293 cells co-transfected with CaV1.2 and CaMN54I. Here, 
coexpression of CaMN54I did not disrupt CDI compared to CaMWT (Figure 2.2A). (B) Average 
normalized peak current-voltage relationship for same cells as in A. Compared to CaMWT 
(Figure 2B), there is no shift in voltage activation. (C) Voltage dependence of r300 values for 
Ca2+ (red) and Ba2+ (black). Ca2+ relation for CaMWT configuration reproduced in gray for 
reference. No significant alteration of CDI across all test voltages. (D-E) Coexpression of 
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CaMN54I does not appreciably affect action potentials (red) as compared to co-expression of 
CaMWT (gray). Format as in Figure 2.1. Data for panel E from 679 action potentials drawn from 
6 myocytes. (F) Expression of CaMN98S, however, modestly diminishes CDI, without affecting 
voltage activation (G). (H) Population data of r300 values confirm a small, but significant 
reduction of CDI across voltages. (I-J)  Overexpression of CaMN98S has the ability to lengthen 
and increase heterogeneity of action potentials (p  <  0.01). Format as in Figure 2.1B. Horizontal 
error bars in panels E and J display standard deviation of APD80 within cells. Data for panel J 












Figure 2.4 CaM mutants diminish CDI in aGPVMs. (A) CDI in native LTCCs recorded from 
one-day-old aGPVMs transduced with CaMWT. Exemplar current traces elicited by a 20-mV 
voltage step (top) display strong CDI with Ca2+ (red), and a small amount VDI with Ba2+ (black). 
(B) Average normalized peak current-voltage relation obtained in Ba2+ for the same cells as in A. 
(C) Population data for CDI across voltages.  f300 is measured at 20 mV. (D) Expression of 
CaMD96V severely blunts CDI in the native setting. (E) Current-voltage relation in the presence 
of CaMD96V remains unaltered. (F) Population data confirms the CaMD96V reduction of CDI 
across voltages. For reference, the Ca2+ r300 curve for CaMWT is reproduced in gray. (G-L) 












Figure 2.5 Mutant CaMs bind to CaV1.2 channels at least as well as wild-type CaM. (A) 
Cartoon depicting CaM interaction domains on the CaV1.2 calcium channel (CI segment). 
Below, construct schematics depicting FRET interaction pairs used for binding assessment. (B) 
The canonical FRET binding curve between the CI region and CaMWT. In particular, an 
acceptor-centric FRET efficiency (EA) is plotted as a function of the relative free concentration 
of donor-tagged molecules Dfree (cerulean-CaMWT). /d EFFK for CaMWT binding to CI region is 
12000 Dfree units (Bazzazi et al., 2013). (C-E) FRET binding curves between the CI region and 
CaMD96V (C), CaMD130G (D) and CaMF142L (E). /d EFFK are 4000, 6500, and 1000 Dfree units, 









Figure 2.6 Dose-dependent effect of mutant CaMs. (A) Langmuir equation relating the extent 
of CDI and wild-type versus mutant CaM expression ratio γ̂ . (B) Predicted CDI as a function of 
γ̂  (black). Solid circles indicate average data for each ratio γ̂ ; open circles pertain to data for 
individual cells. Light rose shaded region indicates the deficit in CDI expected for a expression 
ratio corresponding to heterozygous mutation in CALM2 gene, while dark rose shaded region 
indicates predicted extent of CDI reduction for homozygous mutation. (C) Exemplar current 
traces with the colors corresponding to the Langmuir plot in B. For each set of records, the Ca2+ 
trace is the lighter color waveform, and the corresponding Ba2+ trace is normalized to the peak of 
the Ca2+ trace for comparison of decay kinetics. Scale bar corresponds to Ca2+. Exemplar traces 









Figure 2.7 Proposed mechanism of electrical and calcium dysfunction for LQTS CaM 
mutants. Flow diagram schematizing how heterozygous CALM2 mutation might lead to 










Table 2.1. Average values for APs recorded at 0.5 Hz pacing 
* p < 0.01; **Values consistent with those expected for aGPVMs after one day in culture (Busch 
et al., 1996; Mitcheson et al., 1996). 
  
CaM APD80 (ms) (dV/dt)max (mV/ms) Vrest (mV)** Vmax (mV) 
WT 417.0 ± 6 119.9 ± 3.2 -62.0 ± 0.2 55.7 ± 0.4 
D130G 824.2 ± 16* 112.5 ± 2.1 -61.3 ± 0.2 48.4 ± 0.6 
D96V 973.6 ± 12* 139.5 ± 1.7 -62.6 ± 0.1 56.3 ± 0.3 
F142L 874.8 ± 22* 131.7 ± 3.8 -61.8 ± 0.2 51.8 ± 0.5 
N54I 391 ± 4.5 128.7 ± 1.4 -64.9 ± 0.3 53.6 ± 0.3 
N98S 751.8 ± 5.8* 160.6 ± 1.0 -62.4 ± 0.1 58.1 ± 0.1 
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2.6 Supplementary materials 
2.6.1 WT CaM overexpression has minimal effects on action potential morphology or duration. 
To ensure that transduction of heterologous CaM via adenovirus does not alter the 
baseline action potential, we compared the action potentials of  non-transduced aGPVMs with 
those of aGPVMs transduced with CaMWT. Supplementary Figures 2.1A-B compare action 
potential waveforms from uninfected one-day-old aGPVMs (endogenous CaM) and with one-
day old aGPVMs overexpressing CaMWT. There was no observable change in the action 
potential shape or duration at either 0.5 or 1 Hz pacing. Population data shown in panel C not 
only demonstrate negligible change in action potential duration due to expression of CaMWT, but 
document just how stable and reproducible the action potential durations of these cells are. These 
data thus confirm one-day old aGPVMs as a robust model for the study of action potential 
perturbations. In all, transduction of CaM via adenovirus is well tolerated by aGPVMs, 








Supplementary Figure 2.1 Introducing wild-type 
CaM via adenovirus does not affect shape or 
duration of action potentials. (A-B) Exemplar action 
potentials recorded via current clamp from one-day-old 
aGPVMs without (blue) and with transduction of 
CaMWT (black) via adenovirus. Cells are stimulated at 
0.5 Hz in A, and 1 Hz in B. The stimulus waveform is 
depicted below. There is no observable difference in 
action potential waveform or duration between 
aGPVMs with and without transduction of CaMWT. (C) 
Population data depicting APD80 of aGPVM with 
endogenous CaM (blue), and with transduction of 
CaMWT via adenovirus (gray) at various stimulation 
frequencies. No statistical difference of APD80 was 
observed across all four frequencies.  
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2.6.2 CaM mutants produce similar effects at an alternate pacing rate. 
To confirm our findings that LQTS CaM mutants can recapitulate the long-QT 
phenotypes  at more than a single pacing rate, we also recorded action potential waveforms at 
faster pacing frequencies. Supplementary Figure 
2.2 shows the cumulative histograms of APD80 
for aGVPMs transduced with wild-type and 
mutant CaMs (as labeled) and paced at 1 Hz. 
Here, we observe a similar trend as compared to 
the 0.5 Hz pacing rate from the main text 
(Figures 2.1 and 2.3).  Both action potential 
prolongation and increased APD dispersion are 




Supplementary Figure 2.2 LQTS CaM mutants consistently 
prolong APD and increase heterogeneity during pacing at 1 Hz. 
(A) Population data of APD80 from one-day-old aGPVMs 
expressing CaMWT stimulated at 1 Hz, shown as a cumulative 
histogram  (black). Horizontal gray bars depict averaged standard 
deviation of APD80 within the same cells (SDcell), here and 
throughout. 547 APs from n = 12 cells. (B) Cumulative histogram 
of APD80 from aGPVMs expressing CaMD96V stimulated at 1 Hz 
(red) demonstrates a dramatic increase in APD80 (P < 0.01), 
consistent with data from aGPVMs stimulated at 0.5 Hz (Figure 
1D). Cumulative histogram from aGPVMs expressing CaMWT is 
shown here in gray for reference. Moreover, the CaMD96V also 
significantly increases the heterogeneity of APD, shown here as a 
longer gray horizontal bar (SDcell), compared to panel A. 526 APs 
from n = 9 cells. (C-D) CaMD130G and CaMF142L remarkably 
prolong APD and increase APD heterogeneity in aGPVMs 
stimulated at 1 Hz, consistent with data observed in aGPVMs 
stimulated at 0.5 Hz (Figures 1F and 1H). For D130G, 415 APs 
from n = 8 cells. For F142L, 172 APs from n = 4 cells. (E) The 
CPVT CaM mutant CaMN98S also maintains its ability to increase 
APD at 1 Hz pacing. 724 APs from n = 7 cells. (F) CPVT CaM 
mutant N54I, on the other hand, has no effect on APD. 785 APs 
from n = 5 cells. 
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2.6.3 SR content and diastolic Ca2+.  
The increased Ca2+ load in the presence of LQTS CaM mutants is likely to affect the Ca2+ 
content of myocytes in several ways. Importantly, the sarcoplasmic reticulum (SR) is likely to 
take up some of the excess Ca2+ entry from slowly inactivating LTCCs, yielding a higher SR 
Ca2+ content. We tested this hypothesis by transducing aGPVMs with each LQTS CaM mutant 
and evaluating the SR Ca2+ content, gauged by undertaking Indo-1 imaging during emptying of 
SR Ca2+ by caffeine application (Supplementary Figure 2.3A). The result was a significantly 
larger SR Ca2+ content in the presence of LQTS CaM mutants, in agreement with the increase in 
Ca2+ transient amplitude seen in main text Figure 2.1.  Moreover, expression of LQTS CaM 
mutants also significantly increased the diastolic Ca2+ level (Supplementary Figure 2.3B), 
measured after steady state pacing. Thus it appears that the marked increase in Ca2+ influx via 
LTCCs (due to diminished CDI), conspires with the resulting increased SR Ca2+ load, to produce 







Supplementary Figure 2.3 SR Ca2+ load and diastolic Ca2+ concentrations. (A) SR Ca2+ content of aGPVMs transduced 
with LQTS CaM mutants is significantly higher than that of CaMWT (*, p < 0.01, n = 9, 3, 4 and 4 cells, respectively). Load 
obtained after steady-state pacing. (B) Transduction of LQTS CaM mutants significantly increases the diastolic Ca2+ level of 
aGPVMs. Data obtained after steady-state pacing. (*, p < 0.01; ** p < 0.05, n = 6, 15, 12, 18 cells, respectively). 
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2.6.4 Summary of AP parameters for 1 Hz pacing. 
To confirm phenotypes observed at 0.5 Hz pacing rate upon expression of LQTS and 
CPVT CaM mutants (Table 2.1 in the main text), we also recorded action potentials at other 
pacing rates. Supplementary Table 2.1 summarizes parameters from action potential recordings 






CaM APD80 (ms) (dV/dt)max (mV/ms) Vrest (mV) Vmax (mV) 
WT 402.5 ± 4 104.5 ± 2 -63.7± 0.2 54.0 ± 0.3 
D130G 567.5 ± 10* 112.2 ± 2 -63.7 ± 0.2 50.8 ± 0.7 
D96V 720.2 ± 11* 100.3 ± 2 -63.7 ± 0.2 57.6 ± 0.6 
F142L 685.7 ± 31* 129.7 ± 6 -63.7 ± 0.3 50.6 ± 0.9 
N54I 326.9 ± 4 119.4 ± 1 -65.27 ± 0.3 50.7 ± 0.2 
N98S 580.2 ± 8.6* 170.2 ± 2 -63.2 ± 0.2 53.7 ± 0.2 
Supplementary Table 2.1 Detailed parameters from action potential recordings.  
Besides large increase in APD80 upon expression of LQTS and CPVT CaM mutants, there was no statistically significant 
change in (dV/dt)max (maximum upstroke velocity), Vrest (resting membrane potential), or Vmax (maximum membrane potential), 
as measured in aGPVMs expressing CaM mutants. (*, p < 0.01 versus WT). 
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2.6.5 Reduction of CDI due to LQTS CaM mutants under more physiological buffering 
conditions. 
The data displayed in Figures 2.2-2.3 of the main text was obtained under high Ca2+ 
buffering conditions (10 mM BAPA). This high buffering condition limits Ca2+ elevations to 
within the local domain of Ca2+ channels, resulting in a component of Ca2+ regulation triggered 
predominantly by the C-lobe of CaM (Dick et al., 2008; Tadross et al., 2008). This configuration 
was advantageous because CDI measures became independent of the level of channel 
expression, and the main effect of C-lobe CaM mutations was nicely observed in this 
arrangement. However, under more native Ca2+ buffering, a sustained global elevation of Ca2+ is 
present, which permits additional induction of a CDI component contributed by the N-lobe of 










Supplementary Figure 2.4 LQTS CaM mutants diminish CDI under modest Ca2+-buffering. (A) Exemplar current traces 
recorded using 1 mM EGTA as intracellular Ca2+ buffer in HEK293 cells co-transfected with CaV1.2 and CaMWT. Currents 
were evoked by a voltage step to 30 mV (top). Stronger decay in Ca2+ (red) current as compared to Ba2+ (black) represents CDI. 
Ba2+ current was scaled to the same magnitude as Ca2+ to facilitate comparison of decay kinetics, and the current scale bar 
pertains to Ca2+ here and throughout. f300, representing the extent of CDI, is expressed as mean ± SEM here and throughout. (B) 
Expression of CaMD96V strongly blunts CDI, although to a smaller extent than in high Ca2+ buffering (10 mM BAPTA). (C-D) 
Strong but incomplete blunting of CDI is also observed upon expression of CaMD130G and CaMF142L, respectively. 
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 To assess the effects of CaM mutations under this more physiological buffering, we 
therefore obtained the equivalent whole-cell patch-clamp data (Supplementary Figures 2.4-2.5) 
under modest Ca2+ buffering (1 mM EGTA). Such conditions now allow for both local (C-lobe) 
and global (N-lobe) Ca2+/CaM signaling. As the N-lobe remains unperturbed in the LQTS 
mutant CaMs, a small residual CDI due to N-lobe CaM regulation now emerges (Supplementary 
Figures 2.4B-D). Importantly, compared to CaMWT, each of the LQTS CaM mutants demonstrate 
a dramatic reduction in CDI, validating the overall results under high buffering condition. 
Conversely, neither of the CPVT CaM mutants have a large enough effect on CDI for any deficit 






2.6.6 Calibrating the expression ratio of wild-type to mutant CaM  
Before being able to accurately test the graded response of CDI at different expression 
ratios of wild-type to mutant CaM, we first needed to devise a method to control and validate the 
protein expression ratio relative to a transfected cDNA ratio. Through a simplistic yet powerful 
imaging method, we were able to determine a scaling factor m that relates the protein expression 
ratio ( γ̂ ) to cDNA transfection ratio (γ) as 
Supplementary Figure 2.5 CPVT mutants minimally 
affect CDI under modest Ca2+ buffering. (A) Full CDI 
is seen in the presence of CaMN54I. (B) The small CDI 
deficit seen under high buffering conditions due to 
CaMN98S is masked under modest internal Ca2+ 
buffering. Format is as in Supplementary Figure 2.4.  
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 mγ γ= ⋅       (2.1) 
 First, we assessed the relative brightness of venus- and cerulean-tagged CaMWT (V-
CaMWT and C-CaMWT, in Supplementary Figure 2.6A). An equimolar ratio of cDNAs encoding 
these moities was transfected into HEK293 cells, and cell-by-cell epifluorescence imaging 
undertaken 1-2 days thereafter. Under these conditions, cells should on average express equal 
amounts of V-CaMWT and C-CaMWT. Indeed, this outcome is experimentally verified by: (a) the 
close adherence of cell-by-cell fluorescence measurements to a straight line, and (b) a slope (1/β) 
indistinguishable from the relative brightness of venus compared to cerulean (gauged from 
venus-cerulean dimer analysis, not shown). Indeed, if fV is the venus fluorescence per molar 
concentration of venus in a HEK293 cells, and fC the corresponding cerulean metric, then 
     V C1/ /f fβ =       (2.2) 
Second, we accounted for potential differences in the expression of wild-type versus mutant 
CaM molecules, as elaborated from equimolar transfected cDNA. The approach is illustrated for 
the CaMD96V mutant.  Mixtures of V-CaMWT and C-CaMD96V were expressed, using different 
molar ratios of transfected DNA (γ). Supplementary Figure 6B displays cell-by-cell plots of 
whole-cell venus fluorescence (FV-CaM/WT) versus corresponding cerulean fluorescence (FC-
CaM/D96V), where different-colored relations correspond to different cDNA transfection ratios γ, as 
labeled. The tight adherence of data points to corresponding linear relations confirms that each 
transfection ratio γ largely specifies a specific protein expression ratio ( γ̂ ), irrespective of total 
protein expression levels. Accordingly, the slope of each relation yields a value α, which relates 




where [V–CaMWT] and [C–CaMD96V] are the molar concentrations of the corresponding species 
in HEK293 cells. Thus, the protein expression ratio of CaMWT to CaM96V can be calculated as  
γ α β= ⋅      (2.4) 
for each cDNA transfection ratio γ . Supplementary Figure 2.6C plots these entities (
γ α β= ⋅
versus γ) against each other, furnishing a linear relationship whose slope yields the desired 
conversion factor m (= 0.98) for Equation 1. Thus, we could now specify the protein expression 








 For the remaining two LQTS mutants, we confirmed that these mutations exhibit a 
similar m value, as follows. Holding γ  = 1 (equimolar cDNA ratio of wild-type to mutant CaM) 
fixed for CaMD130G and CaMF142L, the resulting γ̂  data points (colored symbols, Supplementary 
Supplementary Figure 2.6 Calibration of protein expression ratio between CaMWT and CaMD96V. (A) Cell-by-cell plot of 
venus versus cerulean fluorescence intensity, derived from venus- and cerulean-tagged CaMWT (V-CaMWT and C-CaMWT ), 
demonstrating a linear correlation with a slope of 1/ β . (B) Cell-by-cell plots of whole-cell venus fluorescence (FV-CaM/WT) versus 
corresponding cerulean fluorescence (FC-CaM/D96V) for various cDNA transfection ratios γ . Slopes of each relation specify α for 
each γ . (C) Plotting γ̂ as a function of γ  yields a linear relation with a slope equal to the final conversion factor m. 
V-CaM/WT V WT V WT
C-CaM/D96V C D96V C D96V
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Figure 2.7) nicely superimpose on the γ̂  versus  γ  relation for CaMD96V (reproduced as black 








2.6.7 Derivation of Langmuir CaM Ratio Equation 
With careful calibrations of CaM protein expression in hand, we could quantify the 
graded CDI effects of the mutant CaMs. Since all three LQTS mutations are in the C-lobe of 
CaM, we continued to utilize high intracellular buffering (10 mM BAPTA) such that we need 
only consider C-lobe CaM regulation (Dick et al., 2008; Tadross et al., 2008) in our derivations. 
In addition, we have shown that the mutant apoCaMs can bind to the channels at least as well as 
the wild-type counterpart (Figures 2.5B-E). Therefore, at baseline, each channel will be in one of 
the first three configurations depicted in Supplementary Figure 2.8: empty (state 1); occupied by 
a wild-type apoCaM (state 2), or occupied by a mutant apoCaM (state 3). Furthermore, to 
minimize the effect of endogenous CaM, we strongly expressed a mixture of wild-type and 
mutant CaM molecules. Under this condition, essentially all channels will be occupied by 
Supplementary Figure 2.7 Validation of conversion 
factor (m) for all CaM mutants. The linear relationship 
between γ̂  and γ  of CaMD96V (Supplementary Figure 6C) 
is reproduced here in black. The slope of this line is the 
conversion factor (m). The relationship between γ̂   and γ  
for CaMD130G (blue) and CaMF142L (red) fall nicely along 
this same line, obtained from CaMD96V (black). Thus, a 




apoCaM at rest, restricting occupancy to either state 2 or 3 at baseline. Upon a rise in 
intracellular Ca2+, CaMWT will bind Ca2+ and induce conformational changes which result in CDI 
(state 4). All LQTS CaM mutants, on the other hand, feature disrupted Ca2+ binding sites in the 
C-terminal lobe, yielding a complete absence of CDI (Supplementary Figure 2.8, bottom, grayed 










Since overexpression of LQTS CaM mutants produces CDI ~0 (in 10 mM BAPTA), the 
aggregate amount of CDI directly reflects fraction of channels in state 2 ( 2f ): 
     2WTCDI CDI f= ⋅       (2.5) 
At equilibrium, 2f can be calculated as 
Supplementary Figure 2.8 Model of CaM/channel interactions. Model depicting the configurations of CaM interacting with 
CaV1.2 channels. CaMWT is depicted as the gray dumbbell-shaped molecule, and mutant CaM as the red dumbbell-shaped 
molecule. At low, resting Ca2+ levels, channels are either empty (state 1) or preassociated with either a wild-type apoCaM (state 
2) or a mutant apoCaM (state 3). Upon a rise in intracellular, Ca2+ channels bound to a wild type CaM will transition from state 
2 to state 4 upon Ca2+ binding to CaM, yielding CDI. Channels in state 3, however, are pre-bound to a mutant CaM which is 
unable to bind Ca2+ effectively. These channels are therefore unable to transition to state 5 and will thus lack CDI. 
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 which gives  (2.6) 
 
 which gives  (2.7) 
 
where 1f  and 3f represent fractions of channels in state 1 and 3, respectively; WTC and MUTC
represent the concentration of wild-type and mutant CaM, respectively; and d/WTK  and d/MUTK
represent dissociation constants for wild-type or mutant CaM interaction with channels. 
At baseline (before elevation of Ca2+), we have that 
     1 2 3 1f f f+ + =                (2.8) 
such that, we can combine Equations 6, 7 and 8 to obtain 
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                 (2.9) 
Since we strongly overexpressed wild-type and mutant CaM, WTC  and MUTC , which yields 
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Hence, 
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where / //d WT d MUTK KΛ = . 
2.6.8 Dose-Dependent Effect of CaMD130G and CaMF142L 
In Figure 2.6 of the main text, we focused on the graded effects of variable expression 
ratios of CaMWT to CaMD96V. Here, we show that the mutants CaMD130G and CaMF142L also result 
in similar graded reductions of CDI (Supplementary Figure 2.9). Because of the preassociation 
of apoCaM and Ca2+ channels (Zuhlke et al., 1999; Erickson et al., 2001), and the fact that 
mutant apoCaM can bind to the channels at least as well as the wild-type apoCaM (Figures 
2.5D-E), the CDI dose response to the relative protein expression ratio of wild-type and mutant 









Supplementary Figure 2.9 Dose-dependent effect of CaMD130G and CaMF142L. (A) Langmuir plot of normalized CDI as a 
function of  γ̂ , ratio of protein expression levels of CaMWT and CaMD130G. Solid circles indicate average data for each ratio γ̂ ; 
open circles are data from individual cells. Black curve drawn with Λ ~ 0.1. (B) Exemplar current traces corresponding to the 
data in panel A with the similar color code for each value of γ̂ . For each, the Ca2+ trace is the lighter color, with the 
corresponding Ba2+ trace normalized to the peak of the Ca2+ trace for comparison. Scale bar corresponds to Ca2+. Exemplar 
current traces from cells expressing CaMWT only ˆ( )γ = ∞  is reproduced from Figure 2.2A for reference. (C) Langmuir plot of 
normalized CDI as a function of γ̂ , ratio of protein expression levels of CaMWT and CaMF142L in a similar format as A. Black 




A precision medicine approach to the rescue of function in malignant calmodulinopathic 
long QT syndrome 
3.1 Introduction 
 In the previous chapter, we have shown that LQTS-associated calmodulinopathy 
mutations (D96V, D130G, and F142L) mediate a decrease in CDI of CaV1.2. This would result 
in the failure of calmodulinopathy-affected CaV1.2 channels to inactivate during the plateau of 
the cardiac action potential (AP), and is predicted to prolong the AP duration (APD), a cellular 
correlate of prolonged QT intervals identified on the electrocardiogram (Limpitikul et al., 2014; 
Yin et al., 2014). In human, there are three distinct CaM genes, CALM1 (chr14q31), CALM2 
(chr2p21), and CALM3 (chr19q13), with 85% nucleotide sequence homology that encode for 
completely identical 149 amino-acid CaM proteins. In all reported cases of LQTS-associated 
calmodulinopathies, the mutation occurs heterozygously in one of these three redundant CALM 
genes, i.e. with only one out of six alleles harboring the mutation. Thus, only a small fraction of 
mutant CaM protein causes the severe phenotype. This large dominant negative effect may be 
rationalized by the known pre-association of Ca2+-free CaM to the LTCCs (Erickson et al., 2001; 
Limpitikul et al., 2014). In fact, the reduction of CDI due to mutant CaM expression corresponds 
to a highly non-linear effect such that a relatively small amount of mutant CaM can significantly 
decrease CDI in HEK293 cells (Limpitikul et al., 2014).  However, this phenomenon remains to 
be substantiated in a cardiac system under conditions mimicking that of a calmodulinopathy 
patient. To this end, we generated induced pluripotent stem cells (iPSCs) from a patient 
harboring a heterozygous p.D130G-CaM mutation (Boczek et al., 2016) resulting from a single 
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nucleotide substitution (c.389 A>G) within the CALM2 gene. Cardiomyocytes (CMs) 
differentiated from these cells (iPSC-CMs) offer an ideal platform for exploring the dominant 
negative effect of mutant CaM within a patient-specific genetic background and provide a model 
system with which to understand the pathogenesis and treatment options of CaM-mediated 
LQTS.  
 The non-linear CDI effect in calmodulinopathies may also provide an opportunity for 
novel therapeutic interventions. Impaired repolarization resulting from a deficit of LTCC CDI 
exhibits a non-linear threshold such that the fraction of channels harboring a CDI deficit can 
increase without overt electrical dysfunction up to a critical threshold. At this point, addition of 
even a minute fraction of affected channels generates the substrate for flagrant arrhythmogenesis 
(Dick et al., 2016). Should this threshold behavior hold true, a relatively small decrease in 
mutant CaM could result in a significant increase in electrical stability and thus lead to 
substantial clinical improvement. To this end, we exploit the precise genetic control of a variant 
of CRISPR/Cas9 technology, CRISPR interference (CRISPRi) (Gilbert et al., 2013; Qi et al., 
2013; Mandegar et al., 2016), to selectively down-regulate mutant CaM expression without 
permanently altering the genome. Taking advantage of the fact that patients with 
calmodulinopathies harbor mutations in only one of three CALM genes, mutant CaM could be 
attenuated while largely sparing wild-type CaM. As a test bed for therapeutic development, we 
utilize our D130G-CaM containing iPSC-CMs (iPSCD130G-CaM-CMs), as these cells are able to 
form a functional syncytium with the genetic background of the patient. Such a disease model 
readily permits application of CRISPRi to down-regulate mutant CALM genes and enables 
analysis of the functional effects of such a manipulation.  
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 In this chapter, we demonstrate that iPSC-CMs derived from a patient harboring the 
p.D130G-CaM missense mutation within CALM2 accurately recapitulates the cellular LQTS 
phenotype. Specifically, the iPSCD130G-CaM-CMs demonstrate prolonged APs, disrupted Ca2+ 
cycling, and diminished LTCC CDI, consistently across extended culture time. Having 
established a viable model system, we next use CRISPRi to selectively silence the expression of 
the CALM2 gene (both mutant and wild-type CALM2 alleles) and correlate this reduction with a 
functional rescue of the iPSCD130G-CaM-CMs. In particular, we have corrected fully the magnitude 
of CDI in these cells, resulting in normalization of the AP profile and therapeutic attenuation of 
the APD. 
3.2 Materials and methods 
3.2.1 Study participant 
A p.D130G-CaM  missense mutation secondary to c.389 A>G-CALM2 was identified 
previously in a young female patient with severe LQTS that was referred to the Windland Smith 
Rice Sudden Death Genomics Laboratory (Michael J. Ackerman, MD, PhD) at Mayo Clinic, 
Rochester, MN for research-based genetic testing (Boczek et al., 2016). This study was approved 
by the Mayo Foundation Institutional Review Board and informed consent was obtained.   
3.2.2 Generation of iPSCs 
Dermal fibroblasts were isolated from a punch skin biopsy obtained from the p.D130G-
CaM positive patient and expanded in DMEM containing 10% FBS.  These fibroblasts were 
reprogrammed using the CytoTune-iPS 2.0 Sendai Reprogramming Kit (Invitrogen) according to 
manufacturer’s recommendations.  Colonies were isolated as separate clones and characterized 
for pluripotency based on immunofluorescent staining (Supplementary Figures 3.1 and 3.2). 
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Sanger sequencing of genomic DNA of each clone confirmed a heterozygous mutation c.389 
A>G-CALM2. Wild-type iPSCs used for control experiments were a generous gift from Dr. 
Bruce Conklin (Spencer et al., 2014). All cell lines were tested negative for mycoplasma. 
3.2.3 Cell culture 
IPSCs were cultured and differentiated in a feeder-free and xeno-free system using a 
modified protocol described previously (Nakahama and Di Pasquale, 2016). Briefly, iPSCs were 
cultured on Geltrex matrix (Gibco)-coated tissue culture plates and fed daily with Essential 8 
medium (Gibco). When cells were ~30% confluent, they were mechanically dissociated using 
0.5 mM EDTA in Dulbecco`s Phosphate Buffered Saline (DPBS). For differentiation into 
cardiomyocytes, cells were dissociated and plated on fresh Geltrex matrix-coated plates. When 
confluent (day 0), media was exchanged with RPMI-1640 (Sigma-Aldrich) supplemented with 
B-27(-insulin) (Gibco) and 6 µmol/L CHIR99021. Cells were maintained in this media for the 
first 7 days, with medium exchange every 2 days. On day 3, 5 µM IWR-1 was added. On day 7, 
media was changed to RPMI-1640 with B-27 supplement (Gibco) and was exchanged every 2 
days. Spontaneous contraction of iPSC-CMs was observed by day 12. 
 12-14 days post-differentiation, sheets of contracting iPSC-CMs were dissociated using 
0.05% trypsin-EDTA (Gibco).  The isolated cells were pre-plated for 4-8 min on Geltrex-coated 
tissue culture plates in order to decrease the number of non-cardiac cells, and the non-adherent 
cells were then plated on Geltrex matrix-coated glass coverslips at ~2.5x104 cells/cm2 for 





3.2.4 CRISPRi construction, transfection, and transduction 
The lentiviral transfer vectors containing cDNA for enzymatically dead Cas9 fused with 
suppressor Krüppel-associated box (KRAB) and blue florescence protein (BFP) (pHR-SFFV-
dCas9-BFP-KRAB) was purchased from Addgene (Plasmid #46911). BFP was replaced with 
monomeric ruby red fluorescence protein (mRuby). The entire construct (dCas9-mRuby-KRAB) 
was then cloned via Gibson assembly (New England Biolabs) into the lentiviral vector 
pRRLsin18.cPPT.CMV.eGFP.Wpre54 (Kapoor et al., 2014). The lentiviral vector (pKLV-
U6gRNA(BbsI)-PGKpuro2ABFP) containing cDNA for the gRNA backbone (driven by the 
human U6 promoter) and a BFP marker (driven by PGK promoter) was purchased from Addgene 
(Plasmid #50946) and BFP was replaced with cyan fluorescence protein (CFP). E-CRISPR 
gRNA sequence prediction program (Heigwer et al., 2014) was used to generate candidate 
gRNA sequences that selectively complement to the human CALM2 gene (Supplementary Table 
3.1). The candidate gRNA sequences were then cloned into the aforementioned lentiviral transfer 
vector using Golden Gate assembly. 
 For gRNA screening, both dCas9-mRuby-KRAB and candidate gRNA were expressed in 
HEK293 cells by transfection with polyethylenimine (Limpitikul et al., 2014). For iPSC-CM 
transduction, lentivirus was generated using Lenti-X-Concentrator (Clontech) according to the 
manufacturer’s recommendations and added to monolayers on day 21 post-differentiation.   
Expression was confirmed by mRuby and CFP visualization. 
3.2.5 Quantification of mRNA level 
Total RNA was extracted 4 days post-transfection in HEK293 cells and 8-9 days post-
transduction in iPSC-CMs using an RNeasy kit (Qiagen). Complementary DNA was made using 
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the high-capacity cDNA reverse transcription kit (Applied Biosystems). Quantification of CALM 
mRNA levels was performed using real time PCR (qPCR) with TaqMan gene expression assay 
(Applied Biosystems). CALM expression level was normalized to the expression level of a 
house-keeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Probe numbers: 
CALM1; Hs00300085_s1, CALM2; Hs00830212_s1, CALM3; Hs00968732_g1, and GAPDH; 
Hs02758991_g1.  
3.2.6 Electrophysiology 
Whole-cell recordings of iPSC-CMs were performed 28-30 days post-differentiation at 
room temperature using an Axopatch 200B amplifier (Axon Instruments). Traces were lowpass 
filtered at 2 kHz, and digitally sampled at 10 kHz. P/8 leak subtraction was used, with series 
resistances of 1-2 MΩ. Internal solutions contained, (in mM): CsMeSO3, 114; CsCl, 5; MgCl2, 1; 
MgATP, 4; HEPES (pH 7.3), 10; BAPTA, 10; and ryanodine, 0.005; at 295 mOsm adjusted with 
CsMeSO3. Seals were formed in Tyrode's solution containing (in mmol/L): NaCl, 135; KCl, 5.4; 
CaCl2, 1.8; MgCl2, 0.33; NaH2PO4, 0.33; HEPES, 5; glucose, 5 (pH 7.4). Following patch 
rupture, bath solution was switched to Ca2+- or Ba2+- external solution containing (in mM): TEA-
MeSO3, 140; HEPES (pH 7.4), 10; and CaCl2 or BaCl2, 5 (for 30-day-old iPSC-CMs) or 40 (for 
60-day-old iPSC-CMs); at 300 mOsm, adjusted with TEA-MeSO3. The extent of CDI after a 50-
ms depolarization (f50) was calculated as:  
           f50 = (r50/Ba – r50/Ca)/r50/Ba                  






Monolayers of iPSC-CMs expressing either a genetically encoded voltage or Ca2+ sensor 
(ASAP1 (St-Pierre et al., 2014) or GCaMP6f (Chen et al., 2013) respectively via lentiviral 
transduction) were paced using a custom field stimulation apparatus in RPMI-1640 medium with 
B-27 supplement. Expression efficiency of the genetically encoded sensors was assessed via 
flow cytometry (Supplementary Figure 3.3). At 30, 45, and 60 days post-differentiation, green 
fluorescence was imaged with an Evolve 512delta camera at ≥ 190 frames per second and the 
relative change in fluorescence signal was measured. The time from upstroke to 80% 
repolarization (APD80) was used to index the APD while the magnitude of peak transient, time to 
peak, and decay time constant were used as metrics for CaTs.  All metrics were quantified using 
custom Matlab (Mathworks) scripts. For all experiments involving treatment with CRISPRi, 
control cells were recorded on the same day and were from the same culture, minimizing any 
culture dependent variability of the cells.  
3.2.8 Statistical analysis 
All parameters are shown as mean ± SEM. Technical and biological replicates are 
indicated in the figure legend. The D'Agostino & Pearson omnibus normality test was used to 
confirm a normal distribution prior to application of the statistical test for comparison of means. 
Data which did not initially correspond to a normal distribution were logarithmically 
transformed. The F-test was used to compare variances and a two-sided Student's t-test (adjusted 
for unequal variance where applicable) was used to compare the difference in means across 
sample groups. Reported p values are from the two-sided Student's t-test. Minimal sample size to 




3.3.1 Proband identification and generation of mutation-harboring iPSCs  
An increasing number of patients are being diagnosed with calmodulinopathies resulting 
from single heterozygous missense mutations within their CALM1, CALM2, or CALM3 genes.  
Here, we focus on a p.D130G-CaM mutation identified within CALM2 of a female infant with 
severe LQTS (Boczek et al., 2016). The proband was born at term, and noted to have bradycardia 
(Figure 3.1). An ECG, recorded 12 hours after birth, revealed a QTc of 740 ms and 2:1 
atrioventricular block (Figure 3.1A). She was treated with beta-blockers, phenytoin, 
spironolactone, potassium, and placement of a single-chamber pacemaker within the first week 
of life. At 6-years-old, a single-chamber implantable cardioverter-defibrillator was implanted and 
beta-blocker therapy was continued. At 11 and 14 years old, she experienced appropriate 
defibrillator discharges for ventricular fibrillation. 
 Next-generation whole exome sequencing followed by CALM1, CALM2, and CALM3 
gene-specific analysis identified a p.D130G-CaM mutation (c.389 A>G, CALM2) within the 
patient (Figure 3.1B). The mutation maps to an EF-hand within CaM (Figure 3.1C) and, similar 
to other calmodulinopathic mutations, causes a reduction in the Ca2+ binding affinity (Crotti et 
al., 2013). In order to create a model system with which to understand the pathogenesis and 
treatment options for this type of CaM-mediated LQTS, multiple clones of iPSCs were generated 
from the patient’s skin biopsy. Two clones with normal karyotypes at passage 25 and expressing 
the pluripotency markers (Nanog, Oct4, and SSEA4) were selected (Supplementary Figure 3.1). 
In addition, the ability to generate each of the three germ layers was confirmed by staining 
differentiated embryoid bodies for α-fetoprotein (endoderm), smooth muscle actin (mesoderm), 
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and glial fibrillary acidic protein (ectoderm) and by analysis of teratoma formation 
(Supplementary Figure 3.2). Monolayers of iPSC-CMs (iPSCD130G-CaM-CMs) were then 
generated from these two clones of iPSCs. 
 To confirm that the background of these iPSCD130G-CaM-CMs was not significantly 
different than iPSCs derived from healthy individuals, we quantified the mRNA levels for 
multiple proteins that could potentially alter cardiac action potential morphology and/or EC 
coupling. Compared to wild-type iPSC-CMs (iPSCWT-CMs), we found no difference in the 
mRNA levels of CALM1, CALM2, CALM3, CACNA1C, KCNH2, NCX1, SCN5A, PLN or 
SERCA2 (Supplementary Figure 3.4). Only KCNQ1 and RYR2 appeared somewhat elevated in 
the iPSCD130G-CaM-CMs; however, this variation would not be expected to contribute to a LQT 
phenotype. Importantly, this validates our iPSCWT-CMs as a relevant control, despite the 
potential variability which can occur due to differing genetic backgrounds (Sharma et al., 2013). 
3.3.2 Altered APs and calcium transients (CaTs) in iPSCD130G-CaM-CMs  
Previous work has linked mutations in CaM with LQTS; however, direct evidence 
demonstrating AP prolongation due to the D130G-CaM mutation has yet to be shown in human 
cardiomyocytes. We therefore characterized the iPSCD130G-CaM-CMs in order to confirm that 
these cells exhibit prolonged APDs that typically underlie LQTS. To measure APDs, the 
monolayers were transduced with the genetically encoded voltage sensor ASAP1, which features 
rapid kinetics and stable long-term expression, allowing accurate APD measurements over 
multiple time points (St-Pierre et al., 2014). The resultant APDs (Figures 3.1D, E) measured 
from wild-type iPSC-CMs (iPSCWT-CMs) were comparable to those previously reported 
(Supplementary Table 3.1) (Ma et al., 2011; Spencer et al., 2014). Under these same conditions, 
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iPSCD130G-CaM-CMs exhibited dramatically longer APs and APDs (Figures 3.1G, J; red) as 
compared to their WT counterparts (gray). This result could be observed at multiple pacing 
frequencies (Figures 3.1H, K), a feature associated with increased arrhythmogenic risk (Marban, 
2002). Moreover, the phenotype was stable over long periods of time in culture, such that APDs 
measured at 30 days in culture were not significantly different than those measured after 45 days 
or 60 days (Figures 3.1F, I, L; Supplementary Figure 3.6). 
 In addition to the electrical disturbance, dysfunctions in Ca2+ cycling are often associated 
with arrhythmogenesis in LQTS (Xie and Weiss, 2009). As such, we examined the intracellular 
Ca2+ transients (CaTs) of iPSC-CMs using GCaMP6f, a genetically encoded Ca2+ sensor with a 
high signal-to-noise ratio and fast kinetics (Chen et al., 2013). Figure 3.2A shows the CaTs from 
a monolayer of iPSCWT-CMs paced at 0.25 Hz with the rise and decay kinetics comparable to 
those previously reported (Hwang et al., 2015). However, monolayers of iPSCD130G-CaM-CMs 
exhibit CaT amplitudes over three times larger than WT with slower rise and decay kinetics 
(Figures 3.2B-F), akin to the phenotype observed in CaMD130G-overexpressing rodent myocytes 
(Limpitikul et al., 2014; Yin et al., 2014). Likewise, these CaT effects were stable over time 
(Supplementary Figure 3.7). While SR content of the iPSCD130G-CaM-CMs was not significantly 
different from the WT myocytes (Supplementary Figure 3.8), the trend was in the direction of 
increased SR Ca2+. Thus, the patient-derived iPSCD130G-CaM-CMs recapitulate the LQTS 
phenotype, demonstrating significant proarrhythmic potential despite limited, native expression 





3.3.3 IPSCD130G-CaM-CMs exhibit diminished CDI  
Previous studies have implicated the cardiac LTCC as a major contributor to the LQT 
phenotype in patients with CaM-mediated LQTS (Limpitikul et al., 2014; Yin et al., 2014). In 
particular, the D130G mutation weakens the affinity of Ca2+ binding to CaM (Crotti et al., 2013), 
resulting in a significant decrease in CDI when CaMD130G is overexpressed in rodent myocytes 
(Limpitikul et al., 2014; Yin et al., 2014). However, the relevance of these results remains to be 
established in human CMs with physiological levels of mutant CaM expression. We therefore 
examined the effect of the D130G mutation on LTCC CDI in patient-derived iPSC-CMs. To this 
end, we performed whole-cell patch clamp recordings of individual CMs. IPSCWT-CMs 
exhibited a rapid decay in their Ca2+ current in response to a 10-mV depolarizing step (Figure 
3.3A, red). To isolate the extent of pure CDI, Ba2+, which binds poorly to CaM, was used as the 
charge carrier to gauge the extent of voltage-dependent inactivation (VDI) within the same cell 
(Limpitikul et al., 2014). CDI can be seen as the excess inactivation of the Ca2+ trace (Figure 
3.3A, red), as compared to the Ba2+ trace (black). Population data showing the average 
normalized peak Ba2+ currents as a function of voltage is shown in Figure 3.3B. For CDI 
quantification, we first measure the fraction of current remaining after 50 ms (r50) for both the 
Ca2+ and Ba2+ currents. By plotting the r50 values as a function of voltage, a hallmark U-shaped 
relationship is observed with Ca2+ as the charge carrier (Figure 3.3C, red). The difference 
between the Ba2+ and Ca2+ r50 values at 10 mV, normalized by the Ba2+ r50 value, quantifies the 
extent of pure CDI (Figure 3.3C). Applying this same protocol to the iPSCD130G-CaM-CMs reveals 
a profound attenuation in the kinetics and extent of CDI (Figures 3.3D, G) without altering the 
voltage activation profile (Figures 3.3E, H). Quantifying this result across voltages (Figures 
3.3F, I) confirms a significant decrease in CDI (red, p < 0.01), an effect which is maintained over 
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time in culture (Supplementary Figure 3.9). Importantly, this reduction of CDI is significant even 
in the iPSCD130G-CaM-CM background, where the patient’s other five CALM alleles are WT. Thus, 
these iPSCD130G-CaM-CMs not only provide a viable model system for this LQTS-associated 
calmodulinopathy, but also suggest that the loss of LTCC CDI is a significant underlying 
mechanism leading to arrhythmogenesis in these patients.  
 To further bolster this LTCC centric hypothesis, we examined the effects of other 
potential CaM targets which might contribute to the LQT phenotype of calmodulinopathy 
patients. To date, only three genetic forms of LQTS result from mutations within a channel 
known to be modulated by CaM. LQTS type 1 results from loss of function mutations in 
KCNQ1, LQT3 results from gain-of-function mutations in SCN5A, and LQT8 is caused by 
inactivation altering mutations within CACNA1C, somewhat mirroring the LTCC effects 
described in this study. Of these forms of LQT, only LQT8 approaches the extreme APD 
prolongation seen in calmodulinopathy patients (Splawski et al., 2004; Splawski et al., 2005). To 
corroborate this in our model system, we mimicked the effect of each LQT mechanism 
pharmacologically. Consistent with clinical findings, enhancement of the current through the 
LTCC had a profound effect on APD, while blocking IKS or enhancing NaV1.5 produced more 
modest APD prolongation (Supplementary Figure 3.10). We next utilized a validated model of 
an adult mammalian cardiomyocyte (Luo and Rudy, 1994a, b; Livshitz and Rudy, 2007; Dick et 
al., 2016) to investigate the fraction of channels harboring a CaMD130G required to produce 
electrical instability via and LTCC CDI specific mechanism in silico (Supplementary Figure 
3.11). Indeed, only a small fraction of channels harboring CaMD130G was necessary to achieve 
significant arrhythmogenesis in the model cells. Importantly, the simulation predicted a threshold 
for the induction of electrical instability precisely matching the expected levels of mutant CaM 
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expression in calmodulinopathy patients based on reported CALM gene expression (Petryszak et 
al., 2014). Such a threshold highlights an important therapeutic principle; namely, only a small 
reduction in the expression levels of the mutant CaM may be needed to provide significant 
clinical benefit to patients.  
3.3.4 Toward a new therapeutic strategy  
Having confirmed a major role for LTCC CDI deficits in generating the LQT phenotype 
in this calmodulinopathy patient, we next considered the implications of this mechanism on a 
novel therapeutic intervention. As our results predict a significant functional benefit conferred by 
even a small shift in the expression of mutant versus WT CaM (Supplementary Figure 3.11), we 
sought to reduce the fraction of mutant CaM expressed in patients with CaM-mediated LQTS. 
As all three CALM genes encode for identical CaM proteins, we reasoned that we might be able 
to take advantage of the sequence variation at the nucleotide level. We thus utilized CRISPRi 
(Gilbert et al., 2013; Qi et al., 2013; Mandegar et al., 2016) to decrease the transcription of the 
CALM2 alleles, both the WT and the D130G-containing CALM2 alleles. 
 The CRISPRi technology uses a short guide RNA (gRNA) which binds specifically to a 
target nucleotide sequence. By pairing this gRNA with a nuclease-dead Cas9 (dCas9) fused to 
suppressor Krüppel-associated box (KRAB), selective suppression of the target gene could be 
achieved. Our first step was therefore to optimize gRNA sequences capable of selectively 
targeting CALM2. Sequence optimization was first done in silico (Heigwer et al., 2014), 
followed by evaluation of the efficiency and specificity of each candidate gRNA in HEK293 
cells via qPCR (Supplementary Figure 3.12, Supplementary Table 3.2). We choose design 21 
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(Figure 3.4A) as this gRNA specifically reduced the expression of CALM2, without appreciable 
alteration of either CALM1 or CALM3.  
 Having identified a potential treatment strategy, we next sought to test this approach 
within our iPSCD130G-CaM-CMs. Monolayers were lentivirally transduced with genes encoding 
dCas9-mRuby-KRAB and gRNA-CFP, and expression of both constructs was confirmed by 
visualization of red and blue fluorescence, respectively. Compared to untreated iPSCD130G-CaM-
CMs, the CRISPRi-treated iPSCD130G-CaM-CMs exhibited significantly lower levels of CALM2 
mRNA with unaltered levels of CALM1 and CALM3 (Figure 3.4B) mRNA level with the overall 
reduction of total amount of CaM protein (Supplementary Figure 3.5). In addition, we probed the 
effect of treatment on multiple cardiac genes and found no significant change in the mRNA 
levels of CACNA1C, KCNQ1, KCNH2, SCN5A, RYR2, SERCA2, NCX1 or PLN (Supplementary 
Figure 3.4). Having achieved a selective decrease in CALM2 transcription, we next tested if this 
reduction correlated with a functional effect within the iPSCD130G-CaM-CMs. Indeed, treatment of 
the monolayers resulted in a substantial shortening of the APDs in response to 0.5-Hz 
stimulation (Figure 3.4C, blue) as compared to untreated monolayers (gray). This effect was 
consistent across multiple trials, resulting in a significant decrease in APD as compared to 
untreated iPSCD130G-CaM-CMs (Figure 3.4C, right), establishing CRISPRi as a robust and 
promising strategy for the treatment of CaM-mediated LQTS. 
 Having established functional rescue of the iPSCD130G-CaM-CM monolayers, we next 
considered the underlying mechanism. Our previous results suggest that APD prolongation of 
these cells stems from a CDI deficit of the LTCC (Figure 3.3). We therefore predicted that 
successful treatment of these cells should correspond to a correction (increase) in the CDI of the 
LTCCs. Indeed, treated iPSCD130G-CaM-CMs displayed significantly faster CDI (Figure 3.4D) as 
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compared to untreated cells. In fact, CDI in the treated cells was nearly identical to that of 
iPSCWT-CMs (Figure 3.3). Thus, CRISPRi effectively reduced the expression of the mutant and 
WT CALM2 alleles, resulting in normalization of the APD, and restoration of LTCC’s CDI 
mechanism.  
3.3.5 Generalization of the CRISPRi strategy across calmodulinopathy subtypes 
Beyond the proband described in this study, the CRISPRi treatment strategy is readily 
generalizable to any calmodulinopathy. In contrast to the classic CRISPR/Cas9 genome editing 
technique where the gRNA sequence is tailored to an exact locus within the affected gene, 
CRISPRi targets the entire gene of interest itself, resulting in repression regardless of the specific 
base-pair alteration. This technique can therefore be adjusted to target CALM1 or CALM3 genes, 
providing efficacy across calmodulinopathy patient populations agnostic to the phenotype. We 
thus created gRNA sequences targeting each of the CALM genes (Figure 3.5A, Supplementary 
Figure 3.12, and Supplementary Table 3.2) and tested their efficacy in iPSC-CMs. Utilizing 
iPSCWT-CMs, we are indeed able to specifically decrease the expression of either CALM1 
(Figure 3.5B) or CALM3 (Figure 3.5C), thus providing a modular toolkit for the treatment of 
calmodulinopathies resulting from a mutation within any of the three CALM genes. 
3.4 Discussion 
IPSCD130G-CaM-CMs provide a good model system for investigating the underlying 
pathology of LQTS-associated calmodulinopathies. Two distinct iPSCD130G-CaM-CM clones each 
formed a stable contracting syncytium and exhibited prolonged APs, Ca2+ cycling disturbances, 
and diminished LTCC CDI across extended culture. Creation of this model system enabled the 
generation and testing of a new therapeutic strategy. Taking advantage of the genome targeting 
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precision of CRISPRi, we were able to selectively and efficiently silence both the WT and the 
D130G-containing CALM2 alleles, resulting in functional rescue of both LTCC CDI and cardiac 
AP morphology. This proof-of-principle therapy thus represents a first step towards a novel, 
targeted therapeutic design for calmodulinopathies. 
 Previous studies on the underlying mechanism of LQTS-associated calmodulinopathies 
have involved the overexpression of mutant CaM in rodent myocytes (Limpitikul et al., 2014; 
Yin et al., 2014). While such studies have implicated the LTCC (Limpitikul et al., 2014) and 
ruled out the NaV1.5 channel (Yin et al., 2014) as major contributors to the LQT phenotype of 
calmodulinopathy patients, they do not represent the native expression levels of mutant CaM. In 
particular, calmodulinopathy patients harbor a single heterozygous mutation in only one of three 
redundant CALM genes. The ability of the resultant small fraction of mutant CaM protein to 
produce the severe phenotype seen in patients has been attributed to CaM’s pre-association to the 
LTCC (Limpitikul et al., 2014). In this context, a fraction of LTCCs pre-bound to mutant CaM 
will display diminished CDI, disrupting the precise tuning of the AP by Ca2+ influx. The 
profound prolongation of the APs and decreased CDI observed in the iPSCD130G-CaM-CMs 
corroborate just such a dominant negative effect. Moreover, the amelioration of the LQTS 
phenotype of the iPSCD130G-CaM-CMs via suppression of CALM2 transcription firmly establishes 
this mutation as the causative genetic mechanism. However, this new mechanistic insight also 
presents a significant challenge to the treatment of these calmodulinopathy patients. The pre-
association of LTCCs with both mutant and WT CaM makes selective targeting of the disrupted 
LTCCs nearly impossible. Thus, any treatment option for these patients must selectively target 
the mutant CaM, prior to cytosolic expression and binding to the LTCC.  
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 Fortunately, CRISPRi provides just such a therapeutic option. In fact, recent work 
demonstrates that CRISPRi is capable of robust gene knock down within both iPSCs as well as 
iPSC-derived cardiomyocytes, making this a highly attractive method which has already been 
validated for our model system. Moreover, this technique offers the advantages of selectivity, 
reversibility, and generalizability (Gilbert et al., 2013; Qi et al., 2013; Mandegar et al., 2016). 
That is, RNA transcription of specific mutation-containing CALM genes can be repressed, 
without modifying the patient genome and risking permanent alteration of off-target or 
downstream elements (Gilbert et al., 2013; Qi et al., 2013). Further, this technique is 
generalizable to any calmodulinopathy. Here, we present a simple therapeutic toolbox in which 
three gRNAs targeting either CALM1, CALM2, or CALM3 can be chosen to match any 
calmodulinopathy patient. Importantly, this means that while this study focused on the LQTS-
associated calmodulinopathies, the therapy developed here should also be effective for the 
CPVT- and IVF-associated calmodulinopathies. Moreover, as expected due to the widespread 
distribution of CaM, calmodulinopathy patients also exhibit extra-cardiac phenotypes including 
seizures and developmental delays (Crotti et al., 2013). Importantly, the CRISPRi toolkit should 
be effective on these non-cardiac symptoms, as targeting of the CRISPRi can be adjusted to 
include any affected organ systems. 
 More broadly, this therapeutic principle could be applied to the treatment of any disease 
in which there is a redundancy of the affected gene. Thus, the CRISPRi strategy described here 
not only represents a promising new treatment option for calmodulinopathy patients, but could 
provide a generalizable strategy in the treatment of a variety of diseases. Fortuitously, 
development of CRISPR/Cas9 delivery into patients is already well underway (Ran et al., 2015), 
propelling the translation of these findings towards improving patients’ health and quality of life 
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and in the case of patients with a LQTS/CPVT/IVF-associated calmodulinopathy, preventing 
















Figure 3.1 IPSCs recapitulate the calmodulinopathy phenotype. (A) The proband’s 
electrocardiogram taken at 12 hours after birth, illustrating a QTc>700 ms.  (B)  DNA Sanger 
sequencing chromatograms for both a normal control (top) and the patient (bottom) revealing a 
heterozygous c.389 A>G single nucleotide substitution in CALM2 resulting in the p.D130G-CaM 
amino acid substitution.  (C) Schematic rendering of the CaM protein (blue) highlighting the N-
domain and C-domain, each containing two EF hands (labeled EF-I through EF-IV) with Ca2+ 
(red) bound.  Yellow circle indicates the D130G mutation identified in the LQTS patient. (D) 
Exemplar APs from iPSCWT-CMs (WT) paced at 0.5 Hz, recorded via fluorescence imaging 
using ASAP1. Scale bar indicates change in fluorescence as measured by ∆F/F0. (E) Population 
data for mean APDs at various pacing cycle lengths (CL) for iPSCWT-CMs (n=9). Error bars 
indicate ±SEM throughout. Each biological replicate (n) is an average value of 2 technical 
replicates, here and throughout this figure. (F) Population data for iPSCWT-CM APDs at a 2-
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second cycle length across multiple time points (n=9, 9, and 7 on day 30, 45, and 60, 
respectively). G, Exemplar APs from iPSCD130G-CaM-CMs (red). WT reproduced in gray. (H) 
Average APD data for iPSCD130G-CaM-CMs (red) (n=7). WT reproduced in gray (*** p < 0.001 
compared to WT; corrected for unequal variance of normal distributions). (I) Average APDs at a 
2-second cycle length from D130G iPSCs are stable across time (n=7, 7, and 7 on day 30, 45, 
and 60, respectively). (J-L) Alternate D130G clone demonstrating the same result as (G-I) (n=9, 
















Figure 3.2 Disruption of calcium handling in calmodulinopathy iPSCs.  A, Exemplar 
CaTs recorded from iPSCWT-CMs (WT) using GCaMP6f. Scale bar indicates change in 
fluorescence as measured by ∆F/F0. B, Exemplar CaTs recorded from iPSCD130G-CaM-CMs (red) 
as compared to WT (gray). C, Exemplar CaTs from an alternate D130G clone. D-F, Population 
data demonstrating larger amplitude and slower kinetics for both iPSCD130G-CaM-CMs clones (red) 
(Peak, mean peak fluorescence change; Tpeak, mean time to peak; τdecay, mean decay time 
constant; *** p < 0.001 compared to WT and corrected for unequal variance, all populations 
were normally distributed). Error bars indicate ± SEM throughout. Biological replicates (n) are 
10, 7, and 7 for WT, D130G clone #1, D130G clone#2, respectively. Each biological replicate 














Figure 3.3 CDI deficits in calmodulinopathy iPSCs. A, Exemplar whole-cell current 
recordings in Ca2+ (red) and Ba2+ (black) for iPSCWT-CMs. Ba2+ current is normalized to Ca2+ 
peak, scale bar corresponds to Ca2+ here and throughout. B, Mean normalized current and 
voltage relationship obtained in Ba2+ for iPSCWT-CMs. Error bars indicate ± SEM throughout.  
C, Population data for Ca2+ (red) and Ba2+ (black) for iPSCWT-CMs, where r50 quantifies the 
extent of current inactivation across voltages. Red arrow depicts extent of CDI (f50) at 10-mV test 
potential here and throughout (n=6 separate cells for B-C). D, Exemplar whole-cell current 
recordings in Ca2+ (red) and Ba2+ (black) for iPSCD130G-CaM-CMs (n=5). E, There is no significant 
shift (p > 0.05 compared to WT) in the current voltage relationship for iPSCD130G-CaM-CMs as 
compared to WT B. F,  Population data demonstrates a significant decrease in CDI for the 
iPSCD130G-CaM-CMs  (**p < 0.01 compared to WT, corrected for unequal variance). G-I, 












Figure 3.4 Functional rescue of calmodulinopathy via CRISPRi treatment. A, The genomic 
CALM2 gene showing the location of each exon (green).  The gRNA sequence (red) is located in 
an intron prior to the start codon.  B, QPCR results indicating mean relative mRNA levels of 
CALM1-3 in iPSCD130G-CaM-CMs at baseline (gray, n=5) and after CRISPRi treatment (blue, 
n=9). CALM2 level is significantly reduced (*** p < 0.001 compared to untreated and corrected 
for unequal variance) with relatively unchanged levels of CALM1 and CALM3 expression (p > 
0.05) following the treatment. Error bars indicate ±SEM throughout. C, iPSCD130G-CaM-CM APs 
recorded at 0.5-Hz stimulation using ASAP1 at baseline (gray) and after CRISPRi treatment 
(blue). Cells correspond to the same monolayers utilized in B. APD significantly shortens 
following CRISPRi treatment (*** p < 0.001 compared to untreated, corrected for unequal 
variance). Scale bar indicates change in fluorescence as measured by ∆F/F0. D, Exemplar whole 
cell current recordings in Ca2+ (red) and Ba2+ (black) for iPSCD130G-CaM-CMs treated with 
CRISPRi (left panel).  Population data demonstrates a return of CDI following treatment for the 
Ca2+ r50 values (red) as compared to untreated cells (gray, reproduced from Figure 3I).  Black 
shows the r50 values for treated cells in Ba2+. (n=5, * p < 0.05, compared to untreated, no 
significant difference in variance between populations). Each biological replicate (n) is an 
average value of 3 technical replicates/measurements for B and C. There are no technical 












Figure 3.5 CRISPRi can also be used to target either CALM1 or CALM3. A, The genomic 
CALM1 and CALM3 genes showing location of each exon (green).  The gRNA sequence (red) is 
located in an untranslated exon prior to the start codon of CALM1, and in an intron just past the 
start codon of CALM3.   B, QPCR results indicating mean relative mRNA levels of CALM1-3 in 
iPSCWT-CMs at baseline (gray, n=12) and after treatment by CRISPRi targeting CALM1 (blue, 
n=9). CALM1 expression is significantly reduced (*** p < 0.001 compared to untreated, no 
significant difference in variance between populations) with unaltered levels of CALM2 and 
CALM3 (p > 0.05). Error bars indicate ±SEM throughout. C, QPCR results indicating mean 
relative mRNA levels of CALM1-3 in iPSCWT-CMs at baseline (gray) and after treatment by 
CRISPRi targeting CALM3 (blue,  n=9). CALM3 expression level is significantly reduced (*** p 
< 0.001 compared to untreated, no significant difference in variance between populations) with 
unaltered levels of CALM1 and CALM2 (p > 0.05). Each biological replicate (n) is an average 





3.6 Supplementary materials 
3.6.1 Characterization of the iPSC clones 
The iPSC clones generated in this study were derived from a skin biopsy from a patient 
harboring a p.D130G-CaM mutation residing in the CALM2 gene1.  In order to ensure the quality 
of the generated iPSCs, the karyotype and pluripotency of the cells were fully characterized and 





Supplementary Figure 3.1 Assessment 
of karyotype and pluripotency markers 
for the iPSC clones. (A) Sanger 
sequencing of CALM2 genomic DNA 
confirms c.389 A>G. (B) Karyotyping 
results of both iPSC clones revealed 
normal size, shape, and number of 
chromosomes. Karyotyping was 
commercially performed by WiCell 
Cytogenetics. (C) Immunohistochemistry 
demonstrated the presence of pluripotency 
markers: Nanog (red), Oct4 (green), and 
SSEA4 (red).  Nuclei are counter-stained 
with DAPI (blue).  
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3.6.2 iPSCD130G-CaM clones are capable of differentiating into three germ layers 
An important feature of iPSC lines is pluripotency; that is, the ability to differentiate into 
all three germ layers, endoderm, mesoderm, and ectoderm. We have confirmed the pluripotency 
of iPSCD130G-CaM clones both in vitro and in vivo. First, embryoid bodies were generated in vitro 
and markers of three germ layers were labeled by immunohistochemistry (Supplementary Figure 
3.2A). Next, the ability of iPSC clones to form teratomas in vivo was assessed by injection of 
iPSCs into immunodeficient mice (Supplementary Figure 3.2B).  The hematoxyline and eosin 







Supplementary Figure 3.2 Ability of iPSCsD130G-CaM to differentiate into all germ layers. (A) 
Immunostaining of differentiated embryoid bodies for the endoderm-specific α-fetoprotein (AFP, green), the 
mesoderm-specific smooth muscle actin (SMA, red), and the ectoderm-specific glial fibrillary acid protein 
(GFAP, green).  Cells are counter-stained with DAPI for visualization of the nuclei (blue). (B) Five-to-eight-
week-old teratomas harvested from mice injected with undifferentiated iPSCsD130G-CaM. Tissue sections were 
stained with hematoxyline and eosin. All three germ layers, including gut-like structures (Endo: endoderm), 
immature bone and cartilage (Meso: mesoderm), and immature neural tube and neuroectoderm (Ecto: 
ectoderm), are identifiable in teratomas generated from both iPSCsD130G-CaM clones. 
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3.6.3 Expression of genetically encoded sensors 
Expression of the voltage sensor ASAP1 and the calcium sensor GCaMP6f was assesed 
by flow cytometry 7-10 days aftter transduction (Supplementary Figure 3.3).  A large fraction of 
cells expressed the ASAP sensor, while a smaller fraction expressed the GCaMP6f sensor.  The 
expression of GCaMP6f was kept low so as to reduce the potential effect of the sensor on resting 
Ca2+  concentration.  
  
Supplementary Figure 3.3 Quantification of sensor expression. (A-B) Exemplar scatter and histogram plots of 
iPSCWT-CMs and iPSCD130G-CaM-CMs expressing ASAP1. (C) Population data of ASAP1 expression level gauged by 
percentage of fluorescent cells in both iPSC-CM clones. (D-E) Exemplar scatter and histogram plots of iPSCWT-CMs and 
iPSCD130G-CaM-CMs expressing GCaMP6f. (F) Population data of GCaMP6f expression level gauged by % of fluorescent 




3.6.4 qPCR analysis of iPSC-CM mRNA levels 
In this study, we utilized iPSC-CMs with different individual genetic backgrounds for 
control (WT) and calmodulinopathy cells.  In order to ensure that these cells are an appropriate 
control, we examined the RNA profile of the iPSCWT-CMs as compared to the iPSCD130G-CaM-
CMs, focusing on those proteins which might contribute to alterations in QT interval or calcium 
handling (Supplementary Figure 3.4).  Very little difference was found between the two iPSC-
CM lines, with only a small elevation in KCNQ1 (Supplementary Figure 3.4E) and RYR2 
(Supplementary Figure 3.4H) detected.  Importantly, this difference cannot account for the LQT 
phenotype of these cells. In fact, increased levels of KCNQ1 would tend to decrease the QT 
interval.  Moreover, treatment of the iPSCD130G-CaM-CMs did not alter the mRNA level for any 




Supplementary Figure 3.4 Analysis of the genetic background of WT, D130G and D130G treated cells. QPCR 
results indicating mRNA levels of multiple relevant proteins from IPSCWT-CMs (gray), IPSCD130G-CaM-CMs (red) 





3.6.5 Total calmodulin protein levels in iPSC-CMs 
The total calmodulin protein levels in iPSCWT-CMs and IPSCD130G-CaM-CMs was assessed 
using western blot analysis (Supplementary Figure 3.5).  No difference was seen between these 
two cell lines; however a small but statistically significant decrease in calmodulin protein was 
seen following treatment with CRISPRi, consistent with a decrease in CALM2 expression.    
Supplementary Figure 3.5 Assessment of 
calmodulin protein expression. (A) Western 
blot of iPSCWT-CMs, iPSCD130G-CaM-CMs and 
treated iPSCD130G-CaM-CMs probed with anit-
calmodulin.  Samples were normalized to 
total protein as determined with a Coomassie 
stain (inverted intensity image shown at the 
bottom). (B) Normalized intensity of the 
calmodulin protein bands.  No difference in 
calmodulin levels were detected between 
iPSCWT-CMs (gray) and iPSCD130G-CaM-CMs 
(red), however treatment produced a small 
decrease in calmodulin protein (blue). * p < 
0.05. Error bars indicate ± SEM. 
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3.6.6 The AP phenotype is stable at multiple time points 
In the main text we demonstrated APD prolongation at multiple cycle lengths in 
iPSCD130G-CaM-CMs 30 days post-differentiation (Figures 3.1D-L).  The equivalent data was 
obtained 45 and 60 days post-differentiation (Supplementary Figure 3.6) on the same population 
of monolayers in Figure 3.1, demonstrating that the phenotype of the iPSCD130G-CaM-CMs is 
stable over time. Summary data for a cycle length of 2 seconds is displayed in main text Figures 
3.1F, I, L.  
 
  
Supplementary Figure 3.6. Stability of iPSC-CM APs across multiple time points. (A) Exemplar APs from 
iPSCWT-CMs paced at 0.5 Hz, recorded via fluorescence imaging using ASAP1 45 days post-differentiation. Scale 
bar indicates percent change in fluorescence. (B) Population data for average APDs at various cycle lengths (CL) 
for 45-day-old iPSCWT-CMs (n=9). Each biological replicate (n) is an average value of 2 technical 
replicates/measurements for all data in this figure. Error bars indicate ± SEM throughout. (C) Exemplar APs from 
45-day-old iPSCD130G-CaM-CMs (red). WT reproduced in gray. (D) Average APD data for iPSCD130G-CaM-CMs (red, 
n=7) across multiple pacing frequencies. WT reproduced in gray (*** p < 0.001 compared to WT and corrected for 
unequal variance, both populations normally distributed). (E-F) Alternate D130G clone demonstrating the same 
result as C, D (n=9, *** p < 0.001 compared to WT and corrected for unequal variance, both populations normally 
distributed).  (G-L) Equivalent results were observed for iPSCD130G-CaM-CMs 60 days post-differentiation. Format 
as in A-F. (n=7, 7, and 7 for WT, D130G clone#1, and D130G clone#2, respectively; (*** p < 0.001 compared to 
WT and corrected for unequal variance, both populations normally distributed) 
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3.6.7 Disruption of Ca2+ cycling across multiple time points 
In the main text we demonstrated significant disruption of Ca2+ cycling, with CaT 
amplitudes several fold larger in iPSCD130G-CaM-CMs as compared to their WT counterparts 
(Figures 3.2A-F).  The data was collected 30 days post-differentiation, however comparable 
results could also be obtained 45 and 60 days post-differentiation from the same population of 
monolayers in Figure 3.2 (Supplementary Figure 3.7), indicating a stable phenotype of the 
D130G harboring monolayers. 
 
Supplementary Figure 3.7 Stability of iPSC-CM CaTs across multiple time points. (A) Exemplar CaTs 
recorded from 45-day-old iPSCWT-CMs (WT) using GCaMP6f. Scale bar indicates percent change in 
fluorescence. (B) Exemplar CaTs recorded from iPSCD130G-CaM-CMs (red) 45 days post-differentiation, as 
compared to WT (gray). (C) Exemplar CaTs from an alternate D130G clone 45 days post-differentiation. (D-F) 
Population data demonstrating larger amplitude and slower kinetics for both iPSCD130G-CaM-CMs clones compared 
to WT after 45 days in culture (red) (Peak, average peak fluorescence change; Tpeak, average time to peak; τdecay, 
average decay time constant; n=5, 7, and 6 for WT, D130G clone#1, and D130G clone#2, respectively; *** p < 
0.001 compared to WT and corrected for unequal variance, both populations normally distributed). Each 
biological replicate (n) is an average value of 2 technical replicates/measurements for all data in this figure. (G-L) 
Equivalent results were seen for iPSCD130G-CaM-CMs 60 days post-differentiation. Format as in A-F. (n=5, 7, and 6 
for WT, D130G clone#1, and D130G clone#2, respectively; *** p < 0.001 compared to WT and corrected for 




3.6.8 SR content effects in iPSCD130G-CaM-CMs 
Given the large effects of the calmodulinopathy mutation on CaTs, we examined the SR 
content of these cells via application of 5 mM caffeine.  While the SR content did appear 
somewhat enhanced in the iPSCD130G-CaM-CMs as compared to their WT counterparts 
(Supplementary Figure 3.8), this increase did not reach a level of statistical significance.  This 
lack of a significant effect may be representative of the relatively immature nature of the iPSC-
CMs (Rocchetti et al.; Kane et al., 2015). 
  
  
Supplementary Figure 3.8 SR content of iPSCD130G-CaM-CMs. No statistical difference was seen in the SR 
content of iPSCD130G-CaM-CMs (red) as compared to iPSCWT-CMs (gray).  SR content was assessed by application 





3.6.9 Disruption of Ca2+/CaM-dependent inactivation (CDI) of LTCCs at the older 
differentiation age  
In the main text we demonstrated significant disruption of CDI of LTCCs in iPSCD130G-
CaM-CMs as compared to their WT counterparts (Figure 3.3).  The data was collected 30 days 
post-differentiation, however comparable results could also be obtained 60 days post-











Supplementary Figure 3.9 Stability of iPSC-CM LTCC CDI at later time point in culture (A) Exemplar whole-
cell current recordings in Ca2+ (red) and Ba2+ (black) for iPSCWT-CMs 60 days post-differentiation. Ba2+ current is 
normalized to Ca2+ peak, scale bar corresponds to Ca2+. (B) Average normalized current and voltage relationship for 
iPSCWT-CMs (n=7, no technical replicate). Error bars indicate ± SEM throughout.  (C) Population data for Ca2+ (red) 
and Ba2+ (black) for iPSCWT-CMs (n=7, no technical replicate), where r50 quantifies the extent of current inactivation 
across voltages. Red arrow depicts extent of CDI (f50) at 30-mV test potential here and throughout. (D) Exemplar 
whole-cell current recordings in Ca2+ (red) and Ba2+ (black) for iPSCD130G-CaM-CMs 60 days post-differentiation. Ba2+ 
current is normalized to Ca2+ peak, scale bar corresponds to Ca2+. (E) There is no significant shift in the current 
voltage relationship for iPSCD130G-CaM-CMs (p>0.05) as compared to WT (B). (F) Population data demonstrates a 
significant decrease in CDI for the iPSCD130G-CaM-CMs  (n=8, *** p < 0.001 compared to WT, corrected for unequal 
variance). (G-I) Alternate D130G clone at 60 days post-differentiation demonstrating the same result as D-F (n=5, 




3.6.10 A pharmacological study of LQT effects in iPSC-CMs 
Of the various forms of LQT, only three correspond to disruptions in membrane channels 
known to associate with calmodulin: LQT1 (loss of function mutations in KCNQ1), LQT3 (gain-
of-function mutations in SCN5A), and LQT8 (gain-of-function mutations in CACNA1C).  We 
therefore utilized a pharmacological approach to demonstrate that each of these LQT phenotypes 
could be recapitulated within our iPSCWT-CMs.  Application of the LTCC antagonist BayK 8644 
more than doubled the APD80 of iPSCWT-CMs (Supplementary Figure 3.10A). Such a profound 
effect on APD is matched in the clinical setting only by LQT8 (Timothy Syndrome) and LQT15 
(calmodulinopathies) (Supplementary Figure 3.10C), supporting the supposition that the LQT 
seen in calmodulinopathy patients is due, in large part, to disruption of LTCC channels.  
Application of maximal doses of the IKS blocker, chromanol 293B, or the NaV1.5 channel 
agonist, ATX II, produced moderate APD prolongation (Supplementary Figures 3.10A,B), 
corresponding to the clinical phenotype of LQT1 and 3 patients (Supplementary Figures 3.10C).  
Supplementary Figure 3.10 Pharmacological 
study of APD prolongation in iPSCWT-CMs. 
(A) Exemplar AP recordings of iPSCWT-CMs 
(gray) in the presence of 10 µmol/L BayK 8644 
(left, black), 10µmol/L chromanol 293B (middle, 
black) or 0.5 µmol/L ATX II (right, black). (B) 
Average APD80 values measured for each drug. 
Error bars indicate ± SEM throughout.  (C) 
Comparison of reported QT intervals 
corresponding to LQT syndromes associated 
with channels known to interact with CaM.  
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3.6.11 A modeling study of calmodulinopathy CDI deficits 
We have demonstrated a reduction in LTCC CDI underlying the LQTS phenotype of 
iPSCD130G-CaM-CMs (Figure 3.3).  However, it is not possible to rule out the contribution of other 
CaM targets to the overall phenotype. We therefore considered whether a CDI specific effect of 
CaMD130G on the LTCC would be sufficient to produce a calmodulinopathy phenotype. To this 
end, we utilized a validated and publically available model of an adult mammalian ventricular 
myocyte (the Luo-Rudy model: LRd) (Luo and Rudy, 1994a, b; Livshitz and Rudy, 2007; Dick 
et al., 2016).  With this in silico method, we were able to selectively adjust the CDI of the LTCC 
channel to match the CDI data obtained for this mutation (Figure 3.3) (Limpitikul et al., 2014).  
In addition, this model provides insight into calmodulinopathy associated arrhythmias in an adult 
myocyte featuring intact EC coupling (Livshitz and Rudy, 2007; Kane et al., 2015). In 
consideration of the variable expression of mutant CaM expected among calmodulinopathy 
patients, the model was run with variable fractions of LTCC channels harboring CaMD130G.  The 
result was APD prolongation which was dependent on expression levels of CaMD130G in a non-
linear manner (Supplementary Figure 3.11).  At low levels of CaMD130G expression, the APD 
increased monotonically, however a threshold for severe electrical instability was reached near a 
ratio of one in six LTCCs harboring a CaMD130G versus CaMWT.  Importantly, this corresponds to 
the expected expression levels of mutant CaM among calmodulinopathy patients, where the 
cardiac expression of a single CALM allele was determined to be 0.17 ± 0.02 (CALM1), 0.12 ± 
0.01 (CALM2), and 0.21 ± 0.03 (CALM3) based on the average expression levels from five 
different RNAseq databases (Petryszak et al., 2014). Thus calmodulinopathy patients appear to 
lie directly in the vicinity of the threshold for APD instability, making them highly susceptible to 





Supplementary Figure 3.11 Modeling of 
a non-linear dose dependence of APDs 
on mutant CaM expression. (A) Average 
APDs determined from an adult 
mammalian ventricular myocyte model 
(Luo and Rudy, 1994a, b; Livshitz and 
Rudy, 2007; Dick et al., 2016), plotted as a 
function of the fraction of LTCCs 
harboring CaMD130G (relative to the total 
number of LTCCs).  Data is plotted ±SEM.  
The gray area indicates electrical 
instability in the modeled action potentials. 
The rose shading depicts the range of 
physiologically relevant expression levels 
for mutant CaM based on RNAseq 
databases for normal human gene 
expression levels (Petryszak et al., 2014). 
(B) Exemplar action potentials simulated at 
1-Hz pacing corresponding to the colored 
points in A.  Black: no CaMD130G; Blue: 
0.12 CaMD130G; Red: 0.2 CaMD130G.  
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3.6.12 GRNA screening 
Over twenty different gRNAs targeted to CALM1, CALM2 and CALM3 were screened 
(Supplementary Figure 3.12).  Design 21 (Kg116) was chosen for treatment of the CALM2 
iPSCD130G-CaM-CMs (Figure 3.4) as this design demonstrated significant efficacy against CALM2, 
and no appreciable effect against CALM1 or CALM3.  Similarly, design 2 was used for selective 
efficacy against CALM1 (Figure 5B), and design 8 was utilized for CALM3 (Figure 3.5C). 
 
  
Supplementary Figure 3.12 GRNA screening. QPCR results indicating mRNA levels of CALM1-3 in HEK293 
cells after CRISPRi treatment using various candidate gRNA sequences. The dashed line at 1 indicates control cells 
treated with scrambled gRNA. Designs 18-21 (rose) caused a significant decrease in CALM2 mRNA (n=3, * p < 
0.05 compared to control) without altering CALM1 or CALM3, while design 2 selectively decreased CALM1 (n=4, 
# p < 0.05 compared to control) and design 8 selectively decreased CALM3 (n=6, $ p < 0.05 compared to control). 
Each biological replicate (n) is an average value of 3 technical replicates/measurements for all data in this figure. 
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APD90 (ms) Reference 
477 Du et al., 2015(Du et al., 2015) 
548 Spencer et al., 2014(Spencer et al., 2014) 
425 Scheel et al., 2014(Scheel et al., 2014) 
340 Sinnecker et al., 2013(Sinnecker et al., 2013) 
340 Lee et al., 2012(Lee et al., 2012) 
286 Lopez-Izquierdo et al., 2014(Lopez-Izquierdo et 
al., 2014) 
414 Ma et al., 2011(Ma et al., 2011) 
392 This study 
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Supplementary Table 3.2 Sequence of candidate gRNAs. 
gRNA design Sequence 



























3.6.13 Supplementary Methods 
Flow cytometry 
100 uL of 1011 PFU/ml of lentivirus containing either ASAP1 or GCaMP6f gene was 
added to a single well of a 24 well plate, with iPSC-CMs seeded at a density of 2.5 x105 
cells/well.  Flow cytometery was done 7-10 days after the addition of virus using an Accuri C6 
flow cytometer (BD Biosciences). 
Sequencing of CALM2 genomic DNA 
Genomic DNA was isolated from iPSCs using DNeasy Blood & Tissue Kit (Qiagen) 
following manufacturer's protocol. A portion of CALM2 200 base pairs up and downstream from 
c.389 A>G mutation was cloned using standard PCR (forward primer: 5'-
AGGTGTCACTTGACTTTGGGA-3'; reverse primer: 5'-ATTTCAGGGGAAGGGTCACT-3')  
Standard Sanger sequencing was performed on the PCR product using the aforementioned 
forward primer. 
Immunohistochemistry 
Standard fluorescent immunohistochemistry was performed on non-differentiated iPSCs 
and embryoid bodies. Briefly, cells were fixed with 4% paraformaldehyde, permeabilized with 
0.1% Triton X, and stained with primary, secondary antibodies, and finally counter-stained with 
DAPI for nuclear visualization. Primary antibodies included (manufacturer, catalog number): 
polyclonal rabbit anti-Oct4 IgG (AbCaM, ab19857), polyclonal rabbit anti-nanog IgG (AbCaM, 
ab80892), monoclonal mouse anti-SSEA4 IgG (AbCaM, ab16287), polyclonal rabbit anti-glial 
fibrillary acidic protein Ig (Dako, Z0334), rabbit polyclonal anti-smooth muscle action IgG 
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(AbCaM, ab5694), and mouse monoclonal anti-α-fetoprotein IgG1 (R&D Systems, MAB1368). 
Secondary antibodies (all purchased from Invitrogen) include (catalog number): 594 goat anti-
mouse IgG (A-11020), 594 donkey anti-rabbit IgG (A-21207), 488 goat anti-mouse IgG (A-
31620), and 488 donkey anti-rabbit IgG (A-21206). 
Embryoid body formation analysis 
Embryoid bodies (EBs) were formed using a previously described method (Limphong et 
al., 2013). Briefly, iPSCs were enzymatically dissociated using Accutase (Sigma Aldrich) and 
transferred into low-attachment tissue culture plates filled with EB medium to allow clusters of 
cells grown in suspension. After 8 days, EBs were transferred into gelatin-coated treated tissue 
culture plates. EBs were then collected for analysis after 25 days in culture. EB medium included 
20% FBS in knockout DMEM (ThermoFisher Scientific, 10829018) supplemented with 1% L-
glutamine, 1% non-essential amino acids, 1% penicillin-streptomycin, and 0.1 mmol/L β-
mercapto ethanol. 
Teratoma formation 
Teratoma formation analysis was performed as previously described (Ye et al., 2014). 
Briefly, 5x106 of undifferentiated iPSCs were mixed with Matrigel (BD Biosicences) at a 1:1 
ratio and injected intramuscularly into NOD/SCID IL2 receptor gamma chain knockout (NSG) 
mice. Teratomas were harvested 5-8 weeks post injection, paraffin-embedded, sectioned, and 





Western blot for CaM protein quantification 
IPSC-CMs were collected 8-9 post transduction. Cells were lyzed in a Tris-HCl based 
buffer and a western blot of the collected protein was as previously described (O'Rourke et al., 
1999). All samples were run in duplicate on 12.5% Tris-HCl precast gels (Bio-Rad) in 25 
mmol/L Tris, 192 mmol/L glycine, and 0.1% (wt/vol) SDS running buffer. Primary antibody 
incubations were performed overnight at 4°C using rabbit monoclonal anti-calmodulin antibody 
(Abcam, Cat. No. ab45689). Relative band densities were quantified using ImageJ software. The 
intensity of the bands is normalized by total amount of protein obtained from a Coomassie stain. 
SR content measurement 
SR content was measured using the ratiometric calcium dye Indo-1 AM. Cells were 
loaded with 1µmol/L dye for 30 minutes at 37 °C, and rinsed 3 times, followed by additional 10 
minutes incubation in Tyrodes at 37 °C to allow for de-esterification of Indo-1 AM. Cells were 
stimulated for several minutes by application of an electric field across the coverslip using a C-
Pace electrical stimulator (Ion Optix). The bath solution was then exchanged for a Na+-free 
Tyrode’s  solution (Na+ was replaced with choline ion to minimize the action of Na-Ca 
exchanger) with 1.8 mmol/L Ca2+, and 10 mmol/L 2,3-butanedione monoxime. After baseline 
imaging, SR content was determined by the addition of 5 mmol/L caffeine. Fluorescence was 
measured using 340-nm excitation and 405- to 485-nm emission wavelengths. The intracellular 
Ca2+ concentration ([Ca2+]) was calculated as 2 / min max[ ] ( ) /( )d IndoCa K R R R Rβ
+ = ⋅ ⋅ − − , where R 
is the ratio of fluorescence signal at 405 and 485 nm. /d IndoK was 800 nmol/L (Limpitikul et al., 
2014). minR was determined to be 0.33 in a ~ 0 mmol/L Ca2+ Tyrode’s after 30 min incubation 
with BAPTA-AM. maxR was determined to be 20.85 in a Na+-free Tyrode’s (Na+ was replaced 
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with choline ion to minimize the action of Na-Ca exchanger) with 10 mmol/L Ca2+, 25 µmol/L 
digitonin and 10 mmol/L 2,3-butanedione monoxime. β , as defined by the ratio of fluorescence 
signal at 485 nM under Ca2+-free and Ca2+-bound conditions, was determined to be 0.85.  
Ventricular myocyte model (LRd model) 
The original LRd model(Livshitz and Rudy, 2007) was adjusted as previously described 
such that the duration and shape of the action potential was more similar to human(Dick et al., 
2016). Additional adjustments were made to the LTCC module, primarily substituting a CDI 
specific deficit expected for calmodulinopathy into a variable fraction of LTCC channels.  
Equations governing the final LTCC channel pools are as follows:  





The activation gate (d), followed standard Hodgkin and Huxley equations (Hodgkin and Huxley, 
1952): 
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With the gates set, the total current through the L-type channel, as well as the Na+/Ca2+ exchange 





Where POmodeCa represents the relative open probability of the L-type channel in mode Ca2+ as 
compared to mode 1.  iCa, iNa and iK represent the single channel open level as set by the GHK 
equation.  
With the wild type channel in place, a second pool of LTCC channels was added to 
simulate the effect of CaMD130G on the channel. Properties of this pool of channels were made 
based on this study and on the previous biophysical characterization of these channels 
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All other equations in the model not mentioned here were identical to those described(Dick et al., 
2016) and are entirely based on the original 2007 LRd model (Livshitz and Rudy, 2007).  
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Bi-lobal kinetic model of CaV1.2 calcium-dependent inactivation 
4.1 Introduction 
As described in previous chapters, CaV1.2 channel plays a major role in both shaping the 
action potential and triggering myocyte contraction (Bodi et al., 2005). Disruption of the normal 
function of this channel has been linked to multiple disorders, including severe forms of LQTS 
(Crotti et al., 2013; Limpitikul et al., 2014; Yin et al., 2014; Dick et al., 2016; Limpitikul et al., 
2017). To properly perform these critical roles, CaV1.2 channels employ CDI as a major form of 
feedback regulation (Sun et al., 1997; Morotti et al., 2012). Thus accurate knowledge of the 
quantitative details of CDI progression is of critical importance to understanding normal cardiac 
physiology.   
Thus far, we have discussed that the mediator of CDI in CaV1.2 is CaM which is known 
to preassociate with the carboxy-tail of the channel in its Ca2+-free form (apoCaM) (Erickson et 
al., 2001; Pitt et al., 2001; Mori et al., 2004) and has an ability to module the open probability of 
the channel (Adams et al., 2014). This resident CaM also has the remarkable ability to respond 
differentially to Ca2+ originating from distinct spatial sources. Specifically, the C-lobe of CaM 
senses the fluctuation of local Ca2+ concentration at the mouth of the channel, while the N-lobe 
detects the global cytosolic Ca2+ level (Dick et al., 2008; Tadross et al., 2008). However, the 
extent of cooperativity between the two lobes in this bi-lobal scheme remains to be determined. 
This bi-lobal scheme plays an important role in human (patho)physiology, allowing channels to 
respond appropriately to both local and distant signals. In particular, mutations disrupting Ca2+ 
binding within the C-lobe of CaM were shown to cause a malignant form of LQTS via disruption 
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of CaV1.2 CDI (Crotti et al., 2013; Limpitikul et al., 2014; Yin et al., 2014; Limpitikul et al., 
2017). Thus full understanding of both normal and pathologic states requires consideration of the 
bi-lobal regulation of CaM on CaV1.2. 
Given the importance of CDI to physiological function, numerous in-silico models have 
been utilized to gain a more in-depth understanding of how CDI plays a role in the context of the 
cardiac action potential. To date, several methods have been deployed to model the CDI of 
cardiac CaV1.2 channels. One method involves treating both VDI and CDI like canonical 
Hodgkin and Huxley gates, dependent on voltage or Ca2+ concentration, respectively. That is, 
total Ca2+ current is a product of conductance, VDI ‘gate,’ CDI ‘gate,’ and a driving force based 
on Goldmann-Hodgkin-Katz equation (Hund and Rudy, 2004; ten Tusscher et al., 2004; ten 
Tusscher and Panfilov, 2006). Building on this, a second method includes Markovian models 
containing closed, open, and inactivated states of CaV1.2. Here, rate constants for the transition 
into a fraction of the inactivated states depend on voltage (representing VDI) while transitions 
into remaining inactivated states depend on Ca2+ concentration (representing CDI). However, 
these aforementioned models fail to consider the true allosteric mechanism of CDI, where Ca2+-
inactivated channels maintain the ability to open, but with a reduced (yet non-zero) Po (Faber et 
al., 2007; Mahajan et al., 2008b). A few models have partially addressed this issue. However, in 
these models, the majority of inactivation is carried out by VDI (Jafri et al., 1998; Greenstein and 
Winslow, 2002; Decker et al., 2009), in contrast to the known dominance of CDI over VDI in 
CaV1.2 channels in a physiological setting (Sun et al., 1997; Morotti et al., 2012). Although these 
approximations of CaV1.2 inactivation can indeed produce Ca2+ current (ICa(L)) with kinetics that 
grossly resembles experimental ICa(L) recorded during action potentials in vitro, they do not take 
into account the true allosteric and bi-lobal nature of CaM regulation of CaV1.2, thus limiting 
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their utility in describing CaV1.2 gating in response to variable spatial Ca2+ signals (Sun et al., 
1997; Dick et al., 2008; Tadross et al., 2008). Attempting to capture this distinct CDI kinetics, 
some have included the addition of two time constants for CDI (Hund and Rudy, 2004; O'Hara et 
al., 2011). Yet the true bi-lobal response of CaV1.2 remains unexplored.  
One obstacle to development of accurate CDI models is the quality of experimental data. 
As the CaV1.2 channel fluxes the very Ca2+ ions that modulate its own opening, it is challenging 
to accurately control and measure the amount of Ca2+ that the preassociated CaM actually senses. 
Moreover, during the action potential, there is at least ~ 10 fold difference in Ca2+ concentration 
in the dyadic space facing the mouth of the channel and the rest of the cytoplasm (Neher, 1998). 
Most experimental values of Ca2+ used to drive and/or validate the CDI models are measured by 
cytosolic Ca2+-sensitive fluorescence dyes, of which the readout represents average of 
bulk/global and subspace/local Ca2+ concentrations. This readout thus does not accurately 
represent the concentration resident CaM actually sees. Here, we take advantage of a method 
called photo-uncaging (Lipp et al., 1996) to deliver a controlled amount of Ca2+ to the channels 
while simultaneously monitor the cytosolic concentration of Ca2+.  
Using this technique, we measured CDI for each lobe of CaM individually and resolved the 
kinetic response to known levels of Ca2+.  This new, high resolution data enabled the creation of 
a four state model for independent N- or C-lobe mediated CDI.  Our models 
successfully recapitulate both the kinetic and steady-state properties of CDI for each 
lobe. Next, we considered the integrated effect of bi-lobal CaM on CaV1.2 CDI.  Using 
experimental CDI measurements for wild-type CaM (CaMWT), we constructed a sixteen-
state model of bi-lobal CaM regulation. Not only can this full model effectively 
capture both the kinetics and steady-state behavior of CDI under physiological conditions, but it 
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also recapitulates the behavior of calmodulinopathic CaM. Thus, this novel CDI model could 
prove to be an invaluable asset in understanding of both physiological and pathological states 
of CaV1.2 regulation. 
4.2 Materials and methods 
4.2.1 Molecular Biology 
The CaV1.2 channel used in this study was comprised of the human α1C cardiac isoform 
corresponding to Acc# Z34810 within the pcDNA3 vector.  The original channel backbone was a 
kind gift from Tuck Wah Soong (Tang et al., 2004) and was modified as previously described  
(Dick et al., 2016) to conform to the desired cardiac isoform.  The point mutation E736A (in the 
S6 helix of domain II) (Ellinor et al., 1995) was introduced using standard overlap extension 
PCR, resulting in a Ca channel with increased selectivity for Li+ (CaV1.2E2A).  
Engineered rat brain CaM12, CaM34, and CaM1234, in which the aspartate-to-alanine 
mutations were introduced in the EF hands of N-lobe, C-lobe, and both lobes respectively, were 
kind gifts from John P. Adelman (Vollum Institute, Portland, OR). The LQTS CaMD130G 
mutation was generated using QuikChange™ site-directed mutagenesis (Agilent) on rat brain 
CaM (M17069) in the pcDNA3 vector (Invitrogen). Both wild-type and engineered CaMs were 
cloned into the pIRES2-ECFP vector, modified from pIRES2-EGFP (Clontech Laboratories, 
Inc.), using NheI and BglII, thus allowing visualization of positively transfected cells. 
4.2.2 Transfection of HEK293 cells 
HEK293 cells were cultured on glass coverslips in 10-cm dishes. α1C along with its 
auxiliary subunits β2a (M80545) and α2δ (NM012919.2) were transiently transfected along with 
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either WT or mutant CaM using a standard calcium phosphate method (Peterson et al., 1999). 8 
µg of each plasmid was used, along with 2 µg of simian virus 40 T antigen cDNA in order to 
ensure robust expression. 
4.2.3 Whole Cell Electrophysiology 
Whole-cell voltage-clamp recordings of HEK293 cells were performed at room 
temperature 1-2 days after transfection. Recordings were obtained using an Axopatch 200B 
amplifier (Axon Instruments). Whole-cell voltage-clamp records were digitally sampled at 10 
kHz and low pass filtered at 5 kHz. P/8 leak subtraction was used, with series resistances of 1-2 
MΩ. For Ca2+-uncaging experiments, internal solutions contained (in mM): 135 CsCl, 40 
HEPES (pH 7.4), 1-2 Citrate, either 5 μM Fluo-2 (TefLabs) + 5 μM Fluo-2 Low Affinity 
(TefLabs) or 10 μM Fluo-4FF (Invitrogen), 2.5 μM Alexa568 (Invitrogen), 2 DMNP-EDTA 
(Invitrogen) and 0.25-1 CaCl2. In order to ensure proper quantification of Ca2+ at various levels, 
we selected ca dyes with variable Ca2+ affinities as required for the range of Ca2+ measured.  For 
all Ca2+ steps below 10 μM, we utilized an internal solution containing the mixture (see above) 
of Fluo-2 Low Affinity (Kd = 6.7 µM) and Fluo-2 high Affinity (Kd = 230 nM).  This allowed 
clear resolution of low basal Ca2+ (pre-flash) as well as the ability to distinguish even small or 
moderate Ca2+ steps (post-flash) (Lee et al., 2015). This enhanced range of Ca2+ measurements 
permitted precise measurement of the time varying Ca2+ concentration following the flash, 
allowing our model to account for the kinetic changes in both Ca2+ and CDI.  In order to obtain 
accurate measurements of Ca2+ steps in the range above10 uM, Fluo-4FF (Kd = 9.7 µM) was 
used (Dick et al., 2016). To decrease the variability across experiments, each dye mixture was 
pre-mixed in a large stock and used throughout the study. Calibration of premixed stocks of 
Fluo-2/Alexa was performed by Lee et al (Lee et al., 2015) and Fluo-4FF/Alexa by Dick et al 
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(Dick et al., 2016). Experiments were performed in external solutions containing (in mM): 80 
TEA-MeSO3, 10 HEPES (pH 7.4), 80 LiCl, and 2 EGTA at 300 mOsm adjusted with glucose. 
During current recordings, Ca2+ concentration was measured by exciting the dyes with a 
514-nm Argon laser, via a 545DCLP dichroic mirror and either a 545/40BP (Fluo) or 580LP 
(Alexa568) filter. Fluorescence intensity was measured via photomultiplier tubes. Brief UV 
pulses used to produce Ca2+ steps were generated by a Cairn UV flash photolysis system. The 
amount of Ca2+ delivered to channel was controlled by adding different ratios of CaCl2 to DMN 
in the pipette solution and varying the UV intensities achieved by adjusting the voltage (50-
200V) and total capacitance (500-4000 μF) of the flash photolysis system. 
4.2.4 Computational Simulations 
For all models of CDI, a set of ODEs was used to represent probability of being in each 
state (Figures 4.3A, 4.4A, and 4.5A) with the sum of all probabilities equal to 1. All simulations 
were performed using Matlab (MathWorks). ODEs were solved using ode23t. Ca2+ input, 
[Ca2+](t), was idealized from experimental data before feeding into the model. Model 
optimization was performed by using patternsearch to minimize the error between 
experimental and simulated current. 
4.3 Results 
4.3.1 Experimental quantification of CDI as a function of Ca2+ 
In order to create a detailed kinetic model of CDI, we first need to address the paucity of 
high resolution experimental data at known Ca2+ concentrations. To do this, we must overcome 
the experimental challenge of coupled CaV1.2 gating and Ca2+ entry. We thus utilize Li+ as the 
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charge carrier across the channel (Figure 4. 1A) (Ellinor et al., 1995), while controlling 
intracellular Ca2+ via the Ca2+ cage DM-nitrophen (DMN). We are thus able to deliver a spatially 
uniform concentration of intracellular Ca2+ such that measured bulk cytosolic Ca2+ is identical to 
that surrounding the CaM residing on the channel (Tadross et al., 2013; Lee et al., 2015).  
Specifically, during patch clamp recording, we dialyzed DMN into HEK293 cells co-transfected 
with CaM and human cardiac CaV1.2 channels. Then, upon delivery of a UV pulse, the ester 
bonds of DMN are cleaved and Ca2+ is released into the cytosol. In this setting, the magnitude of 
the Ca2+ step delivered can be controlled by adjusting the intensity of the UV light and the 
varying the ratio between Ca2+ and DMN in the dialysate (Figures 4.1B, C). To measure the real-
time concentration of Ca2+, we added Ca2+ sensitive dyes into the dialysate and simultaneously 
recorded the fluorescence intensity and Li current (Figure 4.1A). As the physiologically relevant 
range of Ca2+ is larger than the dynamic range of a single Ca2+ dye, we combined known ratios 
of low- and high-affinity Ca2+ dyes (Fluo-2 HighAff and Fluo-2 LowAff) to accurately measure 
[Ca2+] across the entire range (Lee et al., 2015).  
We next considered the effect of intracellular Ca2+ on Li+ entry (Ellinor et al., 
1995)through the channel.  Due to the high affinity of Ca2+ for the channel pore, intracellular 
Ca2+ has been shown to block the entry of monovalent ions in a process known as pore block 
(Ellinor et al., 1995). In order to mitigate this artifact, we introduced a mutation (E736A) into the 
selectivity filter of domain II in the α1 subunit of the CaV1.2 channel (CaV1.2E2A) which is known 
to shift the selectivity of the channel in favor of Li+ (Ellinor et al., 1995). In order to characterize 
the extent of residual Ca2+ pore block in CaV1.2E2A, we co-expressed the channel with CaM1234, 
an engineered CaM in which the Ca2+ binding of all four EF hands has been disrupted.  Under 
these conditions, Li+ current displays a slow decay in current amplitude, indicative of VDI 
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(Figure 4.1A). Upon Ca2+ photouncaging, a small instantaneous drop in current demonstrates the 
remaining pore block of the CaV1.2E2A channel (Figures 4.1B, C). This residual pore block can 
be quantified as: 






         (4.1) 
where IpreUV is current measured 20 ms before the UV pluses, Iend is current remaining at the end 
of the voltage step, and ‘nf’ and ‘f’ represent current without and with UV flash delivered at 150 
ms after channel activation, respectively. For CaV1.2E2A, fblock increases monotonically as a 
function of Ca2+ (Figure 4.1D) and can be fitted with the Hill equation,  
      𝑓𝑓block = ampblock ∗
[Ca ]nHill
[Ca ]nHill +Kd /block
nHill         (4.2) 
with amplitude (ampblock) = 1, Hill coefficient (nHill) = 1, and Kd/block = 33 µM for Fluo-2/Alexa 
or 55 µM for Fluo-4FF/Alexa, which are comparable to what was previously described (Ellinor 
et al., 1995; Dick et al., 2016). 
This setup can now be used to probe the extent of CDI of CaV1.2 at various cytosolic 
level of Ca2+. When CaV1.2E2A is now co-expressed with wild-type CaM (CaMWT), step release 
of Ca2+ (Figure 4.1F, red) results in robust inactivation of the Li+ current (Figure 4.1F, black) 
indicating CDI. Importantly, the confounding effects of VDI can be eliminated in two ways.  
First, we co-expressed our channels with the beta2A isoform, which is known to minimize the 
extent of VDI in the channel complex (Dafi et al., 2004).  Second, we can eliminate any residual 
VDI by utilizing the pre-flash current as our baseline for CDI measurements (Eqn. 3). Further, by 
varying the amplitude of the Ca2+ step, we can quantify the extent of steady-state CDI as a 
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function of Ca2+ (Figure 4.1G). Here, the normalized ratio of current reduction after Ca2+ 
delivery (fCDI,app, Figure 4.1G) represents the combination of true CDI (fCDI,true, Figure 4.1H) and 
residual pore block (fblock, Figure 4.1D): 






= 1 − (1 − 𝑓𝑓𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 ) ∗ �1 − 𝑓𝑓𝐶𝐶𝐶𝐶𝐼𝐼 ,𝑡𝑡𝑝𝑝𝑡𝑡𝑒𝑒 �       (4.3) 
(see APPENDIX [1] for derivation).  Thus, the true CDI can be calculated (Figure 4.1H) and fit 
with a Hill equation of the form 
    𝑓𝑓𝐶𝐶𝐶𝐶𝐼𝐼 = 𝐶𝐶𝐶𝐶𝐼𝐼𝑚𝑚𝑎𝑎𝑚𝑚 ∗
[Ca ]nHill
[Ca ]nHill +Kd
nHill          (4.4) 
where CDImax,WT = 0.88,  nHillWT = 2.5, and Kd,WT = 0.52 µM, comparable to previously 
described values (Dick et al., 2016). Thus, we have a robust method for quantifying the extent of 
CDI in response to controlled concentrations of intracellular Ca2+, providing parameters which 
will serve as a foundation for in silico models. 
4.3.2 Measurement of N- and C-lobe mediated CDI 
Prior studies have demonstrated separate forms of CDI mediated independently by the N- 
or C-lobe of CaM.  Importantly, these two forms of CDI respond to spatially distinct Ca sources, 
each utilizing different mechanistic schemes (Dick et al., 2008; Tadross et al., 2008). However, 
this unique feature of CaM is not represented in published in silico models of CDI.  This lack of 
lobe-specific detail is, in large part, the result of limited data pertaining to each lobe of CaM.  
We therefore undertook detailed characterization of the N- and C-lobe mediated CDI.  
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To begin, we utilize an engineered CaM (Keen et al., 1999), in which Ca2+ binding of the 
C-lobe is abolished (CaM34), allowing the resolution of N-lobe mediated CDI alone (Peterson et 
al., 1999). CaV1.2E2A co-expressed with CaM34 displays robust Li+ current at baseline (Figure 
4.2A).  However, upon photouncaging of Ca2+, the current decays exponentially (Figure 4.2B, 
black) with notably different kinetics as compared to CaMWT (Figure 4.1F). By varying the 
amount of Ca2+ delivered, we can describe the extent of steady-state N-lobe-mediated CDI as a 
function of intracellular Ca2+ (Figure 4.2C). This relationship can be fitted with a Hill equation 
(Eqn. 4) with CDImax,N = 0.62, Hill coefficient nHillN = 1.8, and Kd,N = 0.9 µM. 
Similarly, CDI mediated by the C-lobe CaM can be probed by measuring Li+ current 
through CaV1.2E2A co-expressed with an engineered CaM with restricted C-lobe only Ca2+ 
binding (CaM12) (Keen et al., 1999). Here, photouncaging Ca2+ results in a rapid inactivation of 
the Li+ current (Figure 4.2E, black) at a faster rate than in the presence of CaM34 (Figure 4.2B).  
Notably, this increased kinetic response of C-lobe CaM occurs at each level of Ca2+ measured.  
Moreover, steady-state CDI mediated by the C-lobe of CaM can also be fit by a Hill equation 
(Eqn. 4), with CDImax,C = 0.66, Hill coefficient nHillC = 1.4, and Kd,C = 1.15 µM. Importantly, the 
Kd values obtained for N- and C-lobe CaM are each greater than that obtained for CaMWT (0.9, 
1.15 and .5 µM respectively), indicating that the two lobes are not functioning entirely 
independently, and cooperativity between the two lobes must be considered in determining the 
behavior of CaMWT.  
4.3.3 CaM lobe specific models of CDI 
Having achieved robust experimental measurements of CDI mediated by each lobe of 
CaM, we now have the necessary components to build a kinetic model of CDI in silico. We 
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begin by first considering each lobe of CaM independently, utilizing the experimental results 
obtained for CaM34 and CaM12. As current models sufficiently address the voltage dependent 
component of inactivation (VDI), we restrict our model to the context of CDI. Importantly, this 
focus does not ignore the importance of VDI, as this component can be added into any model 
due to the independence of these two processes (Luo and Rudy, 1994a; Jafri et al., 1998; Hirano 
and Hiraoka, 2003; Findlay et al., 2008) as such: 
     𝐼𝐼(𝑡𝑡) = 𝐼𝐼𝑚𝑚𝑎𝑎𝑚𝑚 (𝑡𝑡) ∗ 𝑝𝑝𝐶𝐶𝐼𝐼(𝑡𝑡) ∗ 𝐶𝐶𝐶𝐶𝐼𝐼(𝑡𝑡)        (4.5) 
where I(t) is the total current remaining after CDI and VDI are considered, Imax(t) is the 
maximum current amplitude based solely on channel activation.  
To create our CDI models, we first considered the allosteric nature of CDI, in which 
channels bound to apoCaM open with a relatively high Po (mode 1 gating), while channels 
harboring a Ca2+-bound CaM transition into a low Po mode of gating ‘mode Ca’(Imredy and Yue, 
1994; Adams et al., 2014). Once in mode Ca, channels maintain the ability to open, but with a 
reduced open probability, resulting in CDI.  Importantly, recent work indicates that this mode 
transition occurs upon the departure of apoCaM, such that channels devoid of apoCaM may be 
indistinguishable from channels bound to Ca2+/CaM. We first applied these principles to create a 
model of N-lobe mediated CDI.  Here, we assume that the C-lobe will remain in the apo-state 
and thus will not contribute to CDI, while the N-lobe will independently orchestrate its own form 
of CDI (Figure 4.2C). We therefore created a 4-state model of N-lobe CDI, such that each 
individual state represents a channel in either the mode 1 (apoCaM bound, high Po) or mode Ca 
(empty channel or Ca-CaM bound; low Po) (Figure 4.3A). Specifically, state 1 represents 
apoCaM34 bound to the carboxy-terminus of the channel, while state 2 depicts a departure of the 
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N-lobe from the channel, allowing Ca2+ to bind (state 3) and the calcified N-lobe to subsequently 
bind to its effector site on the amino-terminus of the channel (state 4) (Dick et al., 2008; Tadross et 
al., 2010). For the binding of Ca to CaM, we employed simultaneous Ca2+ (un)binding, as has 
been demonstrated for the two EF hands within each lobe of CaM (Martin et al., 1985; Linse et al., 
1991). Moreover, we define the open probability of state 1 (apoCaM34 bound) to be 𝑃𝑃𝑂𝑂,𝑚𝑚𝑎𝑎𝑚𝑚  while 
assuming the open probability of states 2, 3 and 4 is reduced by a factor fN (fractional open 
probability in mode Ca) (Tadross et al., 2008; Tadross et al., 2010) such that  
𝑓𝑓𝑁𝑁 = 1 − 𝐶𝐶𝐶𝐶𝐼𝐼𝑚𝑚𝑎𝑎𝑚𝑚 ,𝑁𝑁       (4.6) 
And the open probability of these mode Ca states is fN*𝑃𝑃𝑂𝑂,𝑚𝑚𝑎𝑎𝑚𝑚 . From our experimental 
measurements (Figure 4.2C) we obtain fN = 0.38.  We can then express the time-varying extent 
of CDI as 
   𝐶𝐶𝐶𝐶𝐼𝐼(𝑡𝑡) = 𝐼𝐼𝑓𝑓(𝑡𝑡)
𝐼𝐼𝑒𝑒𝑓𝑓 (𝑡𝑡)
= 𝑀𝑀1(𝑡𝑡) + 𝑓𝑓𝑁𝑁 ∗ (𝑀𝑀2(𝑡𝑡) +𝑀𝑀3(𝑡𝑡) +𝑀𝑀4(𝑡𝑡))      (4.7) 
where 𝑀𝑀𝑚𝑚(𝑡𝑡) is the probability of channels being in state x at time t (see APPENDIX [2] for 
detailed differential equations). 
We next optimized our model parameters (Table 4.1) to create the best fit to our kinetic 
(Figure 4.2B) and steady state (Figure 4.2C) experimental data for CaM34. To begin, we 
idealized our experimental Ca2+ measurements, to be used as a model input (Figure 4.3B, 
bottom). Accordingly, we simulated currents in response to three different Ca2+ step inputs, 
yielding optimized rate constants as described in Table 4.1.  Notably, our model accurately 
recapitulates the kinetic and steady state aspects of our experimental data (Figures 4.3B, C red = 
simulation, black = experiment), with kon,N and koff,N, comparable to values previously reported 
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(Bayley et al., 1984; Martin et al., 1985; Stemmer and Klee, 1994; Black et al., 2005; Saucerman and 
Bers, 2008).  
We next considered whether the parameters of this N-lobe model preserve the spatial 
Ca2+ selectivity of N-lobe CaM. In particular, the N-lobe of CaM is known to respond 
preferentially to local vs. global Ca2+, dependent on the channel context (Dick et al., 2008; Tadross 
et al., 2008). This ability to switch between spatial Ca2+ selectivity is an important feature of N-
lobe CaM regulation, allowing some channels to tune their response to different Ca2+sources 
(Tadross et al., 2008).  It is therefore necessary to ensure that our model remains consistent with 
this feature.  To address this, we consider the closed form solution of steady-state CDI described 
by Tadross et al which defines the spatial selectivity of N-lobe CaM: 
    𝐶𝐶𝐶𝐶𝐼𝐼(∞) = 𝐶𝐶𝐶𝐶𝐼𝐼𝑚𝑚𝑎𝑎𝑚𝑚 ∗
𝑃𝑃𝑂𝑂∗𝑝𝑝
𝑃𝑃𝑂𝑂∗(𝑝𝑝−1)+1/𝜀𝜀+1
        (4.8) 
where CDI(∞) is steady-state CDI; CDImax is the extent of CDI when all channels are in mode 
Ca; Po is the open probability; 𝜀𝜀=bN/aN; and r = eN/(dN*𝜀𝜀) (Tadross et al., 2008). Here, r > 1 and 
r < 1 represents local and global Ca2+ selectivity, respectively. Based on our N-lobe model 
parameters (Table 4.1), r = 1.1, which confirms a local Ca2+ selectivity with a relatively 
intermediate profile (r close to 1), as expected for this channel (Dick et al., 2008; Tadross et al., 
2008). Thus, while the model was optimized using a spatially uniform release of Ca2+, the local 
selectivity of N-lobe CaM remains intact. 
Having established a functional model of N-lobe CaM signaling, we next sought to create 
a similar model for C-lobe mediated CDI.  Using the same approach as with the N-lobe model, 
we created a 4-state model of C-lobe mediated CDI (Figure 4.4A, see APPENDIX [2] for 
detailed differential equations for each mode). We again defined the open probability of state 1 
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(apoCaM12 bound) to be 𝑃𝑃𝑂𝑂,𝑚𝑚𝑎𝑎𝑚𝑚  while assuming the open probability of states 2, 3 and 4 to be 
fC*𝑃𝑃𝑂𝑂,𝑚𝑚𝑎𝑎𝑚𝑚  with fC defined as:  
𝑓𝑓𝐶𝐶 = 1 − 𝐶𝐶𝐶𝐶𝐼𝐼𝑚𝑚𝑎𝑎𝑚𝑚 ,𝐶𝐶=0.34      (4.9) 
We then express the time-varying extent of CDI as 
   𝐶𝐶𝐶𝐶𝐼𝐼(𝑡𝑡) = 𝐼𝐼𝑓𝑓(𝑡𝑡)
𝐼𝐼𝑒𝑒𝑓𝑓 (𝑡𝑡)
= 𝑀𝑀1(𝑡𝑡) + 𝑓𝑓𝐶𝐶 ∗ (𝑀𝑀2(𝑡𝑡) + 𝑀𝑀3(𝑡𝑡) + 𝑀𝑀4(𝑡𝑡))       (4.10) 
where 𝑀𝑀𝑚𝑚(𝑡𝑡) is the probability of channels being in state x at time t (see APPENDIX [2] for 
detailed differential equations). We then optimized the parameters (Table 4.1) by matching the 
kinetic (Figure 4.2E) and steady state (Figure 4.2F) experimental data for CaM12. The simulated 
currents (Figure 4.4B) align well with the experimental data, capturing both the initial rapidly 
inactivating and the following slowly inactivating phases, as well as the steady-state response to 
Ca2+ (Figure 4.4C). Again, the kinetics of Ca2+ binding and unbinding to C-lobe of CaM, kon,C 
and koff,C, are comparable to those previously described for this lobe (Bayley et al., 1984; Martin et 
al., 1985; Stemmer and Klee, 1994; Black et al., 2005; Saucerman and Bers, 2008).  
Next, we confirmed that the invariably local Ca2+ selectivity of C-lobe CaM  (Dick et al., 
2008; Tadross et al., 2008) is preserved in our model.  Previous reports have demonstrated that the 
C-lobe of CaM consistently responds to local Ca2+ signals due to the relatively slow kinetics of 
Ca2+ release from the C-lobe as compared to channel closings (‘slow CaM’ mechanism) (Tadross 
et al., 2008). Quantitatively this can be expressed as a constraint of the parameter Keff, which 
represents the balance between Ca2+ entry through the channel and the affinity of C-lobe CaM 








     (4.11) 
where Calocal is the Ca2+ concentration at mouth of the channel (Tadross et al., 2008). When Keff 
<<1, CaM will invariably produce a local Ca selectivity.  For our model, is we approximate the 
local Ca2+ concentration to be that expected for Ca2+ entry during a single channel opening 
(Calocal ~ 100 µM) we obtain a value of Keff = 3.3e-3, thus validating that the C-lobe of CaM will 
function as a local Ca2+ sensor.  
4.3.4 Integrated model of CaM regulated CDI 
Having established independent models of lobe-specific CaM mediated CDI, we next 
sought to integrate these models into a full model representing the kinetic response of both lobes 
of CaM simultaneously (CaMWT). Cognizant of the potential interdependence of the two lobes of 
CaM, we created a 16-state bi-lobal model of CDI (Figure 4.5A).  Our model incorporates the 
rate constants from both the N- and C-lobe models (Figures 4.3A, 4A, and Table 4.1), as well as 
multiple cooperativity factors (g, h, k, l, m, n, p, and q) representing potential communication 
between the lobes (Figure 4.5A).  In addition, we assumed that a transiently dissociated CaM 
(states 6, 7, 10, 11) is unlikely to diffuse away from the channel alcove due to the limiting rate of 
exchange between cytosolic and channel-associated CaMs (Chaudhuri et al., 2005).  As in the 
reduced models,  the open probability in state 1 (both lobes of apoCaM bound) is defined to be 
𝑃𝑃𝑂𝑂,𝑚𝑚𝑎𝑎𝑚𝑚 , while the open probability in states 2, 3 and 4 is defined as  fN* 𝑃𝑃𝑂𝑂,𝑚𝑚𝑎𝑎𝑚𝑚 , the open 
probability in states 5, 9 and 13 is fC* 𝑃𝑃𝑂𝑂,𝑚𝑚𝑎𝑎𝑚𝑚 , and the open probability in states 6, 7, 8, 10, 11, 






= 𝑀𝑀1(𝑡𝑡) + 𝑓𝑓𝑁𝑁 ∗ �𝑀𝑀2(𝑡𝑡) + 𝑀𝑀3(𝑡𝑡) + 𝑀𝑀4(𝑡𝑡)�+𝑓𝑓𝐶𝐶 ∗ (𝑀𝑀5(𝑡𝑡) + 𝑀𝑀9(𝑡𝑡) +
𝑀𝑀13(𝑡𝑡))+𝑓𝑓𝑊𝑊𝑊𝑊 ∗ (𝑀𝑀6(𝑡𝑡) + 𝑀𝑀7(𝑡𝑡) + 𝑀𝑀8(𝑡𝑡)+𝑀𝑀10(𝑡𝑡) + 𝑀𝑀11(𝑡𝑡) + 𝑀𝑀12(𝑡𝑡)+𝑀𝑀14(𝑡𝑡) +𝑀𝑀15(𝑡𝑡) +
𝑀𝑀16(𝑡𝑡))              (4.12) 
where 𝑀𝑀𝑚𝑚(𝑡𝑡) is the probability of channels being in state x at time t (see detailed equations in 
APPENDIX [3]).  
Fitting our experimental data for CaV1.2E2A co-expressed with CaMWT with our model 
enabled us to optimize the parameters (Table 4.1), resulting in a bi-lobal model which accurately 
recapitulates both the kinetic (Figure 4.5B) and steady state (Figure 4.5C) behavior of CaM 
mediated CDI. In addition, our model predicts cooperativity factors with both positive (>1, 
increased likelihood of the transition) and negative (<1, decreased likelihood of the transition) 
cooperativity. Scrutinizing these cooperativity factors, we see that the unbinding of a single 
apoCaM lobe from the channel appears to result in a less favorable conformation, promoting 
transitions out of these states (g, m >1). Moreover, states in which CaM has fully dissociated 
from the channel (states 6, 7, 10, 11) reveal decreased transitions to CaM bound states (n, h <1), 
fitting with an effectively decreased local CaM concentration (Mori et al., 2004). Finally, 
transitions to full CDI (state 16) proceed more rapidly following single lobe CDI (states 12, 15, q 
and l >> 1). Thus our model successfully captures the interplay between the two lobes of CaM, 
commenting on an important feature of CDI.   
4.3.5 Modeling calmodulinopathy 
To gauge the utility of our bi-lobal CDI model, we applied it in the context of a known 
calmodulinopathic mutation D130G.  This missense mutation occurs within the fourth EF hand 
of CaM, resulting a  ~ 50 fold decrease in the Ca binding affinity of the C-lobe (Crotti et al., 2013; 
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Hwang et al., 2014) and results in a significantly increased QT interval, rendering patients 
susceptible to arrhythmogenic activities (Arevalo et al., 2007).  At the cellular level, this is 
demonstrated by a prolongation of the action potential (Figure 4.6A), which is largely due to 
disruption of CaV1.2 CDI. We thus applied our 16-state model to CaMD130G mediated CDI.  To 
begin, we probed CDI from CaV1.2 channels co-expressed CaMD130G using our photouncaging 
technique (Figure 4.6B, C black). Here, the CDI is significantly reduced even at very high 
concentrations of calcium (Figure 4.6C).   Moreover, the steady-state CDI mediated by 
CaMD130G (Figure 4.6C) can be fit with a Hill equation (Eqn. 4) with CDImax,D130G = 0.62, 
nHillD130G = 1.8, and Kd,D130G = 0.9 µM.  Notably, this represents the identical parameters used to 
describe the steady-state behavior of the N-lobe-mediated CDI. Thus, this mutation in a single 
EF hand appears to disrupt CDI to the same extent as CaM34, in which both C-lobe EF hands are 
ablated.   
In order to incorporate this mutation within our 16-state CDI model, we decreased kon,C by 50 
fold in accordance with the loss of Ca binding affinity for this lobe, and dramatically reduced the 
cooperativity factors g and m, preventing CDI from proceeding via C-lobe CaM (Table 4.2). The 
resultant model was able to accurately predict the kinetic (Figure 4.6B) and steady-state (Figure 
4.6C) properties of CaMD130G mediated CDI, thus demonstrating the utility of this bi-lobal CDI 
model in both physiologic and pathologic conditions. 
4.4 Discussion 
CDI is a critical regulatory feature of CaV1.2 channels, playing a critical role in setting the action 
potential duration in the heart.  Disruption of the normal CDI of these channels has been linked 
to severe LQTS and life-threatening arrhythmias (Limpitikul et al., 2014; Yin et al., 2014; Dick 
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et al., 2016; Limpitikul et al., 2017), demonstrating the importance of improving our mechanistic 
understanding of CDI. While multiple cardiac and neuronal models employ CDI components 
(Hund and Rudy, 2004; ten Tusscher et al., 2004; Faber et al., 2007; Mahajan et al., 2008b), few 
take into account the detailed kinetics or bi-lobal nature of CaM binding to the channel. This is 
due, in part, to a paucity of quantitative experimental data determining the Ca2+ dependence of 
CDI.  Here, we address this by obtaining rigorous experimental data, and using it to create a 
detailed kinetic model of CaV1.2 CDI featuring full bi-lobal CaM regulation. Specifically, we 
measured the kinetic response of channel inactivation due to measurable changes in intracellular 
Ca2+ by pairing photouncaging with simultaneous patch clamp recording (Tadross et al., 2013; 
Lee et al., 2015; Dick et al., 2016). This method allowed us to uncouple channel gating from 
intracellular Ca2+ dynamics, allowing precise control of bulk cytosolic Ca2+ and overcoming the 
ambiguity caused by diffusion limited Ca2+ dispersion in traditional patch clamp experiments. 
Moreover, by using single and combinations of Ca2+-sensitive dyes with different affinities, we 
were able to accurately measure Ca2+  at both resting (~ 0.01 µM) and elevated Ca2+(as high as 
100 µM right at the mouth of the channel (Neher, 1998)). As such, we concurrently measured 
CDI in response to known concentrations of Ca2+ on a sub-millisecond timescale. This use of 
high-resolution data enabled the development of two independent single-lobe models of CaV1.2 
CDI, which were then used as building blocks to create a 16 state bi-lobal model of CDI. 
Overall, this full-scale model recapitulates the kinetics of CDI in both physiological and 
pathologic conditions, and provides significant insights into the cooperativity of the N and C 
lobe of CaM in the context of CaV1.2 binding. 
To build this bi-lobal model of CDI, we utilized a reductionist approach, first examining the CDI 
elicited by each lobe of CaM independently.  To do this, we isolated N- or C-lobe mediated CDI 
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by utilizing engineered CaM with only one lobe capable of Ca2+ binding (CaM34 and CaM12, 
respectively (Peterson et al., 1999). Our experimental data showed that despite minimal 
difference in steady-state CDI profiles, N-lobe mediated CDI exhibits much slower kinetics as 
compared to C-lobe mediated CDI.  Using this data, we created a 4-state single-lobe model for 
each lobe of CaM, which accurately captured both the steady-state and dynamic properties of 
CDI. In addition, these models preserve the spatial Ca2+ selectivity of N- and C-lobe mediated 
CDI (Dick et al., 2008; Tadross et al., 2008), an important feature allowing CaV1.2 to respond 
differentially to Ca2+ elicited by various Ca2+ sources. Next, we incorporated these two models 
into a 16-state bi-lobal model of CDI, enabling us to describe the integrated kinetic behavior of 
the two lobes of CaM. Importantly, this allowed us to gauge the extent of cooperativity between 
the two lobes in the context of CaV1.2 binding.  While cooperativity between the N- and C-lobe 
of CaM is well known in response to Ca2+ binding (Teleman et al., 1986; Yazawa et al., 1987; 
Jaren et al., 2002), the extent of cooperativity in the initiation of CaV1.2 CDI remains 
undetermined.  Given the importance of this feature, we can corroborate the positive 
cooperativity factor determined by our model by scrutinizing our experimental data.  
Specifically, we express the closed-form solution of steady-state bi-lobal mediated CDI as: 
 𝐶𝐶𝐶𝐶𝐼𝐼(∞) = 𝐾𝐾𝐶𝐶∗𝐶𝐶𝑎𝑎
𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶∗(1−𝑃𝑃𝐶𝐶)+𝐾𝐾𝑁𝑁∗𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁∗(1−𝑃𝑃𝑁𝑁 )+𝐾𝐾𝐶𝐶∗𝐾𝐾𝑁𝑁∗𝜆𝜆∗𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑊𝑊𝑊𝑊 ∗(1−𝑃𝑃𝑊𝑊𝑊𝑊 )
1+𝐾𝐾𝐶𝐶∗𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶+𝐾𝐾𝑁𝑁∗𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁+𝐾𝐾𝐶𝐶∗𝐾𝐾𝑁𝑁∗𝜆𝜆∗𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑊𝑊𝑊𝑊
    (4.12) 
where KN and KC are the Kd of N- and C-lobe CaM respectively. PN, PC, and PWT are the relative 
open probabilities of mode Ca compared to mode 1 for N-, C- and both lobes of CaM 
respectively, and 𝜆𝜆 is the cooperativity factor (see SOM [4] for derivation). Here, 𝜆𝜆 >1 and < 1 
represent positive and negative cooperativity between CaM lobes. Applying this equation to our 
steady-state CaMWT CDI data (Figure 4.1H) reveals 𝜆𝜆 ~ 5, demonstrating that both lobes of CaM 
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modulate CaV1.2 in an inter-dependent manner with positive cooperativity. Thus, this finding 
substantiates the necessity for a 16-state model for bi-lobal CaM mediated CDI, as opposed to 
two independent 4-state models. Moreover, this cooperativity implies that perturbation in one 
lobe of CaM can affect the overall CDI to a larger extent than what would be predicted based on 
an alteration within a single lobe, and may be an important feature in understanding the 
pathogenesis of diseases such as calmodulinopathies. 
Calmodulinopathies are caused by genetic mutations within the calmodulin gene, and result in a 
severe, multisystem phenotype associated with significant cardiac deficits. We therefore applied 
our bi-lobal CDI model to simulate the effect of the LQTS-associated calmodulinopathy 
mutation, D130G (Crotti et al., 2013; Limpitikul et al., 2014; Yin et al., 2014; Limpitikul et al., 
2017). Residing in the fourth EF hand of CaM, this mutation minimally increases the apoCaM 
binding affinity to CaV1.2 (~ 2 fold) (Limpitikul et al., 2014) while dramatically diminishing the 
Ca2+ binding affinity of C-lobe CaM (~ 50 fold) (Crotti et al., 2013; Hwang et al., 2014),  with 
no discernable effect on the Ca2+ binding affinity of N-lobe CaM (Hwang et al., 2014). 
Interestingly, although the C-lobe of CaMD130G maintains some Ca2+-binding capacity, our 
experimental data shows that overall, CaMD130G behaves nearly identically to CaM34 (Figs 2C 
and 6C). Moreover, prediction from our bi-lobal CDI model corroborates this finding. 
Decreasing decreasing kon,C by 50 fold and dramatically reducing the cooperativity factors g and 
m, preventing CDI from proceeding via C-lobe CaM, the model can accurately recapitulate both 
the kinetic and steady-state behavior of CaMD130G. Such strong inter-lobal cooperativity implies 
that when the Ca2+-binding affinity of one lobe of CaM falls under a certain threshold, CDI from 
that lobe may become physiologically irrelevant. In fact, it appears that even a 5 fold reduction in 
the C-lobe Ca2+ binding affinity (F142L mutation (Crotti et al., 2013; Hwang et al., 2014)) can 
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alter the overall behavior of CaM to resemble that of CaM34 (Limpitikul and Yue, 2014). Thus, 
our bi-lobal CDI model predicts that any mutation causing at least a 5-fold reduction in C-lobe 
CaM Ca2+ binding affinity will manifest a nearly identical effect on CaV1.2 as CaMD130G, 
furthering our understanding of the pathogenesis of calmodulinopathies.  
Beyond predicting the CDI profile of a LQTS-associated calmodulinopathies, our model could 
be applied in a broader context to gain insights into (patho)physiology of cardiac electrical 
activity. Previous studies have implicated that CDI, as compared to VDI, may be the dominant 
form of feedback regulation of CaV1.2 in the context of the cardiac action potential (Sun et al., 
1997; Morotti et al., 2012), and the development of arrhythmia (Tanskanen et al., 2005; Morotti 
et al., 2012). Therefore, it is critical to employ a realistic mathematical representation of CDI that 
can capture the distinct kinetics, spatial Ca2+ selectivity, and cooperativity of the two lobes of 
CaM. Our bi-lobal kinetic model of CDI not only serves this purpose but also serves as a self-
contained and versatile module. That is, this model does not explicitly include specific 
parameters for channel gating, and thus, can be readily utilized in a variety of settings with 
known channel gating paradigms. Specifically, this CDI model utilizes an input Ca(t), and 
generates CDI(t) as output while using minimal computational power. Moreover, as VDI and 
CDI are generally treated as independent processes (Luo and Rudy, 1994a; Jafri et al., 1998; 
Hirano and Hiraoka, 2003; Findlay et al., 2008), the final current magnitude is simply a product 
of maximal current, VDI(t), and CDI(t), allowing our model to be modularly incorporated into 
existing cellular and tissue-level cardiac action potential models (Luo and Rudy, 1994a; Jafri et 
al., 1998; Findlay et al., 2008). Finally, the model can be utilized within other cellular contexts, 
including neurons, vascular and gastrointestinal smooth muscles, and chromaffin cells (Zamponi 
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et al., 2015). Therefore, this ‘plug-and-play’ model could be an invaluable asset to the field of 
computational electrophysiology. 
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4.5 Tables and figures 
Table 4.1Parameters used in CDI simulation. 
Parameters Values (units) 





kon,N 1.236e5 (mM-2 * ms-1) 
koff,N 5.273e-2 (ms-1) 
nHill,N 1.8 
fN 0.38 





kon,C 2.15e4 (mM-2 * ms-1) 
koff,C 1.2e-2 (ms-1) 
nHill,C 1.4 
fC 0.34 





m = g 7.5 
p = g*h 5.63 
k = g*n 1.99e-1 






Table 4.2 Parameters used in long-QT CaM (CaMD130G) simulation. 
Parameters Values (units) 
















































Figure 4.1 Steady-state behavior of bi-lobal CDI. (A-D) Behavior of CaV1.2E2A channels 
coexpressed with mutant CaM1234 in HEK293 cells, so as to characterize residual pore block. (A) 
Li+ currents prior to Ca2+ uncaging with simultaneously measured resting [Ca2+] deduced from 
mixture of two Fluo-2 and red Alexa568 dyes (bottom panel). (B) Same cell during UV Ca2+ 
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uncaging during steady activation of current (black trace). Gray trace, taken from panel A as 
reference. (C) Li+ current from another cell before (gray trace) and after (black trace) delivery of 
with higher Ca2+ step. (D) Steady-state pore block as a function of [Ca2+] measured by Fluo-
2/Alexa dye mixture, fitting with binding isotherm with Hill coefficient of 1 and large Kd of 33 
µM (black curve). Similarly, pore block characterization experiment using Fluo-4FF/Alexa dye 
mixture was performed, resulting in Hill coefficient of 1 and large Kd of 55 µM. (E-H) Bi-lobal 
CDI from CaV1.2E2A channel co-expressed with CaMWT. Li+ current at resting [Ca2+] (E) and 
after Ca2+ step (F). (G) Fraction of current diminution in panel I reflects both CDI and pore 
block. Using Eq 4.3, these data can be corrected (with fit in panel D) for pore block to isolate 

























Figure 4.2 Steady-state CDI mediated by N- and C-lobes of CaM. (A-C) Behavior of 
CaV1.2E2A channels coexpressed with enigneered CaM34 to isolate N-lobe component of CDI. 
(A) Li+ current in the absence of Ca2+ uncaging. (B) N-lobe-mediated CDI triggered upon Ca2+ 
uncaging. (C) Steady-state N-lobe-mediated CDI as function of [Ca2+] defining relation with Hill 
coefficient of 1.8 and Kd of 0.9 µM. (D-F) CaV1.2E2A channels coexpressed with mutant CaM12 
to isolate C-lobe component of CDI. (F) Steady-state C-lobe-mediated CDI as function of [Ca2+] 


















Figure 4.3 Kinetic model of CDI mediated by N-lobe of CaM. (A) Schematic representation 
of N-lobe-mediated CDI of CaV1.2 channels. This minimal model contains four states where 
each state contains five closed and one open channel configurations. Rate constants were written 
above and below the arrows depicting the direction of state transition (see Table 4.1 for values). 
(B) Simulated ICa(L) (red) in response to three different level of [Ca2+](t) can recapitulate the N-
lobe CDI kinetics of current recorded from CaV1.2E2A coexpressed with CaM34 (black) at various 
levels of Ca2+ step. Idealized [Ca2+](t) bottom row. (C) Steady-state N-lobe-mediated CDI 
predicted by this simple 4-state N-lobe model (red) matches almost precisely to the experimental 

















Figure 4.4 Kinetic model of CDI mediated by C-lobe of CaM. (A) Schematic representation 
of C-lobe-mediated CDI of CaV1.2 channels with similar assumption as Figure 4.3A. (B) When 
compared to experimental data from CaV1.2E2A coexpressed with CaM12, this kinetic model (red) 
can recapitulate the kinetics of C-lobe-mediated CDI obtained experimentally (black) relatively 
well. Idealized [Ca2+](t) bottom row. (C) Steady-state C-lobe-mediated CDI predicted by this 
simple 4-state C-lobe model (red) matches almost precisely to the experimental data (black, 
























Figure 4.5 Kinetic model of bi-lobal CDI. (A) Schematic representation of CDI generated from 
both lobes of CaM (CaV1.2E2A + CaMWT). (B) Bi-lobal model of CDI can precisely recapitulate 
the kinetic behavior of both lobes of CaM at various Ca2+ levels. Idealized [Ca2+](t) bottom row. 
(C) Steady-state CDI predicted by 16-state bi-local CDI model (red) matches almost precisely to 


















Figure 4.6 Steady-state and kinetic behavior of LQTS-associated CaMD130G. (A) Disruption 
of action potentials in guinea-pig ventricular myocytes by CaMD130G. When CaMD130G was 
overexpressed, cardiac action potentials become markedly lengthened and irregular (red) 
compared to CaMWT (shown in gray). Figure adapted from (Limpitikul et al., 2014) with 
permission. (B) Bi-lobal model of CDI can precisely recapitulate the kinetic behavior of 
pathologic CaMD130G at various Ca2+ levels. Idealized [Ca2+](t) bottom row.  (C) Experimental 
data showing steady-state CDI as function of [Ca2+] of CaMD130G (black) with Hill coefficient of 
1.8 and Kd of 0.9 µM, similarly to the N-lobe-mediated CDI. Steady-state CDI predicted by 16-





4.6.1 Derivation of apparent and true CDI (Equation (4.2)) 
Let b = absolute current size at 600 ms after voltage activation at baseline Ca2+ level and r = 
absolute current size 450 ms after UV flash (600 ms after voltage activation) at step Ca2+. 
Fraction of current after pore block (u), 
𝑡𝑡 = 1 − 𝑓𝑓𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏  
Therefore, absolute current left at 450 ms post-flash (r) is 
𝑝𝑝 = 𝑏𝑏 ∗ 𝑡𝑡 ∗ (1 − 𝑓𝑓𝐶𝐶𝐶𝐶𝐼𝐼 ,𝑡𝑡𝑝𝑝𝑡𝑡𝑒𝑒 ) 
Thus, apparent CDI can be described as 





𝑏𝑏 − 𝑏𝑏 ∗ 𝑡𝑡 ∗ (1 − 𝑓𝑓𝐶𝐶𝐶𝐶𝐼𝐼 ,𝑡𝑡𝑝𝑝𝑡𝑡𝑒𝑒 )
𝑏𝑏
 
𝑓𝑓𝐶𝐶𝐶𝐶𝐼𝐼 ,𝑎𝑎𝑝𝑝𝑝𝑝 = 1 − (1 − 𝑓𝑓𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 ) ∗ (1 − 𝑓𝑓𝐶𝐶𝐶𝐶𝐼𝐼 ,𝑡𝑡𝑝𝑝𝑡𝑡𝑒𝑒 ) 
4.6.2 Differential Equations for N-lobe and C-lobe CDI (Figures 4.3A and 4.4A) 
Let 𝑀𝑀𝑚𝑚(𝑡𝑡) be the probability of being in state x at time t. Therefore,  
𝑀𝑀4(𝑡𝑡) =  1 −𝑀𝑀1(𝑡𝑡) −𝑀𝑀2(𝑡𝑡) −𝑀𝑀3(𝑡𝑡) 
𝑒𝑒𝑀𝑀1(𝑡𝑡)
𝑒𝑒𝑡𝑡





= 𝑎𝑎𝑦𝑦 ∗ 𝑀𝑀1(𝑡𝑡) − �𝑏𝑏𝑦𝑦 + 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝑦𝑦 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑦𝑦(𝑡𝑡)� ∗ 𝑀𝑀2(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝑦𝑦 ∗ 𝑀𝑀3(𝑡𝑡) 
𝑒𝑒𝑀𝑀3(𝑡𝑡)
𝑒𝑒𝑡𝑡





= 𝐶𝐶𝐶𝐶𝐼𝐼(𝑡𝑡) = 𝑀𝑀1(𝑡𝑡) + 𝑓𝑓𝑦𝑦 ∗ (𝑀𝑀2(𝑡𝑡) + 𝑀𝑀3(𝑡𝑡) + 𝑀𝑀4(𝑡𝑡)) 
where y represents value from either N- or C-lobe (Table 4.1), [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑦𝑦(𝑡𝑡) represent Ca2+ 
concentration in mM as a function of time, and Inf and If are experimental currents at baseline and 
step Ca2+, respectively. 
For all simulations, we set initial values [𝑀𝑀1(𝑡𝑡0) ,𝑀𝑀2(𝑡𝑡0),𝑀𝑀3(𝑡𝑡0),𝑀𝑀4(𝑡𝑡0)] to [1,0,0,0]. 
4.6.3 Differential Equations for bi-local CDI (Figure 4.5A) 
Let 𝑀𝑀𝑚𝑚(𝑡𝑡) be the probability of being in state x at time t. Therefore,  
𝑀𝑀16(𝑡𝑡) =  1 −𝑀𝑀1(𝑡𝑡) −𝑀𝑀2(𝑡𝑡) −𝑀𝑀3(𝑡𝑡) −𝑀𝑀4(𝑡𝑡) −𝑀𝑀5(𝑡𝑡) −𝑀𝑀6(𝑡𝑡) −𝑀𝑀7(𝑡𝑡) −𝑀𝑀8(𝑡𝑡) −𝑀𝑀9(𝑡𝑡)
−𝑀𝑀10(𝑡𝑡) −𝑀𝑀11(𝑡𝑡) −𝑀𝑀12(𝑡𝑡) −𝑀𝑀13(𝑡𝑡) −𝑀𝑀14(𝑡𝑡) −𝑀𝑀15(𝑡𝑡) 
𝑒𝑒𝑀𝑀1(𝑡𝑡)
dt
= 𝑏𝑏𝑁𝑁 ∗ 𝑀𝑀2(𝑡𝑡) + 𝑏𝑏𝐶𝐶 ∗ 𝑀𝑀5(𝑡𝑡) − (𝑎𝑎𝑁𝑁 + 𝑎𝑎𝐶𝐶) ∗ 𝑀𝑀1(𝑡𝑡) 
𝑒𝑒𝑀𝑀2(𝑡𝑡)
dt










= 𝑒𝑒𝑁𝑁 ∗ 𝑀𝑀3(𝑡𝑡) + 𝑏𝑏𝐶𝐶 ∗ 𝑀𝑀8(𝑡𝑡) − (𝑒𝑒𝑁𝑁 + 𝑝𝑝 ∗ 𝑎𝑎𝐶𝐶) ∗ 𝑀𝑀4(𝑡𝑡) 
𝑒𝑒𝑀𝑀5(𝑡𝑡)
dt




= 𝑚𝑚 ∗ 𝑎𝑎𝐶𝐶 ∗ 𝑀𝑀2(𝑡𝑡) + 𝑔𝑔 ∗ 𝑎𝑎𝑁𝑁 ∗ 𝑀𝑀5(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝑁𝑁 ∗ 𝑀𝑀7(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝐶𝐶 ∗ 𝑀𝑀10(𝑡𝑡)
− �𝑏𝑏𝑁𝑁 + 𝑏𝑏𝐶𝐶 + 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝑁𝑁 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝐶𝐶 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶(𝑡𝑡)� ∗ 𝑀𝑀6(𝑡𝑡) 
𝑒𝑒𝑀𝑀7(𝑡𝑡)
dt
= 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝑁𝑁 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁(𝑡𝑡) ∗ 𝑀𝑀6(𝑡𝑡) + 𝑚𝑚 ∗ 𝑎𝑎𝐶𝐶 ∗ 𝑀𝑀3(𝑡𝑡) + 𝑒𝑒𝑁𝑁 ∗ 𝑀𝑀8(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝐶𝐶 ∗ 𝑀𝑀11(𝑡𝑡)
− �𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝑁𝑁 + 𝑏𝑏𝐶𝐶 + ℎ ∗ 𝑒𝑒𝑁𝑁 + 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝐶𝐶 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶(𝑡𝑡)� ∗ 𝑀𝑀7(𝑡𝑡) 
𝑒𝑒𝑀𝑀8(𝑡𝑡)
dt
= ℎ ∗ 𝑒𝑒𝑁𝑁 ∗ 𝑀𝑀7(𝑡𝑡) + 𝑝𝑝 ∗ 𝑎𝑎𝐶𝐶 ∗ 𝑀𝑀4(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝐶𝐶 ∗ 𝑀𝑀12(𝑡𝑡)
− �𝑒𝑒𝑁𝑁 + 𝑏𝑏𝐶𝐶 + 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝐶𝐶 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶(𝑡𝑡)� ∗ 𝑀𝑀8(𝑡𝑡) 
𝑒𝑒𝑀𝑀9(𝑡𝑡)
dt
= 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝐶𝐶 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶(𝑡𝑡) ∗ 𝑀𝑀5(𝑡𝑡) + 𝑏𝑏𝑁𝑁 ∗ 𝑀𝑀10(𝑡𝑡) + 𝑒𝑒𝐶𝐶 ∗ 𝑀𝑀13(𝑡𝑡)
− �𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝐶𝐶 + 𝑔𝑔 ∗ 𝑎𝑎𝑁𝑁 + 𝑒𝑒𝐶𝐶� ∗ 𝑀𝑀9(𝑡𝑡) 
𝑒𝑒𝑀𝑀10(𝑡𝑡)
dt
= g ∗ 𝑎𝑎𝑁𝑁 ∗ 𝑀𝑀9(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝐶𝐶 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶(𝑡𝑡) ∗ 𝑀𝑀6(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝑁𝑁 ∗ 𝑀𝑀11(𝑡𝑡) + 𝑒𝑒𝐶𝐶 ∗ 𝑀𝑀14(𝑡𝑡)





= 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝑁𝑁 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁(𝑡𝑡) ∗ 𝑀𝑀10(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝐶𝐶 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶(𝑡𝑡) ∗ 𝑀𝑀7(𝑡𝑡) + 𝑒𝑒𝑁𝑁 ∗ 𝑀𝑀12(𝑡𝑡) + 𝑒𝑒𝐶𝐶
∗ 𝑀𝑀15(𝑡𝑡) − �𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝑁𝑁 + 𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝐶𝐶 + ℎ ∗ 𝑒𝑒𝑁𝑁 + 𝑒𝑒 ∗ 𝑒𝑒𝐶𝐶� ∗ 𝑀𝑀11(𝑡𝑡) 
𝑒𝑒𝑀𝑀12(𝑡𝑡)
dt
= ℎ ∗ 𝑒𝑒𝑁𝑁 ∗ 𝑀𝑀11(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝐶𝐶 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶(𝑡𝑡) ∗ 𝑀𝑀8(𝑡𝑡) + 𝑒𝑒𝐶𝐶 ∗ (1 −𝑀𝑀1(𝑡𝑡) −𝑀𝑀2(𝑡𝑡)
−𝑀𝑀3(𝑡𝑡) −𝑀𝑀4(𝑡𝑡) −𝑀𝑀5(𝑡𝑡) −𝑀𝑀6(𝑡𝑡) −𝑀𝑀7(𝑡𝑡) −𝑀𝑀8(𝑡𝑡) −𝑀𝑀9(𝑡𝑡) −𝑀𝑀10(𝑡𝑡)




= 𝑒𝑒𝐶𝐶 ∗ 𝑀𝑀9(𝑡𝑡) + 𝑏𝑏𝑁𝑁 ∗ 𝑀𝑀14(𝑡𝑡) − (𝑒𝑒𝐶𝐶 + 𝑏𝑏 ∗ 𝑎𝑎𝑁𝑁) ∗ 𝑀𝑀13(𝑡𝑡) 
𝑒𝑒𝑀𝑀14(𝑡𝑡)
dt
= 𝑏𝑏 ∗ 𝑎𝑎𝑁𝑁 ∗ 𝑀𝑀13(𝑡𝑡) + 𝑒𝑒 ∗ 𝑒𝑒𝐶𝐶 ∗ 𝑀𝑀10(𝑡𝑡) + 𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝑁𝑁 ∗ 𝑀𝑀15(𝑡𝑡)
− �𝑏𝑏𝑁𝑁 + 𝑒𝑒𝐶𝐶 + 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝑁𝑁 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁(𝑡𝑡)� ∗ 𝑀𝑀14(𝑡𝑡) 
𝑒𝑒𝑀𝑀15(𝑡𝑡)
dt
= 𝑏𝑏𝑏𝑏𝑒𝑒 ,𝑁𝑁 ∗ [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁(𝑡𝑡) ∗ 𝑀𝑀14(𝑡𝑡) + 𝑒𝑒 ∗ 𝑒𝑒𝐶𝐶 ∗ 𝑀𝑀11(𝑡𝑡)+𝑒𝑒𝑁𝑁 ∗ (1 −𝑀𝑀1(𝑡𝑡) −𝑀𝑀2(𝑡𝑡)
−𝑀𝑀3(𝑡𝑡) −𝑀𝑀4(𝑡𝑡) −𝑀𝑀5(𝑡𝑡) −𝑀𝑀6(𝑡𝑡) −𝑀𝑀7(𝑡𝑡) −𝑀𝑀8(𝑡𝑡) −𝑀𝑀9(𝑡𝑡) −𝑀𝑀10(𝑡𝑡)
−𝑀𝑀11(𝑡𝑡) −𝑀𝑀12(𝑡𝑡) −𝑀𝑀13(𝑡𝑡) −𝑀𝑀14(𝑡𝑡) −𝑀𝑀15(𝑡𝑡)) − �𝑏𝑏𝑏𝑏𝑓𝑓𝑓𝑓 ,𝑁𝑁 + 𝑒𝑒𝐶𝐶 + 𝑏𝑏 ∗ 𝑒𝑒𝑁𝑁�
∗ 𝑀𝑀15(𝑡𝑡) 
and 
𝐶𝐶𝐶𝐶𝐼𝐼(𝑡𝑡) = 𝑀𝑀1(𝑡𝑡) + 𝑓𝑓𝑁𝑁 ∗ �𝑀𝑀2(𝑡𝑡) + 𝑀𝑀3(𝑡𝑡) + 𝑀𝑀4(𝑡𝑡)�+𝑓𝑓𝐶𝐶 ∗ (𝑀𝑀5(𝑡𝑡) +𝑀𝑀9(𝑡𝑡) +𝑀𝑀13(𝑡𝑡))+𝑓𝑓𝑊𝑊𝑊𝑊




where [𝐶𝐶𝑎𝑎]𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑦𝑦(𝑡𝑡) represent Ca2+ concentration in mM as a function of time and y is a 
parameter from either N- or C-lobe CDI (parameters from Table 4.1). 
With microscopic reversibility, 
𝑚𝑚 = 𝑔𝑔 
𝑝𝑝 = 𝑔𝑔 ∗ ℎ 





For all simulations, we set initial values [𝑀𝑀𝑚𝑚(𝑡𝑡0)] to  �
1, 𝑚𝑚 = 1
0, 𝑚𝑚 = 2 − 16
 . 
4.6.4 Derivation of cooperativity between CaM lobes 
Let 𝑃𝑃𝑦𝑦′  be the absolute open probabilities of channels in mode 𝑦𝑦 and 𝑃𝑃𝑦𝑦  be the relative open 
probabilities of mode 𝑦𝑦 compared to Ca2+-free mode 1 (𝑃𝑃1), where 
𝑦𝑦 = �
𝑁𝑁, 𝑁𝑁 − 𝑏𝑏𝑏𝑏𝑏𝑏𝑒𝑒 𝐶𝐶𝐶𝐶𝐼𝐼
𝐶𝐶, 𝐶𝐶 − 𝑏𝑏𝑏𝑏𝑏𝑏𝑒𝑒 𝐶𝐶𝐶𝐶𝐼𝐼
𝑊𝑊𝑊𝑊, 𝑏𝑏𝑛𝑛 − 𝑏𝑏𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏 𝐶𝐶𝐶𝐶𝐼𝐼
  








where 𝐼𝐼𝑝𝑝𝑒𝑒𝑎𝑎𝑏𝑏  and 𝐼𝐼𝑒𝑒𝑒𝑒𝑒𝑒  represent current magnitude at the beginning and the end of voltage step. 
130 
 
Here, since 𝐼𝐼𝑝𝑝𝑒𝑒𝑎𝑎𝑏𝑏  and 𝐼𝐼𝑒𝑒𝑒𝑒𝑒𝑒  are recorded from the same cell, they have the same number of 
channels, channel conductance, and electrochemical driving force. Therefore, CDI can be re-
written as 




where 𝑃𝑃𝑂𝑂,𝑝𝑝𝑒𝑒𝑎𝑎𝑏𝑏  and 𝑃𝑃𝑂𝑂,𝑒𝑒𝑒𝑒𝑒𝑒  represent open probability of a channel at the beginning and the end of 
voltage step. 
At any given amount of Ca2+, 
𝑃𝑃𝑂𝑂 = 𝑃𝑃1 ∗
1
1 + 𝐾𝐾𝐶𝐶 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶 + 𝐾𝐾𝑁𝑁 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁 + 𝐾𝐾𝐶𝐶 ∗ 𝐾𝐾𝑁𝑁 ∗ 𝜆𝜆 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑊𝑊𝑊𝑊
 
where 𝐾𝐾𝑦𝑦 , 𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏,𝑦𝑦, and 𝜆𝜆 are dissociation constant of y-lobe of CaM, Hill coefficient of y-lobe 
of CaM, and cooperativity factor between two CaM lobes, respectively. 
Instantaneously right after the beginning of the voltage step, no significant amount of Ca2+ has 
entered the cells so 𝐶𝐶𝑎𝑎~0. Therefore, 
𝑃𝑃𝑂𝑂,𝑝𝑝𝑒𝑒𝑎𝑎𝑏𝑏 = 𝑃𝑃1 
That is, all channels effectively reside in mode 1. 
At the end of the voltage step, 
𝑃𝑃𝑂𝑂,𝑒𝑒𝑒𝑒𝑒𝑒 = 𝑃𝑃1 ∗
1









𝐾𝐾𝐶𝐶 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏 𝑏𝑏 ,𝐶𝐶
𝑧𝑧
+ 𝑃𝑃𝑁𝑁′ ∗
𝐾𝐾𝑁𝑁 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁
𝑧𝑧
+ 𝑃𝑃𝑊𝑊𝑊𝑊′ ∗




𝑧𝑧 = 1 + 𝐾𝐾𝐶𝐶 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶 + 𝐾𝐾𝑁𝑁 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁 + 𝐾𝐾𝐶𝐶 ∗ 𝐾𝐾𝑁𝑁 ∗ 𝜆𝜆 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑊𝑊𝑊𝑊  
Thus, CDI can be written as 




′ ∗ 𝐾𝐾𝐶𝐶 ∗ 𝐶𝐶𝑎𝑎
𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶
𝑧𝑧 + 𝑃𝑃𝑁𝑁
′ ∗ 𝐾𝐾𝑁𝑁 ∗ 𝐶𝐶𝑎𝑎
𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁
𝑧𝑧 + 𝑃𝑃𝑊𝑊𝑊𝑊





which is equivalent to 
𝐶𝐶𝐶𝐶𝐼𝐼
=  
𝐾𝐾𝐶𝐶 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝐶𝐶 ∗ (1 − 𝑃𝑃𝐶𝐶) + 𝐾𝐾𝑁𝑁 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑁𝑁 ∗ (1 − 𝑃𝑃𝑁𝑁) + 𝐾𝐾𝐶𝐶 ∗ 𝐾𝐾𝑁𝑁 ∗ 𝜆𝜆 ∗ 𝐶𝐶𝑎𝑎𝑒𝑒𝑛𝑛𝑛𝑛𝑏𝑏𝑏𝑏 ,𝑊𝑊𝑊𝑊 ∗ (1 − 𝑃𝑃𝑊𝑊𝑊𝑊)







An autism-associated mutation in CaV1.3 channels has opposing effects on voltage- and 
calcium-dependent regulation 
5.1 Introduction 
The CaV1.3 channel represents a distinctive subtype of LTCCs, important in neurological 
(Berger and Bartsch, 2014; Striessnig et al., 2014; Zamponi et al., 2015; Pinggera and Striessnig, 
2016), cardiac (Striessnig et al., 2014; Mesirca et al., 2015; Zamponi et al., 2015), and endocrine 
(Marcantoni et al., 2007; Zamponi et al., 2015; Barrett et al., 2016) function.  The biophysical 
properties of these channels are thus precisely tuned to this function, as they are activated at 
relatively hyperpolarized potentials compared to other LTCCs (Koschak et al., 2001; Scholze et 
al., 2001; Xu and Lipscombe, 2001; Lipscombe et al., 2013; Lieb et al., 2014; Striessnig et al., 
2014) and undergo distinct forms of negative feedback regulation (Tadross et al., 2010; Satin et 
al., 2011; Striessnig et al., 2014).    
CaV1.3 channels employ two major forms of feedback regulation, VDI and CDI (Tadross 
et al., 2010). These two regulatory processes are controlled within each cell type, utilizing splice 
variation (Liu et al., 2010; Tan et al., 2011; Adams et al., 2014; Striessnig et al., 2014), RNA 
editing (Huang et al., 2012; Bazzazi et al., 2013), and auxiliary subunit pairing (Dolphin, 2009; 
Roberts-Crowley and Rittenhouse, 2009) to tune the inactivation properties of the channel to 
specific cellular functions. In particular, both splice variation and RNA editing are able to 
modulate both CDI (Shen et al., 2006; Singh et al., 2008; Bock et al., 2011; Tan et al., 2011; 
Huang et al., 2012; Bazzazi et al., 2013; Lipscombe et al., 2013; Striessnig et al., 2014) and 
channel open probability (Adams et al., 2014) by tailoring the components contained within the 
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channel carboxy tail. In addition, channel beta subunits are known to both traffic channels to the 
membrane (Dolphin, 2012; Buraei and Yang, 2013) and alter their voltage inactivation properties 
(Colecraft et al., 2002; Dolphin, 2003, 2009; Buraei and Yang, 2013).   
The precise control of these regulatory processes are a vital component of normal 
physiology and disruption of this regulation has been linked to multiple human disorders 
including autism (O'Roak et al., 2012; Striessnig et al., 2014; Breitenkamp et al., 2015; Pinggera 
et al., 2015), auditory deficits (Platzer et al., 2000; Baig et al., 2011), and hyperaldosteronism 
(Azizan et al., 2013; Scholl et al., 2013).  In mice, knockout of CaV1.3 results in profound 
deafness and severe bradycardia (Platzer et al., 2000; Dou et al., 2004), while in humans a 
similar phenotype is observed in patients harboring a 3-base pair insertion in exon 8b (Baig et al., 
2011).  This insertion abolishes channel conduction, resulting in sinoatrial node dysfunction and 
deafness (SANDD) syndrome, a phenotype similar to that described in CaV1.3-knockout mice. 
Moreover, multiple gain-of-function mutations have been linked to patients with 
hyperaldosteronism (Azizan et al., 2013; Scholl et al., 2013).  Finally, two gain-of-function 
mutations in CaV1.3 (G407R and A749G) have been linked to autism spectrum disorders (ASD) 
(Iossifov et al., 2012; O'Roak et al., 2012; Pinggera et al., 2015). Prior studies of these two 
mutations demonstrated alterations in channel gating including a hyperpolarizing shift in channel 
activation and inactivation curves (Pinggera et al., 2015), but the differential effects on CDI 
versus VDI have yet to be determined.  Discerning these precise effects may be highly relevant 
to understanding the mechanism of pathogenesis, as disruption of each of these components in 
the related CaV1.2 L-type channel has been shown to underlie Timothy syndrome (a severe 
multisystem disorder including autism and cardiac deficits) (Splawski et al., 2004; Splawski et 
al., 2005; Dick I. E., 2016), as well as long-QT syndrome associated with mutations in 
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calmodulin (Limpitikul et al., 2014).   It is interesting to note that, unlike the CaV1.2 
channelopathies, CaV1.3 mutations have often been associated with single-system phenotypes 
(Iossifov et al., 2012; O'Roak et al., 2012), despite the multi-system distribution of CaV1.3 
channels. This isolation of symptoms is curious and requires further mechanistic investigation.  
Here, we examine the underlying channel regulatory deficits of the autism-associated 
A760G mutation in rat CaV1.3 (equivalent to the A749G (Pinggera et al., 2015) or A769G 
(O'Roak et al., 2012) mutation in the human, depending on the channel backbone), focusing on 
the specific biophysical alterations produced by the mutation.  We find that the mutation causes a 
significant reduction of CDI and a delay in channel deactivation in two major channel splice 
variants. In addition, we utilize an allosteric model of channel gating to gain insight into the 
underlying mechanism of this CDI deficit.  Further examination of the biophysical defects of this 
mutation also revealed a beta subunit-dependent increase in VDI, an effect which would oppose 
the Ca2+ overload due to the decrease in CDI and a delay in channel deactivation.  Thus the 
severe effects of this ‘gain-of-function’ mutation could be mitigated by a ‘loss-of-function’ effect 
on VDI. 
5.2 Materials and methods 
5.2.1 Molecular Biology 
The point mutation (A760G) was introduced into rat CaV1.3 short and long splice 
variants (gifts from Dr. Tuck Wah Soong (Huang et al., 2013)) in the homologous position to 
that found in humans using QuikChange™ site-directed mutagenesis (Agilent). The equivalent 
human mutation was found in patients at A769G in chromosome 3, position 53764493 (O'Roak 
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et al., 2012) and corresponds to the A749G mutation previously described in an alternate human 
splice variant (Pinggera et al., 2015).  
5.2.2 Transfection of HEK293 cells 
HEK293 cells were cultured on glass coverslips in 10-cm dishes and WT or mutant 
CaV1.3 channels, along with their auxiliary subunits, were transiently transfected using a 
standard calcium phosphate method (Peterson et al., 1999). 8 µg of rat CaV1.3 was co-expressed 
with 8 µg of rat brain β2a (M80545) or β1b (NM_017346), 8 µg of rat brain α2δ (NM012919.2) 
subunits, and 2 µg of simian virus 40 T antigen cDNA. Expression of all constructs was driven 
by a cytomegalovirus promoter and β subunits were contained within an EGFP-IRES bicistronic 
vector to allow visualization of transfected cells. 
5.2.3 Whole Cell Electrophysiology 
Whole-cell voltage-clamp recordings of HEK293 cells were done 1-2 days after 
transfection at room temperature. Recordings were obtained using an Axopatch 200B amplifier 
(Axon Instruments). Whole-cell voltage-clamp records were low pass filtered at 2 kHz, and then 
digitally sampled at 10 kHz. P/8 leak subtraction was used, with series resistances of 1-2 MΩ. 
For voltage-clamp experiments, internal solutions contained (in mM): CsMeSO3, 114; CsCl, 5; 
MgCl2, 1; MgATP, 4; HEPES (pH 7.3), 10; and either BAPTA, 10 or EGTA, 0.5; at 295 mOsm 
adjusted with CsMeSO3. External solutions contained (in mM): TEA-MeSO3, 140; HEPES (pH 
7.4), 10; and CaCl2 or BaCl2, 40; at 300 mOsm, adjusted with TEA-MeSO3.  
For simultaneous ratiometric Ca2+ measurements and current recordings, a fixed ratio of 
two Ca2+-sensitive dyes (Fluo-2 high affinity, TEFLabs; Fluo-2 low affinity, TEFLabs) and 
Alexa568 (Invitrogen) were added into a 0.5-mM EGTA internal solution. Two Ca2+ indicators 
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at different binding affinity were chosen to accurately measure both baseline and peak Ca2+ 
concentrations. The dye mixture was calibrated to obtain absolute Ca2+ concentrations (Joiner 
and Lee, 2015). The external solution (Tyrode's solution) contained (in mM): NaCl, 135; KCl, 
5.4; CaCl2, 1.8; MgCl2, 0.33; NaH2PO4, 0.33; HEPES, 5; glucose, 5 (pH 7.4). During current 
recordings, Ca2+ concentration was measured by exciting dyes using a 514-nm Argon laser, via a 
545DCLP dichroic mirror and either a 545/40BP (Fluo) or 580LP (Alexa568) filter. Cells were 
held at -80 mV and a 1-Hz train of neuronal action potential recordings from cortical neurons of 
E18 mouse embryos were used as voltage stimulus. 
5.2.4 Generation of a CaV1.3 Homology Model 
We used MODELLER v9.14 (Sali and Blundell, 1993) to build a homology model of 
CaV1.3 pore regions (Figure 1A) based on the crystal structure of the bacterial Na channel 
NaVAb (PDB accession code: 4EKW) (Payandeh et al., 2012) as previously described (Tadross 
et al., 2010). Briefly, we generated 10 decoy models from which a model with lower objective 
function was chosen. The four domains of CaV1.3 were constrained to adopt a clockwise 
orientation when viewed from the extracellular surface by analogy to the orientation of the 
related voltage-gated sodium channels (Li et al., 2001). The alignment used for the various pore 
subsegments are as follows: 
S5 Segment 
NaVAb    SVAALLTVVFYIAAVMATNLYGATFP 
CaV1.3 Domain I  HIALLVLFVIIIYAIIGLELFIGKMH 
CaV1.3 Domain II SLLLLLFLFIIIFSLLGMQLFGGKFN 
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CaV1.3 Domain III NIMIVTTLLQFMFACIGVQLFKGKFY 
CaV1.3 Domain IV YVALLIAMLFFIYAVIGMQMFGKVAM 
P Loop 
NaVAb    EWFGDLSKSLYTLFQVMTLESWSMGIVRPVMNV 
CaV1.3 Domain I  TNFDNFAFAMLTVFQCITMEGWTDVLYWVNDAI 
CaV1.3 Domain II STFDNFPQALLTVFQILTGEDWNAVMYDGIMAY 
CaV1.3 Domain III FNFDNVLSAMMVLFTVSTFEGWPALLYKAIDSN 
CaV1.3 Domain IV NNFQTFPQAVLLLFRCATGEAWQEIMLACLPGK 
S6 Segment 
NaVAb    HPNAWVFFIPFIMLTTFTVLNLFIGII 
CaV1.3 Domain I  WEWPWVYFVSLIILGSFFVLNLVLGVL 
CaV1.3 Domain II GMIVCIYFIILFICGNYILLNVFLAIA 
CaV1.3 Domain III RVEISIFFIIYIIIVAFFMMNIFVGFV 
CaV1.3 Domain IV SNFAIVYFISFYMLCAFLIINLFVAVI 
5.2.5 Data Analysis and Statistics 




     𝑝𝑝300 =
𝐼𝐼(300)
𝐼𝐼(𝑡𝑡𝑝𝑝𝑒𝑒𝑎𝑎𝑏𝑏 )
      (5.1) 
and CDI measurements were corrected for VDI effects by calculating a metric for pure CDI (f300) 
as follows: 
     𝑓𝑓300 =
𝑝𝑝300𝐵𝐵𝑎𝑎 −𝑝𝑝300𝐶𝐶𝑎𝑎
𝑝𝑝300𝐵𝐵𝑎𝑎
       (5.2) 
r300 and f300  values were reported at 10 mV for the CaV1.3short channel and at 0 mV for 
CaV1.3long. The relative open probability (PO,rel) was determined by a tail activation protocol 
(Tadross et al., 2008) where channels are fully activated at 100 mV prior to stepping to variable 
test potentials. The ratio of peak and steady state currents then represent the relative PO,rel of each 
voltage. The voltage activation curve was fit by the Boltzmann equation: 
    𝑃𝑃𝑂𝑂,𝑝𝑝𝑒𝑒𝑏𝑏 = 𝑠𝑠𝑏𝑏𝑎𝑎𝑏𝑏𝑒𝑒 ∗ (1 + 𝑒𝑒
− 
𝑝𝑝−𝑝𝑝1/2
𝑏𝑏 )−1    (5.3) 
where V1/2 and k represent the half activation voltage and slope factor, respectively. 
Time constants for channel deactivation (τfast and τslow in Figures 5.1F, 5.1K, 5.3E, and 
5.3J) were calculated by fitting the deactivating Ba2+ tail currents resulting from a transition from 
80 mV (channels maximally open based on the activation curve, Figures 1D, 1I, 3C, 3H) to 
multiple voltages near the base of the activation curve (channels closed) with the equation: 
       𝐼𝐼𝑓𝑓𝑛𝑛𝑡𝑡 = 𝐴𝐴 ∗ (𝑓𝑓 ∗ 𝑒𝑒
−� 𝑡𝑡−𝑡𝑡0𝜏𝜏𝑓𝑓𝑎𝑎𝑠𝑠𝑡𝑡
�
+ (1 − 𝑓𝑓) ∗ 𝑒𝑒
−� 𝑡𝑡−𝑡𝑡0𝜏𝜏𝑠𝑠𝑏𝑏𝑏𝑏𝑠𝑠
�
)    (5.4) 
where  f  is the fraction of the faster portion of the current decay, and time constants τfast and τslow 
represent the fast and slow components of the current decay.  
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All data are presented as mean ± SEM. Statistical significance for variability was 
determined by a two-tailed student's t-test. 
5.3 Results 
5.3.1 A760G significantly decreases CDI and alters CaV1.3 channel gating 
Voltage-gated Ca2+ channel α1-subunits are composed of four domains, each containing 
six transmembrane α -helices (Figure 5.1A). The four S6 helices line the channel pore through 
which Ca2+ enters the cell. The intracellular portion of these S6 helices form the activation gate 
of the channel, and mutations within this region are known to alter channel activation (Kraus et 
al., 2000; Hoda et al., 2005; Hohaus et al., 2005; Raybaud et al., 2006; Raybaud et al., 2007; 
Pinggera et al., 2015). Moreover, the S6 helices are known to contribute to VDI and CDI in 
many CaV channels, including CaV1.3 (Kraus et al., 2000; Stotz et al., 2000; Stotz and Zamponi, 
2001; Splawski et al., 2004; Stotz et al., 2004; Hoda et al., 2005; Hohaus et al., 2005; Raybaud et 
al., 2006; Raybaud et al., 2007; Barrett and Tsien, 2008; Tadross et al., 2010). Thus, the effect of 
the A760G mutation on channel activation and inactivation (Pinggera et al., 2015) may be 
explained by its location in the S6 helix of domain II (IIS6).  
In order to study the effects of the A760G mutation on Ca2+ regulation of channels, we 
undertook whole-cell voltage clamp recordings of CaV1.3 channels heterologously expressed in 
HEK293 cells. To minimize the possible confounding effects on CDI measurements, the 
channels were co-expressed with the β2a subunit which is known to minimize VDI (Stea et al., 
1994; Colecraft et al., 2002; Dafi et al., 2004; Dolphin, 2009; Buraei and Yang, 2013).  In 
addition, an internal solution containing 10 mM BAPTA was utilized to restrict Ca2+ elevation to 
only the nanodomain of the channel, thus diminishing cell-to-cell variability (Dick et al., 2008; 
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Tadross et al., 2008). Figure 5.1B shows exemplar current traces for wild-type (WT) CaV1.3.  
The sharp decay of Ca2+ current (red) evoked by a 10-mV depolarizing step depicts CDI, while 
the Ba2+ current trace (black) exhibits only VDI, which is mostly absent here due to the choice of 
β subunit. This robust CDI can be observed in the population data, where the fraction of current 
remaining after 300-ms depolarization (r300) is displayed as a function of voltage (Figure 5.1C), 
and the U-shaped dependence on voltage recapitulates a classic hallmark of CDI (Brehm and 
Eckert, 1978; Brehm et al., 1980). Here, the difference between the r300 values for Ca2+ and Ba2+, 
normalized by the Ba2+ r300, gauges the magnitude of CDI (f300). However, when the A760G 
mutation is introduced into these channels, a drastic reduction in the speed and magnitude of CDI 
is observed (Figure 5.1G, Supplementary Figure 5.1).  This effect is further evident in the 
population data across multiple voltages (Figure 5.1H) illustrating a clear CDI deficit due to the 
autism-associated A760G mutation.  
Beyond CDI, S6 mutations are likely to affect channel activation (Kraus et al., 2000; 
Hoda et al., 2005; Hohaus et al., 2005; Raybaud et al., 2006; Raybaud et al., 2007; Pinggera et 
al., 2015). We therefore probed the effect of the A760G on the voltage dependence of CaV1.3 
channel activation. Here, we measured the relative open probability (Po,rel) of the channels across 
voltages via a tail activation protocol optimized for CaV1.3 channels (Tadross et al., 2008) 
(Figure 5.1D). Introduction of the A760G mutation produced a significant hyperpolarizing shift 
(13 mV; p < 0.01) in channel activation (Figure 5.1I), consistent with previous studies of this 
channel (Pinggera et al., 2015).  Moreover, analysis of the deactivation kinetics during the tail 
activation protocol revealed a marked effect of A760G on channel deactivation. Evaluation of 
the deactivation kinetics during transitions from 80 mV to multiple voltages near the foot of the 
activation curve provided an estimation of the kinetics of channels transitioning from fully open 
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to closed (Figures 5.1E, F). A double exponential function was used to quantify a fast and slow 
component of channel deactivation (τfast, τslow respectively). The A760G mutation significantly 
increased both time constants across voltages, indicating a considerable slowing of channel 
closing (Figures 5.1J, K). 
L-type channel S6 mutations have previously been shown to affect CDI via modulation 
of modal channel gating (Imredy and Yue, 1994; Tadross et al., 2010; Dick I. E., 2016). We 
therefore consider the underlying mechanism linking channel activation and CDI. An allosteric 
model of channel gating (Figure 5.2A) is known to describe CDI of CaV1.3 channels well 
(Tadross et al., 2010).  Within this model, channels initially open within the mode 1 regime, 
which is characterized by a relatively large open probability (PO/mode1).  Upon channel opening, 
Ca2+ influx drives channels into the mode Ca regime where channels maintain the ability to open, 
but with a significantly reduced PO (PO/modeCa).  It is this reduction in PO that results in the CDI 
seen in whole-cell currents, such that 
    𝐶𝐶𝐶𝐶𝐼𝐼 = 𝐹𝐹𝐶𝐶𝐶𝐶𝐼𝐼 ∗
(𝑃𝑃𝑂𝑂/𝑚𝑚𝑏𝑏𝑒𝑒𝑒𝑒 1−𝑃𝑃𝑂𝑂/𝑚𝑚𝑏𝑏𝑒𝑒𝑒𝑒𝐶𝐶𝑎𝑎  )
𝑃𝑃𝑂𝑂/𝑚𝑚𝑏𝑏𝑒𝑒𝑒𝑒 1
       (5.5) 
where FCDI is the fraction of channels within mode Ca. Therefore at a saturating level of Ca2+, 
FCDI will approach unity as virtually all channels will reside within mode Ca.  Under this 
condition, a maximal level of CDI (CDImax) is achieved: 
    𝐶𝐶𝐶𝐶𝐼𝐼𝑚𝑚𝑎𝑎𝑚𝑚 =
(𝑃𝑃𝑂𝑂/𝑚𝑚𝑏𝑏𝑒𝑒𝑒𝑒 1−𝑃𝑃𝑂𝑂/𝑚𝑚𝑏𝑏𝑒𝑒𝑒𝑒𝐶𝐶𝑎𝑎  )
𝑃𝑃𝑂𝑂/𝑚𝑚𝑏𝑏𝑒𝑒𝑒𝑒 1
    (5.6) 
We now consider the effects of the S6 mutation A760G within our model.  As we and 
others (Pinggera et al., 2015) have shown that this mutation causes a hyperpolarizing shift in 
channel activation, the variable a was introduced to account for the altered free energy (∆∆Ga) 
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required to open the mutant channels (Tadross et al., 2010).  For a hyperpolarizing mutation such 
as A760G, ∆∆Ga will be negative, indicating decreased energy required to open the mutant 
channel.  This decrease in free energy will result in increased channel opening in both mode 1 
and mode Ca, thus decreasing CDImax (Eq 5.6, Figure 5.2B, green).  This reduction of CDImax 
could account for the overall decrease in CDI (Figure 5.2B, black) observed in whole-cell 
experiments (Figure 5.1), despite the increased FCDI (Figure 5.2B, blue) due to increased Ca2+ 
influx.   
To test the hypothesis that the CDI deficit due to A760G is primarily a result of a 
decrease in CDImax, we undertook whole-cell patch clamp recordings in which conditions 
enabled a sustained saturating level of Ca2+ at the mouth of the channel.  By significantly 
reducing the intracellular Ca2+ buffer  (0.5 mM EGTA), the accumulation of Ca2+ within the cell 
should overpower the nanodomain Ca2+ signal, thus raising Ca2+ to saturating levels as whole 
cell current increases (Yang et al., 2006) and providing an estimation of CDImax (Tadross et al., 
2008). For WT CaV1.3 channels, exemplar Ca2+ traces illustrate a saturating amount of CDI as a 
function of current density (Figures 5.2C, D).  The lack of additional CDI accumulation beyond a 
current density of 50 pA/pF indicates that we reached CDImax at a value of ~ 0.9 for WT channels 
(Figure 5.2D, red dashed line).  A760G channels, however, demonstrate a significant reduction 
in CDImax to ~ 0.7 (Figures 5.2E, F), which can be observed at multiple test potentials 
(Supplementary Figure 5.2), confirming the underlying mechanism of CDI loss (Figure 5.2B).   
5.3.2 The A760G mutation differentially affects CaV1.3 splice variants  
CaV channels are a critical conduit for Ca2+ entry into multiple cell types and must 
therefore be precisely tuned for specific cellular functions. Nature employs multiple mechanisms 
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with which to accomplish such fine tuning, including modulation of channel splice patterns 
(Shen et al., 2006; Bock et al., 2011; Tan et al., 2011; Huang et al., 2013; Striessnig et al., 2014). 
An example of such splicing in CaV1.3 channels results from inclusion of exon 42 or 42a, 
yielding a channel with a long versus short C-terminus (Huang et al., 2013). The long channel 
variant activates at a somewhat more positive potential (Singh et al., 2008; Striessnig et al., 
2014), has a lower open probability (Adams et al., 2014), and exhibits dramatically reduced CDI 
as compared to the short splice variant (Liu et al., 2010; Striessnig et al., 2014). Due to these 
distinct properties, we examined the effect of the A760G mutation in both relevant splice 
variants.  Having already demonstrated a significant reduction in CDI within the short channel 
variant, the isoform with more robust CDI (Huang et al., 2013; Striessnig et al., 2014) (Figure 
5.1), we next undertook a similar approach within the long CaV1.3 splice variant (CaV1.3long). 
Examination of CDI within the WT CaV1.3long channel under high buffering conditions 
(10 mM BAPTA) demonstrated significantly smaller, yet appreciable CDI (Figures 5.3A, B), as 
compared to the short channel variant (Figures 5.1B, C). Introduction of the A760G mutation 
blunted this CDI (Figures 5.3F, G), though to a lesser extent as compared to the short variant. 
We next examined the activation of WT and A760G CaV1.3long channels. The resulting Po,rel 
versus voltage relationships (Figures 5.3C, H) demonstrated an 11 mV hyperpolarizing shift due 
to the introduction of A760G (p < 0.01), similar to that observed in the short variant (Figures 
5.1D, I).  Likewise, analysis of the deactivation kinetics also revealed a significant slowing of 
channel closing across multiple voltages (Figures 5.3D, E, I, and J). Thus, the biophysical 
deficits produced by the A760G mutation are qualitatively similar within each relevant channel 




5.3.3 Opposing VDI changes may mitigate the detrimental effects of A760G  
In addition to the critical Ca2+-dependent feedback, VDI also plays a major role in 
controlling Ca2+ entry through CaV1 channels.  The underlying structural components for VDI 
have been shown to involve the linker region between domains I and II (I-II linker), which acts 
as a hinged-lid to close the pore following depolarization (Stotz et al., 2000; Tadross et al., 
2010). This process is known to be variably modulated by the binding of different isoforms of 
channel β subunits to the I-II linker (Tadross et al., 2010; Buraei and Yang, 2013). For example, 
when coexpressed with β2a, CaV1 channels display little VDI due to restricted movement caused 
by palmitoylation, and thus membrane anchoring, of the β2a (Figure 5.4A, blue) (Stea et al., 
1994; Colecraft et al., 2002; Dafi et al., 2004). On the other hand, if the channels are coexpressed 
with the β1b subunit, most CaV1 isoforms will display strong VDI due to the lack of the 
palmitoylation site (Colecraft et al., 2002; Shen et al., 2006).  CaV1.3 channels, however, are 
unique in that their S6 helices have been shown to act as a shield (Figures 5.4A, D, red) to 
prevent closing of the I-II linker lid, thus, endowing the channels with minimal VDI regardless 
of β subunit isoform co-expressed.   
A close inspection of the Ba2+ current through the A760G CaV1.3 channels reveals a 
slight, but significant re-emergence of VDI despite the presence of the β2a subunit (Figures 5.4B, 
C).  Importantly, this mutation-induced VDI can be discerned in either of the two channel 
variants (Figures 5.1G versus B, Figures 5.3F versus A). This re-emergence of VDI is 
accentuated when A760G CaV1.3 is coexpressed with β subunits lacking a palmitoylation site. 
Figures 5.4E, F demonstrate a significant increase in VDI in channels harboring the A760G 
mutation in the presence of the β1b subunit. Note that the WT CaV1.3 channels (black) have 
minimal VDI even in the presence of the β1b subunit due to the existence of the 'shield'. Thus the 
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re-emergence of VDI in these channels indicates that the A760G mutation may disrupt the VDI 
shield (Figures 5.4A, D, bottom). This increase in VDI may act in opposition to the loss of CDI 
within these mutant channels, thus mitigating the detrimental effects of increased Ca2+ flux into 
cells. 
5.3.4 The A760G mutation can cause an increase in intracellular Ca2+  
We now know that the A760G mutation has a significant effect on CDI, VDI, and 
deactivation. Given the known link between excess cytosolic Ca2+ and severe disease states 
(Splawski et al., 2005; Schulz, 2007; Zhang et al., 2011), we wondered if Ca2+ overload due to 
an increased Ca2+ influx may play a role in the phenotype of A760G patients. However, the 
effects of the A760G mutation on Ca2+ entry are multi-fold, such that a decrease in CDI and 
slowing of channel deactivation are opposed by an increase in VDI.  We therefore sought to 
confirm the cumulative effect of the A760G mutation on overall Ca2+ entry and intracellular Ca2+ 
concentration ([Ca2+]i).  
To this end, we stimulated HEK293 cells expressing CaV1.3 channels with a 1-Hz train of 
neuronal action potentials (Figure 5.5A, top) and recorded both the Ca2+ current passing through 
the channels as well as the intracellular Ca2+ level. This stimulation protocol was chosen as it 
matches well with the spontaneous neuronal firing frequencies in some populations of 
hippocampal neurons, thus mimicking a basal activity level (Hirase et al., 2001; Mizuseki and 
Buzsaki, 2013).  When this protocol was applied to WT CaV1.3 channels, a small decrease in 
peak current amplitude was observed over time as CDI accumulated (Figure 5.5A, middle panel).  
This amplitude decay matches well with the relatively small increase in [Ca2+]i, (Figure 5.5A, 
bottom panel). When the A760G mutation was introduced into the channel, however, a 
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significant increase in both the rate and extent of intracellular Ca2+ accumulation was observed 
(Figures 5.5B-D, blue) due to an increased duration of Ca2+ entry during each action potential 
(Figure 5.5B, left). This increased Ca2+ entry is likely a net result of decreased channel 
inactivation, and a slowing of channel deactivation. This excess [Ca2+]i increased the extent of 
CDI observed in the current recordings over time although this decrease in current entry was not 
sufficient to counteract the Ca2+ overload within the cytosol.  Overall, the cumulative effect was 
a steady state Ca2+ level approaching 0.8 uM (Figure 5.5C), substantially larger than the normal 
resting [Ca2+]i of a neuron (Verkhratsky et al., 1994).  This excess cytosolic Ca2+ due to A760G 
could be a significant contributing factor to the disease pathogenesis. 
5.4 Discussion 
We have demonstrated a significant effect of the autism-associated mutation A760G on 
the gating of CaV1.3 such that channel activation is significantly left-shifted, CDI is decreased, 
and deactivation is slowed, resulting in excess Ca2+ entry through channels.  However, these 
effects are mitigated by an increase in VDI.  Importantly, the balance between these opposing 
mechanisms may be dependent on the specific properties of the particular channel complex 
harboring the mutation. In particular, we have demonstrated that two major CaV1.3 splice 
variants respond to the introduction of the A760G mutation with distinct levels of CDI disruption 
(Figures 5.1, 5.3). As each of these splice variants has a significantly different affinity for 
commonly used L-type channel blockers (Huang et al., 2013), such a variation in CDI effects 
may have important implications on the response of patients to treatment. Moreover, these two 
splice variants represent only a subset of a panoply of channel isoforms found across different 
tissues, each with uniquely tuned channel gating and feedback regulation (Tan et al., 2011; 
Huang et al., 2012; Bazzazi et al., 2013; Huang et al., 2013; Lieb et al., 2014; Striessnig et al., 
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2014).  Like the short versus long splice isoforms, it is possible that the A760G mutation may 
differentially alter the biophysical properties of these variants. Thus the extent of channel 
alteration may depend on the expression pattern within each specific cell type resulting in 
variable phenotypes across different tissues. 
The original case report for A760G describes a patient exhibiting primarily neurological 
deficits classified as ASD (O'Roak et al., 2012).  Upon further examination of the Simons 
Simplex Collection database, the classification of ASD in this proband appeared to be of a 
relatively milder nature on the autism spectrum (pervasive developmental disorder not otherwise 
specified or PDD NOS) without additional non-neurological symptoms.  Such a narrow 
symptom profile without any cardiac or hearing deficits stands in contrast to the broad tissue 
distribution of CaV1.3.  Moreover, this lack of severe multisystem characteristics is unusual for 
autism-related Ca2+ channelopathies (Splawski et al., 2004; Hemara-Wahanui et al., 2005; 
Splawski et al., 2005; Breitenkamp et al., 2015). The multitude of CaV1.3 channel variants across 
different tissues (Shen et al., 2006; Bock et al., 2011; Tan et al., 2011) may account for some of 
this lack of a multi-system phenotype. The relatively moderate symptoms of this proband may be 
due, in part, to differential effects of the A760G mutation on specific channel variants expressed 
in each system.  In addition, the VDI effects of the A760G mutation could also contribute to the 
milder phenotype displayed by the proband. In particular, the increased Ca2+ entry due to altered 
CDI and channel activation/deactivation may be partially offset by increased VDI.  As this VDI 
enhancement is accentuated in the presence of select beta subunits (Figure 5.4), expression 
patterns of different beta subunits (Ludwig et al., 1997) may further increase the variability of 
A760G effects across systems. 
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The A760G mutation is capable of substantially raising cytosolic Ca2+ concentration 
when overexpressed in HEK293 cells (Figure 5.5).  Of note, this effect was achieved even at a 
relatively slow 1-Hz pacing rate, comparable to the spontaneous firing rate of some hippocampal 
neurons (Hirase et al., 2001; Mizuseki and Buzsaki, 2013).  The experimental conditions utilized 
here were optimized for maximal resolution of the A760G effect.  However, under physiological 
heterozygous expression levels, the effect of the A760G channels will likely be considerably 
less. Nonetheless, the idea of excessive Ca2+ entry underlying ASD is not unprecedented as the 
ASD phenotype has been linked to Ca2+ overload through a myriad of Ca2+ handling molecules 
(Chen et al., 2003; Barnby et al., 2005; Zhou et al., 2006), including multiple voltage-gated Ca2+ 
channels (Splawski et al., 2004; Hemara-Wahanui et al., 2005; Splawski et al., 2005; Krey and 
Dolmetsch, 2007). Overall, it seems plausible that the gating defects of the CaV1.3 channels 
harboring the A760G mutation may result in excess Ca2+ entry, which in turn may be over-
activating the downstream Ca2+ signaling pathways involved in neural development and 
plasticity (Chen et al., 2003; Barnby et al., 2005; Zhou et al., 2006; Krey and Dolmetsch, 2007). 
While the mechanisms underlying ASD remain elusive, the identification of mutations such as 






























Figure 5.1 A760G decreases CDI and promotes channel activation. (A) Cartoon representing 
CaV1.3 and the location of the autism-associated mutation A760G. Left, the A760G missense 
mutation resides in the S6 helix of domain II. Right, structural homology model of CaV1.3 S5/S6 
segments, based on NaVAb with the A760G highlighted in red. (B) Exemplar Ca2+ (red) and Ba2+ 
(black) current traces through WT CaV1.3short evoked by a 10-mV depolarizing step. Currents are 
normalized for comparison. Scale bar corresponds to the Ca2+ trace. (C) Population data of 
fraction of current remaining after 300 ms (r300) for Ca2+ (red) and Ba2+ (black). f300 determined 
at 10 mV (n=12). Data are plotted as mean ± SEM here and throughout. (D) The activation curve 
for WT CaV1.3short obtained via a tail activation protocol with Ba2+ as the charge carrier (n = 6). 
(E) Exemplar Ba2+ tail currents obtained from a transition from 80 mV to -40 mV (black) 
and -60 mV (green). Traces are normalized to one another. Scale bars correspond to the traces of 
the same color. (F) Population data of the fast (top) and slow (bottom) deactivation time 
constants (τ) plotted as a function of voltage (n = 5). (G) Exemplar Ca2+ (red) and Ba2+ (black) 
current traces through A760G CaV1.3short evoked by a 10-mV depolarizing step. Compared to 
that of WT (B), Ca2+ current through A760G channels displays significantly less CDI. (H) 
Population data of r300 for Ca2+ (red) and Ba2+ (black) currents through A760G channels. CDI is 
significantly smaller (*** p < 0.001, n = 6) than that of the WT channels. (I) The activation 
curve of A760G CaV1.3short channels (black) shows a 13-mV hyperpolarizing shift (** p < 0.01, 
n = 4) compared to WT (reproduced in gray). (J) Exemplar Ba2+ tail currents for the A760G 
channel, obtained from a transition from 80 mV to -40 mV (black) and -60 mV (green). (K) 
Population data of the fast (top) and slow (bottom) deactivation time constants (τ) plotted as a 
function of voltage for the A760G channel. Deactivation is significantly slowed as compared to 
















Figure 5.2 An allosteric mechanism underlying the CDI reduction. (A) Diagram representing 
an allosteric model of CDI. Channels transition from mode 1 with high PO, to mode Ca2+ with 
lower PO, in response to Ca2+ entry.  Equilibrium constants QEFF (concerted movement of S1-S4 
segments), L (S6 movement), and a (mutation effect) govern transitions between open and closed 
channel configurations (Tadross et al., 2010; Dick I. E., 2016), while the effective equilibrium 
constant J(Ca2+) governs entry into mode Ca2+. The parameter f (0 < f < 1) scales the PO in mode 
Ca2+ resulting in CDI. State transitions expected to be effected by the A760G are shaded pink. 
(B) Total CDI (black), the product of FCDI (blue) and CDImax (green), is plotted as a function of 
∆∆Ga for the model shown in panel A.  The A760G mutation left-shifts voltage activation (∆∆Ga 
< 0, a > 1), predicting a decrease in CDI due to a decrease in CDImax. (C) Exemplar Ca2+ current 
traces through WT CaV1.3short channels. Larger current amplitudes (ii, iii) allow a greater influx 
of Ca2+, enhancing entry into mode Ca and thus increasing CDI as compared to diminutive Ca2+ 
currents (i). (D) f300 values for individual cells expressing WT CaV1.3short are plotted as a 
function of current density.  The curve saturates at CDImax ~ 0.9 (red dashed line). Traces in C 
correspond to i-iii. (E) Exemplar Ca2+ current traces through A760G CaV1.3short channels. 
Similar to that of WT (C), larger current amplitude increases f300 values. (F) Population data 
representing CDI of A760G CaV1.3short channels.  f300 values saturate at CDImax ~ 0.7 (red dashed 






Figure 5.3 CDI reduction due to A760G mutation under CaV1.3 long variant. (A) Exemplar 
Ca2+ (red) and Ba2+ (black) current traces through the alternate splice variant CaV1.3long 
illustrating decreased CDI as compared to the short splice variant (Figure 5.1B). (B) Despite the 
reduction in magnitude, significant CDI is demonstrated by the difference in r300 for Ca2+ (red) 
and Ba2+ (black), plotted across multiple voltages. (f300 = 0.28 ± 0.04, n=3). (C) Voltage 
activation curve for Ba2+ current through WT CaV1.3long channels (V1/2 = -1.0 ± 1.8 mV, n = 5). 
(D) Exemplar Ba2+ tail currents obtained from a transition from 80 mV to -40 mV (black) 
and -60 mV (green). Traces are normalized to one another such that the scale bars correspond to 
the traces of the same color. (E) Population data of the fast (top) and slow (bottom) deactivation 
time constants (τ) plotted as a function of voltage. Error bars indicate ± SEM, n=5. (F) Exemplar 
current traces through A760G CaV1.3long channels depicting diminished CDI as compared to WT 
channels. (G) Population data for r300 (red = Ca2+, black = Ba2+) plotted across multiple voltages 
(f300 = 0.10 ± 0.03; n=4, * p < 0.05). (H) The activation curve of A760G CaV1.3long channels 
(black, V1/2 = -12.0 ± 2.1 mV, n = 4) shows an 11-mV hyperpolarizing shift (** p < 0.01) 
compared to WT (reproduced in gray for reference). (I) Exemplar Ba2+ tail currents for the 
A760G CaV1.3long channel, obtained from a transition from 80 mV to -40 mV (black) and -60 
mV (green). Traces are normalized to one another such that the scale bars correspond to the 
traces of the same color. (J) Population data of the fast (top) and slow (bottom) deactivation time 
constants (τ) plotted as a function of voltage for the A760G CaV1.3long channel. Deactivation is 
significantly slowed as compared to WT reproduced as the gray dashed line (* p < 0.05, ** p < 















Figure 5.4 A760G increases VDI. (A) Cartoon depicting a β2a subunit (blue) interacting with 
the VDI hinged lid (green) of a CaV1.3short channel. With palmitoylation, the β2a subunit is 
anchored to the plasma membrane (black coil) restricting the movement of the channel hinged 
lid. CaV1.3short channels also possess a ‘VDI shield’ (red).  The A760G mutation disrupts this 
shield (bottom). (B) Exemplar Ba2+ current through WT (black) and A760G (blue) CaV1.3short 
channels shows re-emergence of VDI even in the presence of β2a. (C) Population data displaying 
Ba2+ r300 values as a function of voltage for WT (black) and A760G (blue). At 10 mV, WT: r300 
=0.98 ±0.01; n=10; A760G: r300 = 0.89 ±0.03, n=6. VDI is significantly increased in A760G 
channels (p < 0.01). (D) Cartoon depicting a β1b subunit (blue) interacting with the hinged lid 
(green) of a CaV1.3 channel. Note the absence of palmitoylation of this β subunit which allows 
the VDI hinged lid to move freely. (E) Exemplar Ba2+ current trace through WT (black) and 
A760G (blue) CaV1.3short channels in the presence of β1b. Note the absence of VDI in WT 
channels despite the lack of β subunit palmitoylation due to the presence of a VDI shield. A760G 
causes a pronounced re-emergence of VDI under these conditions. (F) The increase in VDI is 
confirmed in population data where Ba2+ r300 values for WT (black) and A760G (blue) are 
plotted as a function of voltage. At 10 mV, WT:  r300 = 0.98 ±0.01, n=3; A760G: r300 = 0.77 

















Figure 5.5 Effects of A760G on cytosolic Ca2+. (A) Exemplar Ca2+ currents in response to a 1-
Hz train of neuronal action potentials delivered to HEK293 cells expressing WT CaV1.3short 
channels. On the left, a single action potential and corresponding Ca2+ current is displayed on an 
expanded time course for resolution. Each action potential (top) and corresponding current 
response (middle) is magnified for display purposes and represents a 23 ms interval. The peak of 
each action potential is aligned with the time course displayed on the bottom panel. Note the 
gradual decrease in peak current as the level of cytosolic Ca2+ (bottom right panel) rises. (B) 
Exemplar Ca2+ currents in response to a 1-Hz train of neuronal action potentials delivered to 
HEK293 cells expressing A760G CaV1.3short channels. On the left, a magnified view 
demonstrates an increased duration of Ca2+ entry (blue) during a single action potential as 
compared to WT (A).  At a comparable current density, A760G causes considerably more 
cytosolic Ca2+ accumulation (bottom right panel) as compared to WT channels. This increased 
cytosolic Ca2+ persists despite causing an enhancement of CDI (middle right panel). (C) Steady 
state level of intracellular Ca2+ in response to a 1-Hz train of action potentials.  [Ca2+]ss is 
measured after 60 s of stimulation.  A760G CaV1.3 channels display significantly higher levels 
of [Ca2+]ss than WT channels (WT: 0.28 ± 0.05, n=7; A760G: 0.73 ± 0.13, n=8; p < 0.01). (D) 
Average [Ca2+]i as a function of time as HEK293 cells expressing WT or A760G CaV1.3short 
channels are stimulated by a train of 1-Hz action potential.  Error bars indicate ± SEM, n=7, 8 for 
WT and A760G respectively.  
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5.6 Supplementary materials 
5.6.1 The residual inactivation of A760G CaV1.3 remains Ca2+/CaM dependent 
CDI of CaV channels is known to be orchestrated by the Ca2+ sensor molecule calmodulin 
(CaM) (Halling et al., 2006; Christel and Lee, 2012; Ben-Johny and Yue, 2014). To ensure that 
the residual inactivation of Ca2+ current observed in CaV1.3 channels harboring the A760G 
mutation remains entirely dependent on Ca2+/CaM, we co-expressed the mutant channel with a 
dominant negative mutant CaM (CaM1234) (Xia et al., 1998), incapable of binding Ca2+.  The 
A760G CaV1.3short channels displayed no CDI (Supplementary Figure 5.1), confirming that the 
A760G mutation did not alter the mechanism underlying CDI of these channels. Gratifyingly, 
this Ca2+/CaM dependence is identical to that seen in WT CaV1.3 channels co-expressing with 




Supplementary Figure 5.1 Elimination of CDI of A760G CaV1.3 upon 
co-expression of CaM1234. (A) Exemplar Ca2+ (red) and Ba2+ (black) 
currents from CaV1.3short channels harboring the A760G mutation with 
CaM1234 overexpressed. Scale bar corresponds to Ca2+ trace. Ba2+ trace is 
normalized to Ca2+ for comparison. (B) Population data of Ca2+ (red) and 




5.6.2 A760G decreases CDImax of CaV1.3 at multiple voltages 
In the main text, we illustrate a reduction in CDImax at a 10-mV test potential (main text 
Figure 5.2). To account for the shift in channel activation produced by the A760G mutation, we 
also quantified CDImax of both WT and A760G CaV1.3short at 0-mV and 20-mV test potentials 
(Supplementary Figure 5.2).  CDImax of the WT channels is significantly higher than that of the 




Supplementary Figure 5.2 
Reduction of CDImax at 
various voltages. (A) Ca2+ 
currents of WT CaV1.3short 
obtained under low Ca2+ 
buffering (0.5 mM EGTA) 
evoked by a 0-mV test 
potential. The extent of CDI 
increases as a function of 
current density and reaches a 
maximal value  of ~ 0.9. (B) 
Ca2+ traces from A760G 
CaV1.3short obtained in a 
similar manner as 2A. The 
extent of CDI increases as the 
current density increases and 
reaches a CDImax of ~ 0.7, 
significantly lower than that of 
the WT channel. (C-D) Ca2+ 
currents through WT and 
A760G CaV1.3short channels 
evoked by a 20-mV test 
potential under 0.5-mM EGTA 
buffering. At this test 
potential, CDImax of the WT 
channels (~ 0.9) remains 
consistently higher than that of 




Conservation of cardiac L-type calcium channels and their regulation in Drosophila 
6.1 Introduction 
Cardiac action potentials, which drive rhythmic contractions of the heart, are the result of 
well-choreographed opening and closing of multiple ion channels. Among these is the LTCCs 
which not only permit Ca2+ entry to initiate myocyte shortening, but also set the length of the 
plateau phase of the cardiac action potential and, thereby, determine its duration (Nerbonne and 
Kass, 2005). Disruption of this critical channel or its precise regulations underlies numerous 
pathologies. For example, mutations in CaV1.2, a major type of LTCC in cardiac muscle, lead to 
Timothy syndrome, a multi-system disorder featuring autism, polydactyly, and long-QT 
syndrome, associated with cardiac arrhythmia (Splawski et al., 2004; Splawski et al., 2005; 
Barrett and Tsien, 2008; Dick et al., 2016), while mutations in CaV1.3, an LTCC in nodal cells, 
lead to bradycardia and congenital deafness (Platzer et al., 2000; Baig et al., 2011). Additionally, 
changes in channel density and function are associated with atrial fibrillation (Yue et al., 1997; 
Van Wagoner et al., 1999) and heart failure (Balke and Shorofsky, 1998; Hasenfuss, 1998; 
Mukherjee and Spinale, 1998; Richard et al., 1998; Schroder et al., 1998; He et al., 2001).  
Mechanistic dissection of alterations in LTCC regulation is typically conducted using 
recombinant channels expressed in a heterologous system. Unfortunately, these systems often 
lack key auxiliary elements that are readily available in the context of cardiac myocytes. 
Studying Ca2+channel regulation in native mammalian myocytes is, however, challenging due to 
cellular complexity, including redundancy among genes, and the difficulty of endogenously 
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manipulating the channels, raising the need for an intermediate system that is both genetically 
pliable and is reflective of a cardiac muscle cell. 
Cardiomyocytes from Drosophila melanogaster, the fruit fly, offer an attractive, though 
as-yet-incompletely explored alternative. Drosophila benefit from a completely sequenced 
genome, conservation of disease orthologs (Chorna and Hasan; Rubin et al., 2000; Reiter et al., 
2001; Bier, 2005; Chintapalli et al., 2007; Pandey and Nichols, 2011), and a host of readily 
available genetic tools (Wolf and Rockman; Adams and Sekelsky, 2002; St Johnston, 2002; 
Chintapalli et al., 2007; Pfeiffer et al., 2010; Pandey and Nichols, 2011). For example, the 
bipartite Gal4-UAS expression system (Brand and Perrimon, 1993; Elliott and Brand, 2008) 
permits straightforward control of gene expression across space (Lo and Frasch, 2001; Lai and 
Lee, 2006; Luan et al., 2006; Monnier et al., 2012) (by means of tissue-specific promoters) and 
time (via drug- or temperature-inducible expression (Roman et al., 2001; Kim and Wolf, 2009)). 
This system readily supports investigation of gain- or loss-of-function genes of interest, owing to 
large resources and libraries that include thousands of independent GAL4 and UAS Drosophila 
lines that permit selective transgene overexpression or RNAi (interfering RNA)-mediated gene 
silencing (Dietzl et al., 2007; Haley et al., 2008; Neely et al., 2010). Importantly, mutant genes 
can easily be studied in the same genetic environment as their wild-type counterparts, thus 
minimizing confounding effects, such as those that may result from insertion of transgenes in 
different locations throughout the genome (Rong and Golic, 2000), (Rong and Golic, 2001). 
Many Drosophila proteins are encoded by a single gene that generates multiple distinct isoforms 
through alternative splicing of the primary transcript, simplifying knockout (Wolf and Rockman) 
and/or gene suppression experiments. Flies can also tolerate severe manipulation of heart 
components because oxygen transport occurs through trachea that invaginate from the cuticle 
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into the interior of the flies (Demerec, 1994). The effects of potentially lethal cardiac mutations 
can therefore be studied in vivo without necessarily initiating death. Furthermore, recent 
development of techniques to image (Wolf et al., 2006; Wu and Sato, 2008; Cooper et al., 2009; 
Vogler and Ocorr, 2009; Cammarato et al., 2015; Men et al., 2016) and record electrical field 
potentials (Papaefthmiou and Theophilidis, 2001; Cooper et al., 2009) of both larval (Wu and 
Sato, 2008; Cooper et al., 2009; Vogler and Ocorr, 2009; Men et al., 2016) and adult 
(Papaefthmiou and Theophilidis, 2001; Wolf et al., 2006; Vogler and Ocorr, 2009; Cammarato et 
al., 2015; Men et al., 2016) hearts readily allows functional assessment of different 
developmental stages of Drosophila myocardium after manipulation of genes of interest. Finally, 
flies are economical and easy to breed, generate numerous offspring, and feature a short 
lifecycle, making large-scale genetic and small-compound screens, in wild-type and disease 
models, eminently feasible. 
Drosophila have an open circulatory system with a dorsal vessel or “cardiac tube” 
(Figure 6.1A), which in many ways functionally and developmentally resembles the embryonic 
vertebrate heart (Wolf and Rockman; Bodmer, 1995; Tao and Schulz, 2007; Wu and Sato, 2008). 
The tube is composed of a single layer of two opposing rows of cardiac myocytes (Miller, 1950; 
Wu and Sato, 2008) whose action potential, as found in higher organisms, is myogenic in origin, 
i.e. action potentials originate from muscle itself as opposed to in response to neuronal impulses 
(neurogenic origin) (Dowse et al., 1995; Gu and Singh, 1995; Johnson et al., 2000). The activity 
of these myocytes is modulated by a neurohormonal system that features the adrenaline analog 
octopamine (Johnson et al., 2002). Action potentials of Drosophila heart tubes have been 
coarsely measured (Papaefthmiou and Theophilidis, 2001; Ocorr et al., 2007a; Cooper et al., 
2009; Ocorr et al., 2017), and the voltage waveforms appear comparable in duration and 
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amplitude to those recorded in vertebrate ventricular myocytes. As LTCCs play a major role in 
shaping vertebrate cardiac action potentials, it is plausible that a Drosophila analog is playing a 
similar role in the heart tube. Like vertebrates, flies express hetero-oligomeric voltage gated Ca2+ 
channels (CaV) composed of  α1, β, α2δ, and, in some tissues, ϒ subunits (Chorna and Hasan; 
Hofmann et al., 1994; Isom et al., 1994). Three distinct genes, Ca-α1D (CG4894), cacophony 
(CG43368), and Ca-α1T (CG15899) encode the α1 subunits A1D, cac, and T-type, which specify 
three oligomeric voltage gated Ca2+ channels that correspond to CaV1, CaV2, and CaV3, the main 
Ca2+ channel families in vertebrates (Supplementary Table 6.1). Drosophila A1D is similar to 
the dihydropyridine-sensitive (L-type) channels of vertebrates; cac to N-, P/Q-, R-type channels; 
and T-type to CaV3 channels (Chorna and Hasan). RNA microarray data demonstrate enrichment 
of A1D in the hearts of adult fruit flies compared to the whole body, hinting at the potential 
presence of A1D in Drosophila cardiac tubes (Chintapalli et al., 2007; Robinson et al., 2013). 
Still, the complete molecular biosignature of heart-tube Ca2+ channels in Drosophila is unknown. 
Here, we have elucidated the identity of the Ca2+ channels in the Drosophila heart. Direct 
visualization and quantitation of mRNA revealed an abundance of Ca-α1D and Ca-α1T and a 
paucity of cacophony Ca2+ channel messages in the heart tubes. Suppression of Ca-α1D 
effectively eliminated contraction and Ca2+ cycling activity, while knocking down other channels 
yielded minimal disruption of contraction and Ca2+ activity. Although these two lines of 
evidence suggested the presence of A1D and T-type channels, definitive validation required 
direct measurement of Ca2+ current across the sarcolemma of Drosophila cardiomyocytes. To 
this end, we devised a method for isolating viable single cardiomyocytes from adult Drosophila 
heart tubes. These myocytes enabled whole-cell patch clamp recordings of Ca2+ currents. 
Utilizing pharmacological agents and existing Drosophila lines with hypomorphic channels, we 
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verified the presence of both A1D and T-type Ca2+ currents in fly cardiomyocytes with A1D 
being the major contributor of the Ca2+ influx for contraction. Similar to mammalian LTCCs, 
Drosophila A1D also possesses CDI, a critical feedback regulation of the channel, and Ca2+ 
current augmentation through adrenergic stimulation. Overall, we established the identity of Ca2+ 
channels in the adult Drosophila heart and devised a novel technique for isolating single 
cardiomyocytes, which highlights the fly as a feasible alternative for studying diseases involving 
misregulation of cardiac LTCCs. 
6.2 Materials and methods 
6.2.1 Drosophila strains and maintenance 
TinCΔ4-Gal4 (Lo and Frasch, 2001), TinCΔ4-Gal4;UAS-GCaMP3 (a generous gift from 
Dr. Rolf Bodmer), and Hand4.2-GS-Gal4 (Monnier et al., 2012) Drosophila were employed to 
drive UAS-transgene expression in a cardiac-restricted fashion. UAS-RNAi stocks, obtained from 
the Vienna Drosophila Resource Center (VDRC), included UAS-Ca-α1DRNAi: 51491 (RNAi Ca-
α1D #1), 52644 (RNAi Ca-α1D #2), UAS-cacophonyRNAi: 104168, and UAS-Ca-α1TRNAi: 108827. 
Background (control) RNAi strains included w1118 wild-type and KK injection lines. GFP-
Zasp52 (BDSC Stock no. 6838, which expresses a fluorescently labeled scaffold protein that 
binds α-actinin and localizes to muscle Z-discs), hypomorphic cacophony CacS (a generous gift 
from Dr. Chun-Fang Wu (Smith et al., 1996)), and T-type channel knock out  (a generous gift 
from Dr. Carsten Duch (Ryglewski et al., 2012)) flies were used for electrophysiological studies. 





6.2.2 Fluorescence RNA in situ hybridization (FISH) 
  TinCΔ4-Gal4 virgin females were crossed with w1118 males. Five days post eclosion, the 
heart tubes of the progeny were surgically exposed under artificial hemolymph (Vogler and 
Ocorr, 2009) and the semi-intact preparations fixed as described above. Cardiac in situ 
hybridization was performed as reported previously (Viswanathan et al., 2016) using the 
QuantiGene® ViewRNA Cell Assay kit from Panomics (Affymetrix Inc.), following the 
manufacturer's recommendations. Fluorophore-tagged probes were custom designed to target 
Drosophila mRNA coding for Ca-α1D (VF1-18656, VF4-18190), cacophony (VF4-18657), and 
Ca-α1T  (VF4-18658), and a house keeping gene glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH, VF6-18191). The sequences chosen for probe design are present in all splice variants 
of each channel subunit to ensure complete coverage of mRNA molecules encoding each Ca2+ 
channel. A pre-designed probe targeting human alpha feto-protein (h-AFP, VA1-10125) was 
used as a negative control (Supplementary Figure 6.1). 
Following RNA hybridization, heart tubes were mounted on coverslips in Prolong Gold 
Antifade mounting media with DAPI (Thermo Fisher Scientific, Catalog No. P36941) and 
imaged using a Leica TCS SPE confocal microscope (Leica Microsystems) at 40X 
magnification. Micrographs of heart tubes were analyzed with ImageJ software (National 
Institute of Health). To quantitate transcripts from the confocal micrographs, individual channels 
were separated following binary conversion of the images using the same intensity threshold for 
each channel across all samples. Regions of interest, which included only the cardiomyocytes, 
were outlined using the freehand selection tool. An automated ImageJ particle counting plugin 
was used to determine the number of mRNA particles. Particle numbers were normalized to total 
area and to GAPDH. mRNA quantitation was performed on 10-11 hearts and at least 20 
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cardiomyocytes from each animal. One-way ANOVA and one-way Student's t-test adjusted for 
non-uniform distribution were used to assess the statistical significance of mRNA abundance. 
6.2.3 Cardiac functional analysis and Ca2+ transient imaging 
Homozygous TinCΔ4-Gal4;UAS-GCaMP3 or Hand4.2-GS-Gal4 virgin females were 
crossed with males carrying a UAS-RNAi cassette that targeted a specific Ca2+ channel. Two 
weeks post eclosion, the female progenies’ hearts were surgically exposed and beating semi-
intact heart tubes were recorded using a Hamamatsu Orca Flash 2.8 CMOS camera at ~120 
frames per second on a Leica DM5000B TL microscope with a 10× (NA, 0.30) immersion lens. 
Cardiac performance was assessed from the videos using the Semi-automated Optical Heartbeat 
Analysis (SOHA) motion analysis program (Fink et al., 2009; Cammarato et al., 2015). M-
modes, which provide an edge trace documenting heart wall movement over time, were 
generated via the program. Cardiac function metrics used in this study are similar to those 
described in Fink et al (2009). Heart rate variability, akin to the previously reported 
arrhythmicity index (Fink et al., 2009), is calculated as heart rate standard deviation divided by 
median heart rate. Significant differences in physiological variables were determined using one-
way ANOVAs with Bonferroni post-hoc tests. 
After filming, heart tubes were incubated with 5 µM CellTracker Orange CMTR dye 
(Thermo Fisher Scientific, Catalog No. C2927), a live cell labeling fluorescence dye, at room 
temperature for 30 minutes and rinsed with hemolymph thrice at room temperature for 10-15 
minutes. Flies were then imaged using a dual-camera Andor Revolution X1 spinning disc 
confocal on an inverted microscope (Olympus, Inc) in both green (GCaMP3; ex/em. 488/525 
nm) and red (CellTracker Orange CMTR dye; ex/em 561/617 nm) channels simultaneously. 
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Ca2+ transient analysis was performed using in-house Matlab (MathWorks, Inc.)-based 
algorithms. The green signal was normalized to the red signal and the fractional change of this 
ratio was used to gauge cardiomyocyte Ca2+ handling activity. A single exponential fit was 
performed on the decay phase of the Ca2+ transient to estimate the decay kinetics. One-way 
ANOVAs and unpaired Student's t-tests adjusted for non-uniform distribution were used to 
assess significant differences in Ca2+ dynamics between groups. 
6.2.4 Isolation of live cardiomyocytes from Drosophila heart tubes 
Heart tubes from 30-40 two-week old adult flies were surgically removed and placed into 
modified Ca2+-free hemolymph. The heart-tube suspension was supplemented with collagenase 
type I to achieve a final concentration of 0.2% (weight/volume) and incubated at room 
temperature on a shaker for 20 minutes. Trypsin was added to the suspension to achieve a final 
concentration of 0.1% (weight/volume) and the suspension was further incubated for 10 minutes 
with gentle shaking at room temperature. The digesting tissue was gently triturated every 3 
minutes after addition of trypsin. The reaction was quenched by adding fetal bovine serum at 2:1 
ratio. The solution was centrifuged at 550 x g for 5 minutes. The supernatant was aspirated and 
the cell pellet resuspended in Ca2+-free hemolymph. Cell suspensions were plated on glass 
coverslips 1 hour prior to electrophysiological studies to allow cardiomyocytes to attach to the 
coverslips. 
6.2.5 Assessing Drosophila cardiomyocyte and sarcomeric dimensions 
Heart tubes of GFP-Zasp52 Drosophila were surgically exposed and maintained in 
artificial hemolymph under low Ca2+ as previously described (Vogler and Ocorr, 2009). We 
evaluated the sarcomeric length in three configurations: (1) semi-intact hearts where heart tubes 
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were left attached to the cuticle; (2) detached whole hearts where heart tubes were extracted from 
the cuticle and suspended in hemolymph; and (3) single cardiomyocytes where heart tubes 
undergo enzymatic dissociation. For each configuration, tissues or cells were subjected to 3 
conditions which include (1) low Ca2+ hemolymph; (2) 0.1 mM blebbistatin in DMSO; or (3) 
0.1% volume/volume DMSO. Blebbistatin was used to prevent active myosin crossbridge 
cycling. Tissues or cells from these 9 conditions were then fixed in 4% formaldehyde in 1X PBS, 
washed, and mounted on coverslips in Prolong Gold Antifade mounting media with DAPI 
(Thermo Fisher Scientific, Catalog No. P36941). These specimens were imaged using a Leica 
TCS SPE confocal microscope (Leica Microsystems) at 63X magnification and sarcomere 
lengths were measure using ImageJ. We also measured cellular dimensions (length, width, area) 
in isolated cardiomyocytes under low-Ca2+ condition using ImageJ.        
6.2.6 Electrophysiology 
Whole-cell recordings of individual cardiomyocytes were performed at room temperature 
using an Axopatch 200B amplifier (Axon Instruments). Internal solutions contained (in mM): 
CsMeSO3, 114; CsCl, 5; MgCl2, 1; MgATP, 4; HEPES (pH 7.3), 10; and BAPTA, 10; at 295 
mOsm adjusted with CsMeSO3. Seals were formed in hemolymph solution and following patch 
rupture, the bath solution was switched to Ca2+- or Ba2+- external solution containing (in mM): 
TEA-MeSO3, 140; HEPES (pH 7.4), 10; and CaCl2 or BaCl2, 5; at 300 mOsm, adjusted with 
TEA-MeSO3. Traces were lowpass filtered at 2 kHz, and digitally sampled at 10 kHz. A P/8 leak 
subtraction protocol, where a leak pulse is 1/8 of the test pulse, was used with series resistances 
of 1-2 MΩ. 10 µM nifedipine (Sigma-Aldrich, N7634) or 10 µM forskolin (Sigma-Aldrich, 
F6886) was applied to the bath solution in some experiments to assess the pharmacological 
specificity of the observed Ca2+ currents. Statistical significance of current density among three 
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Drosophila lines at each test potential was assessed by one-way ANOVA and one-way Student's 
t-test adjusted for non-uniform distribution. 
6.2.7 Ca2+ channel sequence alignment 
Amino acid sequences of CACNA1C from Oryctolagus (Gene ID: 100101555; mRNA 
ID: NM_001136522) and A1D from Drosophila (Gene ID: 34950 or CG4894; mRNA ID: 
NM_165147) were aligned using Clustal Omega(McWilliam et al., 2013) to assess sequence 
homology. 
6.3 Results 
6.3.1 Drosophila cardiomyocytes express genes that encode specific voltage-gated Ca2+ 
channels  
The fly genome encodes three α1-subunits (Ca-α1D, cacophony, and Ca-α1T) of CaV. 
These subunits define three distinct Drosophila hetero-oligomeric channels: A1D, cac, and T-
type (Chorna and Hasan; Cooper et al., 2009; Iniguez et al., 2013; Breitenkamp et al., 2015) that 
are homologous to the major mammalian classes CaV1, CaV2, and CaV3, respectively. 
Fluorescence in situ RNA hybridization (FISH), which allows direct visualization and relative 
quantitation of individual mRNA molecules, was utilized to decipher the cardiomyocyte CaV 
biosignature in control TinCΔ4-Gal4 x w1118 Drosophila. Semi-intact fly hearts, which remained 
suspended within the dissected abdominal segment, were fixed, permeabilized, and incubated 
with fluorescent probes that possessed base sequence complementarity to specific α1-subunit 
mRNAs. On average, when normalized to GAPDH particles, Drosophila cardiomyocytes 
showed an abundance of Ca-α1D (0.51±0.03) and Ca-α1T (0.45±0.03) mRNA molecules 
relative to a limited number of cacophony (0.06±0.01) messages (Figures 6.1B-C).  Thus, the fly 
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heart expresses significantly higher amounts of A1D and T-type vs. cacophony Ca2+ channel 
mRNA. 
6.3.2 RNA interference reveals the predominant types of functioning CaV in Drosophila hearts 
The prevalence of Ca-α1D and Ca-α1T CaV mRNA implies that A1D and T-type are the 
major channels that orchestrate cardiac contraction in Drosophila. To verify a direct role of A1D, 
T-type, and potentially of cacophony in cardiomyocyte Ca2+ signaling, functional consequences 
of heart-specific RNAi-mediated silencing of each gene were evaluated. Previous studies have 
shown that transmembrane Ca2+ and not Na+ current substantially contributes to Drosophila 
cardiac action potentials (Gielow et al., 1995; Johnson et al., 1998). Therefore, alteration in heart 
tube contraction after CaV α1-subunit knockdown could hint at the predominant type(s) of Ca2+ 
channels operating in Drosophila cardiomyocytes. A cardiac-specific driver line, TinCΔ4-Gal4; 
UAS-GCaMP3, was crossed with multiple UAS-RNAi lines, yielding progenies with selective 
reduction of one of the three Ca2+ channels (Figure 6.2A). A highly significant reduction of Ca-
α1D, cacophony, and Ca-α1T transcripts was verified using fluorescence in situ RNA 
hybridization (Supplemental Figure 6.3). Spontaneous, myogenic contractions and Ca2+ cycling 
properties in semi-intact heart tubes were assessed in two-week-old adult offspring.  
TinCΔ4-Gal4; UAS-GCaMP3 > RNAi Ca-α1D #1 Drosophila exhibited minimal heart 
tube motion compared to the rhythmic contractions in TinCΔ4-Gal4; UAS-GCaMP3 x w1118 
controls as demonstrated by M-mode recordings (Figure 6.2B). To account for potential 
confounding positional effects that may result from insertion of the RNAi cassette in discrete 
locations throughout the Drosophila genome, two different RNAi lines with the same genetic 
background as the controls were evaluated, and the effects of gene silencing on several cardiac 
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parameters were quantified. Compared to control, both TinCΔ4-Gal4; UAS-GCaMP3 > RNAi 
Ca-α1D #1  and > RNAi Ca-α1D #2 showed significantly decreased heart rates (0.35±0.16 and 
0.36±0.10 vs. 1.24±0.10 beats/s in controls) and increased heart rate variabilities (0.45±0.12 and 
0.22±0.06 vs. 0.10±0.02 in controls) (Figure 6.2C). Moreover, the extent of contraction was 
significantly diminished in the RNAi-expressing heart tubes as demonstrated by ~4 fold 
reduction in fractional shortening (0.08±0.01 and 0.05±0.01 vs. 0.42±0.01 in controls) and ~4.5 
fold reduction in shortening velocities (52.9±17.7 and 69.3±18.7 vs. 872.7±21.3 µm/s in 
controls). 
We next ascertained if Ca2+ signaling was altered following Ca-α1D knock down. 
GCaMP3-based green fluorescence, emitted from actively beating heart cells, was recorded 
simultaneously with orange fluorescence that originated from CellTracker, a fluorescent dye that 
was passively loaded into the cardiomyocytes to monitor cell movement. The relative change in 
ratio between the two signals was used to determine the Ca2+ cycling properties. The ratiometric 
approach helped correct for heart contraction motion artifacts and for different amounts of 
GCaMP3 expression or CellTracker loading within and among the samples. Following Ca-α1D 
knockdown, fluorescent signal analysis suggested a completely abolished Ca2+ transient (Figure 
6.2D). Moreover, population data of cyclical fluorescent fluctuations confirm significant 
reductions of Ca2+ transient rates (RNAi Ca-α1D #1, #2 vs. control: 0.04±0.02, 0.03±0.02 vs. 
1.32±0.08 Hz) and peak Ca2+ transient magnitudes (0.005±0.003, 0.001±0.001 vs. 0.182±0.017) 
upon suppression of Ca-α1D expression (Figure 6.2E) compared to control. This observation is 




These experimental results demonstrate the effects of constitutive Ca-α1D suppression, 
i.e. both during and after heart tube development. To assess functional changes in hearts with 
Ca-α1D knockdown post cardiogenesis, the same UAS-RNAi lines were crossed with the 
inducible, cardiac-specific driver Hand4.2-GS-Gal4 line. Expression of Ca-α1D RNAi in the 
offspring was activated from two days after eclosion by supplementing the food with RU486 and 
the heart tubes of two-week-old Drosophila were imaged. Reduced fractional shortening and 
shortening velocity were observed when Ca-α1D was knocked down post-developmentally, 
although to a lesser extent compared to flies with cardiac-restricted Ca-α1D knockdown 
throughout development (Supplementary Figure 6.2).  Overall, these results suggest a key role of 
A1D CaV in cardiac function in flies, both during and post-development. 
In addition to A1D, potential contributions from cac and, given its high expression levels, 
T-type Ca2+ channels in defining Drosophila cardiac contraction and Ca2+-handling properties, 
were also explored. Individually suppressing expression of these channels in TinCΔ4-Gal4; 
UAS-GCaMP3 > RNAi cacophony and > RNAi Ca-α1T did not significantly alter heart rates 
(RNAi cacophony, RNAi Ca-α1T vs. controls: 2.50±0.17, 1.70±0.14 vs. 1.95±0.19 beats/s), heart 
rate variabilities (0.16±0.02, 0.15±0.03 vs. 0.12±0.03), or shortening velocities (1056±79.3, 
960±58.4 vs. 982.4±67.1 µm/s) (Figures 6.2B-C) compared to TinCΔ4-Gal4; UAS-GCaMP3 x 
KK controls. Although there was a statistically significant reduction of fractional shortening 
subsequent to cacophony or Ca-α1T channel knockdown (0.40±0.01 or 0.40±0.01 vs. 0.44±0.01 
in controls), the extent of reduction is minimal compared to that following Ca-α1D knockdown. 
Similarly, cacophony or Ca-α1T channel knockdown did not yield statistically significant 
changes in Ca2+ transient rate (RNAi cacophony, RNAi Ca-α1T vs. control: 2.04±0.15, 1.32±0.11 
vs. 1.66±0.10 Hz), Ca2+ transient magnitude (0.16±0.02, 0.15±0.02 vs. 0.17±0.02), time to peak 
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(165.0±10.8, 214.0±8.5 vs. 184.6±8.5 ms), or decay time constant (261.2±16.9, 332.6±18.6 vs. 
303.3±16.6 ms) compared to controls (Figures 6.2E). Collectively, these data indicate that A1D 
plays a major role in defining the Drosophila cardiac Ca2+ transient with potentially minor 
contributions from cac and T-type Ca2+ channels. 
6.3.3 Isolation and morphological characterization of Drosophila cardiomyocytes  
So far, we have examined the sources of plasmalemmal Ca2+ flux in Drosophila 
cardiomyocytes using multiple indirect approaches. However, voltage clamping individual cells 
and directly measuring Ca2+ current across the membrane could ultimately confirm the major 
types of active Ca2+ channels functioning in Drosophila myocardium. Although isolated 
cardiomyocytes have been a mainstay for cellular electrophysiology in mammalian systems for 
decades, no published reports of analogous protocols for flies exist. Therefore, we devised a 
method for isolating viable single cells from Drosophila heart tubes, which consist of a single 
layer of bilateral rows of opposing cardiomyocytes (Supplementary Figure 6.4A). Following 
enzymatic dissociation of GFP-Zasp52 hearts, individual cells, which maintain their curved 
shape (Figure 6.3A, Supplementary Figure 6.4B), were successfully obtained. Consistent with a 
gradual tapering of the heart’s diameter along its length, the cardiomyocytes exhibited modest 
variability in dimensions, which on average were 51.3±2.7 µm in length, 32.2±1.0 µm in width, 
and 1561±115 µm2 in maximally projected area. Sarcomere lengths were determined by 
measuring the distance between peak fluorescent signals emanating from the Z-disc-associated, 
GFP-tagged Zasp52. Interestingly, the average sarcomere length along myofibrils of myocytes 
isolated and maintained under low Ca2+ was significantly lower than that determined for semi-
intact or detached whole hearts maintained under a similar condition (1.38±0.04 vs. 2.50±0.0.3 
and 2.54±0.02 µm under low Ca2+ condition, respectively, p < 0.001, Table 6.1, Figure 6.3B). To 
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determine if the shortened sarcomeres resulted from excessive actomyosin associations activated 
upon myocyte dissociation, we compared the distance between the middle of consecutive Z-discs 
along myofibrils of semi-intact hearts, detached whole hearts, and single cells maintained in 
DMSO or in the presence of blebbistatin, a small-molecule inhibitor of several striated muscle 
myosins. The sarcomere lengths in the presence of blebbistatin for these three configurations 
(2.53±0.02, 2.53±0.02, and 1.46±0.04 µm, respectively, p > 0.05, Table 6.1, Figures 6.3B-C) 
were not significantly different from those determined under conditions of low Ca2+, which 
suggests the shortened sarcomeres result from passive processes that accompany cellular 
separation. Despite reduced sarcomere lengths, the individual myocytes nonetheless remained 
viable, as demonstrated by rhythmic contractions and the presence of Ca2+ transients 
(Supplementary Figure 6.4C) for up to 2-3 hours in Ca2+-containing artificial hemolymph at 
25°C.  
6.3.4 Voltage clamp experiments confirm A1D as a predominant mediator of Ca2+ current in 
Drosophila cardiomyocytes  
Isolated Drosophila cardiomyocytes were voltage clamped at -80 mV (resting potential) 
and the Ca2+ current, induced by various depolarizing voltage steps, was measured. For example, 
the Ca2+ current evoked by a 0-mV step potential in control (GFP-Zasp52) cells was 
characterized by a rapid influx of Ca2+ ions, which slowly decayed over time (Figure 6.4A, 
black) and resembled the characteristic inactivating mammalian CaV1 Ca2+ current. Peak Ca2+ 
current density at various test potentials is shown in Figure 6.4B (black). To explore potential 
contributions of Ca2+ current from cac and T-type channels, peak Ca2+ current density was 
measured in cardiomyocytes isolated from hypomorphic cac and null T-type Drosophila lines. 
No significant differences in the peak current density between cardiomyocytes from the control 
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(Figure 6.4B, black) and hypomorphic cac hearts (Figure 6.4B, blue) across all test voltages were 
observed. For example, the current densities of cac hypomorphic vs. control cardiomyocytes 
at -30 mV and 0 mV were -9.3±1.7 vs. -11.0±2.6 pA/pF and -13.9±0.9 vs. -12.2±1.4 pA/pF, 
respectively. These results imply a negligible contribution of cac channels in establishing 
Drosophila myocardial Ca2+ currents. However, peak Ca2+ current density measured from T-type 
null cardiomyocytes was significantly reduced relative to control at the lower voltage range 
(defined here as V < 0 mV with the employed external and internal solutions), e.g. -3.2±0.5 
pA/pF at -30 mV, while there was no significant difference in peak current density between T-
type null and control cells at the higher voltage range (defined as V > 0 mV), e.g. -13.0±2.3 
pA/pF at 0 mV. As both mammalian CaV3 and Drosophila T-type Ca2+ channels are activated 
mainly at low voltages (Hagiwara et al., 1988; Perez-Reyes et al., 1998; Perez-Reyes, 2003; 
Rossier, 2016), the current density profile from null T-type cells compared to the control 
suggests the presence of functional T-type Ca2+ channels in Drosophila heart tubes.  
Finally, to unequivocally validate the necessity of A1D CaV in Ca2+ signaling in 
Drosophila cardiomyocytes, a dihydropyridine, nifedipine, a specific mammalian CaV1 and 
Drosophila A1D channel blocker, was added to the bathing solution of control cells. Application 
of 10 µM nifedipine significantly decreased the magnitude of Ca2+ current (Figure 6.4A, blue) as 
confirmed by population data of current reduction after application of nifedipine across multiple 
test potentials (Figure 6.4C). In sum, these results corroborate the fluorescence RNA in situ 
hybridization data (Figure 6.1), and suggest that both A1D and T-type Ca2+ channels are 





6.3.5 Properties of cardiac A1D channels in Drosophila 
Multiple lines of evidence suggest A1D is a major contributor to transmembrane Ca2+ 
currents in fly cardiomyocytes. Because A1D is homologous to mammalian CaV1, it may possess 
similar properties to its mammalian counterpart including Ca2+-dependent inactivation (CDI). 
CDI is a negative feedback mechanism and key feature of CaV1 channels (CaV1.2, CaV1.3, and 
CaV1.4) that helps regulate the level of intracellular Ca2+. After entering through CaV channels, 
Ca2+ ions bind to calmodulin (CaM), a resident Ca2+ sensor molecule that is pre-bound to the C-
terminus of the channel (Imredy and Yue, 1994; Zuhlke et al., 1999; Adams et al., 2014). This 
Ca2+/CaM induces a conformational change, which decreases open probability of individual 
channels leading to a reduction of current amplitude at the whole cell level (Yue et al., 1990; 
Dick et al., 2008). In addition to CaM, other key components for orchestrating CDI  include N-
terminal spatial Ca2+ transforming element (NSCaTE) (Ben Johny et al., 2013; Taiakina et al., 
2013; Rossier, 2016) (on the N-terminus of the channel), two EF hands (Hagiwara et al., 1988; 
Johnson et al., 2000; Perez-Reyes, 2003; Lalevee et al., 2006; Sanyal et al., 2006), an IQ domain 
(Dowse et al., 1995; Lalevee et al., 2006; Sanyal et al., 2006), and Ca2+-free CaM (apoCaM) 
binding sites (on the C-terminus of the channels) (Imredy and Yue, 1994; Zuhlke et al., 1999) 
(Figure 6.5A). Since Drosophila A1D possesses domains homologous to all the aforementioned 
key CDI components, it also likely exhibits CDI. Ca2+ current recordings (Figure 6.5B, red) 
showed Ca2+ influx due to channel opening followed by a gradual decrease in the current size or 
channel inactivation (Figure 6.5B, red). CDI can be distinguished from voltage-dependent 
inactivation (VDI), another form of channel feedback regulation, by comparing Ca2+ vs. Ba2+ 
current (Figure 6.5B, black) passing through the same channel. Because Ba2+ is unable to 
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efficiently bind to CaM, Ba2+ current inactivation solely represents the degree of VDI. Thus, the 
true extent of CDI (Figure 6.5B, shaded pink) can be calculated as 𝑓𝑓300 = (𝑝𝑝300/𝐵𝐵𝑎𝑎 −
𝑝𝑝300/𝐶𝐶𝑎𝑎)/𝑝𝑝300/𝐵𝐵𝑎𝑎 , where 𝑝𝑝300/𝑚𝑚  is the fraction of Ca2+ and Ba2+ currents remaining after 300 ms 
of channel opening. For example, at a 0 mV test potential the f300 = 0.35±0.14, which confirms 
that the Drosophila Ca2+ current demonstrates robust CDI. 
Another key property of the mammalian cardiac CaV (CaV1.2) channel is current 
augmentation in response to adrenergic stimulation. During the fight-or-flight response, 
epinephrine binds to the β1-adrenergic receptor, a type of G-protein-coupled receptor, and 
initiates a signaling cascade that results in protein kinase A (PKA)-mediated CaV1.2 
phosphorylation. The phosphorylated channels demonstrate higher open probability, which leads 
to an increased whole cell Ca2+ current size. The larger Ca2+ influx augments the force of cardiac 
contraction that is necessary during the flight response. The adrenaline-like octopamine receptors 
(OctαRs, and OctβRs) (Evans and Maqueira, 2005), adenyl cyclase (rutabaga) (Pavot et al., 
2015), phosphodiesterase (dunce) (Pavot et al., 2015), and both regulatory (Taylor et al., 1990) 
and catalytic (Kato et al., 1996) subunits of PKA are also expressed in Drosophila, suggesting 
that A1D may also exhibit  PKA-mediated current augmentation. Application of 10 µM 
forskolin, an upstream activator of PKA (Figure 6.6A), increased the amplitude of Ca2+ currents 
through the A1D channels (Figure 6.6B). For example, at 0-mV test potential, peak Ca2+ currents 
were greatly amplified by 1.58±0.13-fold after forskolin application. Similar current 
augmentation by forskolin was observed across multiple voltages, confirming the presence of 





Drosophila represents a potentially ideal platform for studying regulation of, and diseases 
involving, cardiac Ca2+ channel function and dysfunction. In addition to their genetic pliability, 
flies also possess a Ca2+ channel ensemble akin to that of mammalian cardiac cells. Drosophila 
cardiomyocytes, as shown here, harbor A1D and T-type Ca2+ channels (orthologs of mammalian 
CaV1 and CaV3 channels, respectively (Chorna and Hasan)), which is analogous to the Ca2+ 
channel composition of mammalian cardiomyocytes (Bean, 1985; Nilius et al., 1985; Bodi et al., 
2005). Moreover, Drosophila A1D also possesses striking conservation of two key properties of 
CaV1 channels, which are CDI and PKA-dependent current augmentation.  
In the current study, we show for the first time, that Drosophila cardiomyocytes express 
significantly higher amounts of Ca-α1D and Ca-α1T relative to cacophony mRNA. Functional 
analyses revealed significantly impaired heart tube contraction and decreased Ca2+ transient 
amplitude when Ca-α1D expression was suppressed by RNAi as opposed to a minimal change in 
contractile properties resulting from Ca-α1T or cacophony silencing. These results imply that not 
only is A1D highly enriched in Drosophila cardiomyocytes, but that A1D channels are the major 
contributor to Ca2+ flux responsible for contraction. However, despite an abundance of Ca-α1T 
mRNA, T-type channels were shown to contribute minimally to heart tube contraction. These 
results suggest that there is a potential discordance between Ca-α1T mRNA versus protein load, 
a high transcriptional reserve to ensure an adequate T-type channel stoichiometry, and/or poorly 
effective RNA interference and gene suppression. Direct assessment of plasmalemmal Ca2+ 
currents in cardiomyocytes that are genetically devoid of T-type channels could reveal insight 
into this discrepancy.    
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Although multiple reports previously described changes in contraction rates or chamber 
dimension of intact heart tubes during larval (Gu and Singh, 1995; Zornik et al., 1999; Cooper et 
al., 2009) and pupal (Johnson et al., 1998; Johnson et al., 2002) stages, at baseline or in response 
to pharmacological manipulation, the effort to directly probe plasmalemmal currents in adult 
Drosophila cardiomyocytes is still in its infancy. Field potentials across the surface of the heart 
tubes were recorded (Papaefthmiou and Theophilidis, 2001; Cooper et al., 2009) while a 
rudimentary current clamp recording performed by inserting electrodes into intact hearts 
successfully measured transmembrane voltages (Dulcis and Levine, 2005; Ocorr et al., 2007a; 
Ocorr et al., 2007b). However, the gold standard to directly probe plasmalemmal current is the 
voltage clamp technique, which yields high resolution data when performed on single cells as 
opposed to cellular networks. Voltage clamp experiments have been carried out on neurons of 
Drosophila embryos (Peng and Wu, 2007), pupae (Gu et al., 2009), and adult (Gu et al., 2009) 
brains, motoneurons of adult indirect flight muscle (Ryglewski et al., 2012), motoneurons of 
larval body-wall muscle (Worrell and Levine, 2008), larval retinal cells (Sullivan et al., 2000), 
and larval body wall muscles (Gielow et al., 1995; Ren et al., 1998; Bhattacharya et al., 1999). 
However, to date, no report describes voltage clamp recordings of adult Drosophila 
cardiomyocytes despite multiple well-established methods for isolation of mammalian 
cardiomyocytes in various species. Therefore, based on these approaches, we developed a 
method to enzymatically dissociate viable single cardiomyocytes from Drosophila heart tubes.  
Following brief enzymatic digestion of adult Drosophila cardiac tubes, we obtained 
viable individual cardiomyocytes that appeared well suited for electrophysiological studies. As 
reported for vertebrate cardiomyocytes, which show a significant 17% reduction in sarcomere 
length upon isolation from the intact heart (Bub et al., 2010), fly sarcomeres likewise displayed 
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reduced lengths following cardiomyocyte dissociation. Comparing the sarcomere lengths from 
cells of semi-intact relative to those of detached heart tubes revealed that changes in sarcomere 
length did not transpire in response to heart removal from the abdominal segment. Moreover, 
incubating the hearts in artificial hemolymph blebbistatin, a myosin ATPas inhibitor, did not 
prevent sarcomere shortening upon cell-to-cell detachment. These findings suggest that the 
change in sarcomere length was not due excessive or unregulated Ca2+-mediated tension or 
active actomyosin-based contraction in general. The heightened sarcomeric shortening event that 
occurs upon fly vs. rat cardiomyocyte isolation (i.e. ~40% vs. 17% reduction in sarcomere 
length) may be related to several factors. Firstly, the extreme geometric constraints that are 
imposed upon fly cardiomyocytes, due to two opposing cells establishing the tubular nature of 
the organ, are partially released following proteolytic digestion. Consequently, relatively large 
changes in Drosophila myofibril and sarcomere deformation are therefore expected to occur in 
conjunction with changes in cellular stress/strain upon isolation. Secondly, the Z-discs of 
Drosophila cardiomyocytes are discontinuous or “perforated”, which allow muscles to contract 
to greater than 50% of their resting lengths (Vigoreaux, 1994), a significantly larger degree of 
sarcomere length changes relative to those of vertebrate cardiomyocytes. 
Despite the exaggerated changes in sarcomere length that transpire upon dissociation, we 
show that Drosophila cardiomyocytes are exceptionally amenable to voltage clamp experiments. 
We confirmed the presence of Ca2+ currents through both A1D and T-type Ca2+ channels, which 
are remarkably similar to the those observed in mammalian cardiomyocytes (Bean, 1985; Nilius 
et al., 1985). In mammals, T-type or CaV3 are activated at lower potentials and open with a small 
conductance (Bean, 1985; Nilius et al., 1985), hence the namesake 'T' for tiny current. Cardiac 
LTCCs or CaV1.2, however, are activated at relatively higher potentials compared to CaV3 with 
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higher pore conductance (Bean, 1985; Nilius et al., 1985) ('L' for large current) and, thus, are 
better-suited to drive the shape and duration of the cardiac action potential (Nerbonne and Kass, 
2005). As heart tube contraction is the end-point of a multi-step process, from pacemaker cells 
firing, action potential transmission to myocytes, and Ca2+-centric conversion of electrical to 
mechanical activities, alteration in contractile properties could stem from modulations of any of 
these critical steps. T-type Ca2+ current was proposed to play a modulatory role in pacemaking, 
which is predominantly driven by a Na+/Ca2+ exchanger-dependent Ca2+ clock (Maltsev et al., 
2004; Maltsev and Lakatta, 2007). Therefore, consistent with our finding, suppression of Ca-α1T 
expression by RNAi minimally affects the contractile properties of the heart tubes. LTCCs, on 
the other hand, are responsible for transsarcolemmal Ca2+ flux that triggers the Ca2+-induced 
Ca2+ release from the sarcoplasmic reticulum leading to cardiomyocyte contraction. Hence, it is 
not surprising that Ca-α1D knock down nearly abolishes the heart tube contraction (Figure 6.2). 
Most interestingly, Drosophila A1D also shares key modulatory elements with those of 
mammalian CaV1.2, which include CDI and PKA-mediated current augmentation. This 
conservation of channel modulations might hint at the evolutionary importance of this channel 
and thus their tightly controlled functions. 
In summary, Drosophila proves to be an efficient platform to study regulation of and 
diseases involving cardiac Ca2+ channels. Due to its genetic versatility, readily available tools, 
and multiple modalities for functional assessment, screens to dissect physiological or 




6.5 Tables and figures 
Table 6.1 Sarcomere lengths (µm) in all configurations and conditions. 
mean±SE 
(n) 
Low Ca2+ Blebbistatin DMSO 



































Figure 6.1 Ca-α1D and Ca-α1T transcripts are abundant in Drosophila heart tubes. (A) 
Confocal micrograph of a wild-type w1118 Drosophila heart tube extending along the dorsal side 
of the abdomen. The anterior conical chamber is outlined and displayed in B. Note the non-
cardiac alary muscles (AM) attaching to the heart tube. RT, retractors of tergite muscles. Scale 
bar = 100 µm. (B) Micrograph of the conical chamber after Ca-α1D (red) and GAPDH (white) 
mRNA molecules were labeled by FISH. A representative small region of a single 
cardiomyocyte used for mRNA quantitation is outlined in grey. VM, ventral muscle; PC, 
pericardial cell. Scale bar = 25 µm. (C) Examples of Ca2+ channel mRNA particle densities in an 
area of interest (e.g. grey box in Figure 1B) and the quantitative determination of the number of 
Ca2+ channel messages normalized to the number of GAPDH messages within the same region of 
interest. There are significantly more Ca-α1D and Ca-α1T Ca2+ channel transcripts compared to 
























Figure 6.2 Cardiac contraction and Ca2+ transients are suppressed by A1D knockdown. (A) 
The Drosophila UAS-GAL4 bipartite expression system. Cardiac-specific TinCΔ4-Gal4 drives 
expression of UAS-transgenes including the simultaneous expression of a Ca2+ biosensor (UAS-
GCaMP3) and UAS-RNAi. (B) Exemplar M-mode tracings of heart tubes with A1D, cacophony 
(cac), or T-type (tt) Ca2+ channels knocked down. w1118 and injection lines (KK) crossed with the 
driver line serve as controls. A1D knockdown completely suppresses contraction. (C) 
Quantitative measurements of cardiac physiological parameters. Population data confirm 
substantially altered contraction following A1D suppression. *** p < 0.0001 compared to w1118; 
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## p < 0.01 compared to KK. There are no significant differences in cardiac variables between 
the controls. (n=31, 25, 30, 25, and 28, respectively) (D) Representative Ca2+ transient 
recordings from the same population of heart tubes examined in B-C. Ca-α1D knockdown 
completely suppressed Ca2+ transients in the heart tubes. (E) Measurements of Ca2+ transients 
confirm a significant reduction in Ca2+ transient frequency and magnitude of the peak Ca2+ 
transient upon Ca-α1D RNAi expression. The time required to reach the peak Ca2+ transient 
magnitude (time to peak) and the time constant for the Ca2+ transient decay (tau decay) are not 
shown for A1D(-)#1 and A1D(-)#2 because of inaccurate measurements due to minimal Ca2+ 
activity in these heart tubes. Suppression of cacophony or Ca-α1T produces no significant 
change in Ca2+ transient frequency, Ca2+ transient magnitude, time to peak, or tau decay. *** p < 



















Figure 6.3 Isolated Drosophila cardiomyocytes and their sarcomere length. (A) Isolated 
cardiomyocytes from GFP-Zasp52 heart tubes where z-lines are highlighted by GFP 
fluorescence proteins. Displayed in multiple orientations, all cells maintained the curved shape. 
Cells were suspended in low-Ca2+ hemolymph. Scale bar 20 µm. (B) Sarcomere length for the 
three configurations (semi-intact hearts, detached hearts, and isolated cells) under three 
conditions (low Ca2+, DMSO, and 0.1 mM blebbistatin). Sarcomere length was significantly 
shorter in isolated cells compared to the semi-intact and detached hearts for all three conditions. 
(C) Magnified images of sarcomeres treated with 0.1 mM blebbistatin. Sarcomeres of the 
isolated cardiomyocytes are significantly shorter than those in semi-intact and detached heart 















Figure 6.4 Ca2+ current recordings confirm A1D channels conduct the predominant 
transsarcolemmal Ca2+ current in Drosophila cardiomyocytes. (A) Ca2+ current recording of 
dissociated fly myocytes. The current in wildtype cardiomyocytes is suppressed by a 
dihydropyridine, nifedipine, a hallmark of CaV1 channels. (B) Mean peak current density in 
control, hypomorphic cacophony (cac(s)), and T-type null cardiomyocytes across test potentials. 
At high voltages, comparable to the plateau phase of mammalian cardiac action potentials, peak 
currents of cac(s) hypomorphic and T-type (null) cardiomyocytes are similar to that observed in 
control, indicating that A1D is the major high-voltage-activated Ca2+ channel isoform in the 
Drosophila heart. At low voltages, T-type (null) cardiomyocytes show reduced current densities, 
suggesting a contribution of T-type channels at low activation voltages. * p < 0.5 compared to 
control. (n=4, 6, and 4 for control, Cac (s), and T-type (null)). (C) Population data of the Ca2+ 

















Figure 6.5 Ca2+-independent inactivation is a conserved feature of Drosophila A1D. (A) 
Illustration of the alpha subunit of the vertebrate LTCC with CDI interface regions NSCaTE, two 
EF hands, and the IQ domain shown in yellow, rose, green, and blue respectively. Sequence 
comparison of Oryctolagus’s CACNA1C and Drosophila’s A1D with CDI interface regions 
highlighted in the same color as in the diagram on the left. The binding sites of Ca2+-free CaM 
(apoCaM) are highlighted in grey with key amino acid residues interacting with N-, C-, and both 
lobes of apoCaM bolded in blue, red, and black. (B) Ca2+ currents in fly cardiomyocytes decay 
more rapidly than Ba2+ currents in the same cell, demonstrating CDI (shaded rose) as Ba2+ 
cannot effectively bind calmodulin. (C) Population data showing the fraction of current 
remaining after 300 ms of activation (r300). The different degree of decay between Ca2+ and Ba2+ 









Figure 6.6 Ca2+ current augmentation by protein kinase A is conserved in Drosophila 
cardiomyocytes. (A) Depiction of the β-adrenergic pathway. Epinephrine binds to a G-protein 
coupled receptor and activates the enzyme adenyl cyclase receptor, which converts ATP to cyclic 
AMP (cAMP). This small signaling molecule activates protein kinase A (PKA), which 
phosphorylates LTCCs, augmenting their current size. Phosphodiesterase (PDE) deactivates 
cAMP. Forskolin bypasses this signaling cascade by directly activating adenyl cyclase. 
Drosophila homologs of β-adrenergic pathway elements are in parentheses. Oct, octopamine. (B) 
Ca2+ current in Drosophila cardiomyocytes increases in amplitude after application of 10 µM 





6.6 Supplementary materials 
6.6.1 Homo sapiens and Drosophila melanogaster Ca2+ channel classes 
There are three major classes of voltage-gated Ca2+ channels in mammals, including 
Homo sapiens. Each class contains multiple channel subtypes with different biophysical 
properties, tuned to best serve their biological functions. While class III channels are found in 
various types of tissues, class I channels are commonly found in cardiovascular, muscular, and 
nervous systems and class II channels are mostly responsible for neuronal activities(Hofmann et 
al., 1994). Intriguingly, Drosophila also possess three major classes of voltage-gated Ca2+ 
channels although each contains only one subtype(Chorna and Hasan), reflecting the relative 
genetic simplicity of this animal model. Supplementary Table 6.1 summarizes Drosophila 












6.6.2 Negative controls for fluorescence RNA in situ hybridization in Drosophila cardiomyocytes 
In order to ensure that the fluorescence signal from the complex between voltage-gated 
Ca2+ channel subunit mRNA molecules and custom designed probes was not the result of 
nonspecific artifacts, heart tubes were also incubated with a probe designed to target human 
alpha-fetoprotein (h-AFP), which is not found in Drosophila. This negative control probe was 
simultaneously mixed with probes targeting Drosophila Ca2+ channel subunits and the house-
keeping gene GAPDH. Supplementary Figure 6.1 shows a lack of signal from the h-AFP probe 
and the presence of a GAPDH signal, which confirms the specificity of this fluorescence RNA in 







Supplementary Figure 6.1 Treatment of Drosophila heart tubes with probes targeting human AFP 
mRNA yields limited fluorescence signals. The same heart tube regions shown in Figures 6.1B-C are 
displayed above. Here, however, only the fluorescence channels for probes against h-AFP (green) and GAPDH 
(white) are presented. The insets reveal the presence of specific voltage-gated Ca2+ channel subunit mRNA 
molecules (from Figure 6.1C). VM, ventral longitudinal muscle layer; PC, pericardial cells; RT, retractors of 
tergite muscles. Scale bar = 25 µm. 
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6.6.3 Post-developmental suppression of A1D expression hampers Drosophila heart tube 
contraction 
 Ca-α1D silencing during and after heart tube development leads to cessation of 
myocardial contraction and the generation of Ca2+ transients (Figure 6.2) in adult flies. However, 
it is plausible that A1D only plays a role during development and is not the key driver of 
contraction in mature hearts and, therefore, phenotypes of cardiac tubes with suppression of Ca-
α1D expression post developmentally must be explored. To this end, expression of A1D 
channels was suppressed by RNAi driven by a chemically inducible cardiac-specific promoter. 
Upon supplementing fly food with RU486 two days post-eclosion, and activation of RNAi 
expression, the heart tubes displayed significantly lower fractional shortening and shortening 
velocities (Supplementary Figure 6.2). The effect, however, was not as severe as that observed 
when the A1D expression was silenced throughout cardiogenesis and adulthood (Figure 6.2). 
Therefore, it is likely that A1D channels play a role in the developing heart tube and are also 
required for proper function of mature hearts.  
  
Supplementary Figure 6.2. Adult-specific, cardiac-
restricted suppression of A1D expression. (A) The 
Drosophila Hand-GS-GAL4 inducible expression 
system. Cardiac-specific Hand-Gal4 drives 
expression of UAS-RNAi upon induction by RU486. 
(B) Inducible cardiac-specific knockdown of A1D 
post-developmentally engenders functional 
consequences similar those observed when A1D is 
silenced during and after heart development. *** p < 




6.6.4 Quantitation of Ca2+ channel transcripts in various experimental conditions 
  To ensure sufficient Ca2+ channel suppression by RNAi prior to functional assessment 
(Figure 6.2), the amount of channel transcripts in the female progenies’ hearts was quantitated 
using the fluorescence RNA in situ hybridization (FISH) technique. More than half of the Ca2+ 
channel transcripts were knocked down by RNAi (Supplementary Figures 6.3A, B, D).  
Moreover, the amount of cacophony and Ca-α1T transcripts in the hypomorph and null 
lines, respectively, was measured prior to the Ca2+ current measurement (Figure 6.4). In cacS 
line, a missense mutation (Phe to Ile mutation) is introduced into the S6 segment of domain III 
which results in reduction of current density (Smith et al., 1996; Smith et al., 1998).  This 
mutation renders decreased transcription of the cacophony gene (Supplementary Figures 6.3C). 
In Ca-α1T null line, the proximal 50 kbp of the Ca-α1T gene was deleted (Ryglewski et al., 
2012). All of our designed FISH Ca-α1T mRNA probes lie in this 50-kbp deleted region.  
  
Supplementary Figure 6.3. Ca2+ channel transcripts in heart tubes in various experimental conditions. 
(A) Expression level of Ca-α1D transcripts in control and Ca-α1D RNAi-knockdown lines. *** p < 0.001, n = 
9, 8, and 10 hearts for Ctrl, Ca-α1D(-)#1, and #2, respectively. (B-C) The amount of cacophony transcripts after 
RNAi knockdown (n = 9, 10) (B) and in the cacS, a cacophony hypomorph line (n = 7, 7) (C). (D-E) The 
amount of Ca-α1T transcripts after RNAi knockdown (n = 10, 11) (D) and in the Ca-α1T null, a line with a 






6.6.5 Viable single cardiomyocytes after enzymatic dissociation from adult Drosophila heart 
tubes 
As single cardiomyocytes are the mainstay of cellular electrophysiology, we devised a 
method to dissociate single cardiomyocytes from adult Drosophila hearts. Here, enzymatic 
digestion was utilized and the protocol was optimized to obtain the greatest number of single fly 
myocytes while maintaining their viability. The isolated cardiac cells continued to spontaneously 
contract regularly at room temperature as evident by the presence of fluorescently monitored 
Ca2+ transients (Supplementary Figure 6.4). 
 
  
Supplementary Figure 6.4 Single 
cardiomyocytes from Drosophila heart tube 
dissociation are viable. (A) An intact GFP-
ZASP52 Drosophila heart tube in cross section 
demonstrating two opposing C-shaped 
cardiomyocytes (CM) forming a hollow tube 
covered by the ventral longitudinal muscle layer 
(VM). (B) Isolated GFP-ZASP52 
cardiomyocytes after dissociation maintain their 
curved morphology. (C) Isolated myocytes from 
TinCΔ4-Gal4 > UAS-GCaMP5 flies remain 
viable after enzymatic digestion as evident by the 
presence of fluorescently monitored Ca2+ 
transients. Cells were imaged under a Nikon 
TE300 Eclipse fluorescence microscope and 
signal intensity was measured by a custom 
fluorometer (University of Pennsylvania 




6.6.6 Supplementary Methods 
Post-developmental suppression of A1D channel expression in adult Drosophila heart tubes 
Female virgins harboring the inducible Hand-GS-Gal4(Nicholson et al., 2008) cardiac-
specific driver (a kind gift from Dr. Rolf Bodmer) were crossed with males obtained from the 
Vienna Drosophila RNAi Stock Center carrying a cassette of UAS-RNAi targeting the A1D 
subunit of Ca2+ channels (Catalog No. 51491). Two-days post-eclosion, adult progeny were 
placed on food supplemented with 100 µg/ml of RU486 (dissolved in 100% ethanol) or vehicle 
(100% vehicle). Flies were transferred onto new food every day to ensure constant exposure to 
the drug or vehicle. At two weeks, flies were dissected(Vogler and Ocorr, 2009) to expose the 
heart tubes and contractions were imaged and quantified as described in the main text. 
Quantitation of Ca2+ channel transcripts in various experimental conditions 
 Prior to functional assessment, the amount of Ca2+ channel transcripts was assessed using 
the fluorescence RNA in situ hybridization (FISH) technique. The experimental procedure, 
measurement, and statistics are described in the main text. For the Ca-α1D RNAi knockdown 
experiment, TinCΔ4-Gal4 was crossed with either w1118 (Ctrl) or UAS-Ca-α1DRNAi: 51491 or 
52644 (Ca-α1D(-)#1, or #2, respectively). Five days post eclosion, the heart tubes of the 
progenies were surgically exposed and underwent an in situ hybridization using a fluorophore-
tagged probe custom designed to target Drosophila mRNA coding for Ca-α1D (VF4-18190). For 
the cacophony and Ca-α1T RNAi knockdown experiments, TinCΔ4-Gal4 was crossed with 
either KK injection line (Ctrl), UAS-cacophonyRNAi: 104168, or UAS-Ca-α1TRNAi: 108827. 
Custom designed probes targeting cacophony (VF4-18657) and Ca-α1T (VF4-18658) were 
utilized, respectively. For the cac hypomorph and T-type null lines, we used Canton-S as a 
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control to match the background genetic of these two lines (Smith et al., 1996; Smith et al., 1998; 
Ryglewski et al., 2012).  
Heart tube morphology 
Confocal microscopy was performed as detailed by Alayari et al. (2009)(Alayari et al., 
2009). Briefly, w1118 Drosophila hearts were surgically exposed according to the method of 
Vogler and Ocorr (2009)(Vogler and Ocorr, 2009) and arrested using 10mM EGTA in artificial 
hemolymph. The relaxed, semi-intact hearts were fixed (4% formaldehyde in 1X PBS) and 
washed three times with 1X PBST (PBS with 0.1% Triton X-100). Fixed hearts were then 
stained with Alexa594 TRITC-phalloidin (1:1000 in PBST), rinsed three times in 1X PBST, 
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